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The integrity of endothelial cell-cell junctions is required for the maintenance 
of normal physiological processes. The expression of junctional proteins is particularly 
important in the endothelial cells of the blood-brain barrier (BBB), the cellular unit that 
protects the brain via regulated transport between the peripheral blood and the central 
nervous system. Dysfunction of the BBB is linked with decreased junctional protein 
localization and is implicated in several diseases including Alzheimer’s disease and 
multiple sclerosis. On the other hand, the tight junctions of the BBB impede the 
delivery of medications targeting the brain. Therefore, understanding the key players 
driving junction stability could hold significant promise for therapeutic discovery and 
drug delivery applications. Despite this, the mechanisms underlying junction disruption 
aren’t fully understood. While several studies have linked different junction protein 
patterns with altered barrier function, the quantification of this parameter remains 
  
limited due to the lack of efficient measurement techniques. Here, we aimed to 
investigate the influence of junction phenotype on brain endothelial barrier properties. 
To accomplish this, we developed the Junction Analyzer Program (JAnaP) to semi-
automatically calculate edge-localization protein phenotypes.  
Application of the JAnaP to measure the junctional proteins VE-cadherin and 
ZO-1 in different physiological and pathophysiological conditions revealed that 
discontinuous junctions contribute more to barrier permeability compared to 
continuous, linear junctions. Continuous junctions were also increased in endothelial 
cells with decreased contractility, mediated biochemically or by lowered 
subendothelial matrix stiffness. Finally, breast cancer cell secreted factors increased 
immature adherens junctions, likely through VEGF signaling, but minimally affected 
tight junction presentation. Thus far, the development and application of the JAnaP has 
revealed insights into the effects of junction patterns on barrier function, the 
mechanobiology of endothelial cells, and the response of brain endothelial cells to 
biochemical cues involved in breast cancer metastasis. Understanding the conditions 
driving altered junction presentation, and the resultant effects on barrier integrity, could 
lead to the development of therapeutics capable of traversing the BBB for delivery to 
the brain or for diseases associated with BBB dysfunction. Future use of this program 
holds significant potential for physiological and pathophysiological study in various 
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 - Introduction 
The blood-brain barrier (BBB) is the cellular unit that modulates transport 
between the circulatory and central nervous systems, thereby maintaining homeostasis 
of the brain microenvironment [1]. One role of the BBB is to protect the central nervous 
system from potentially toxic substances circulating in the blood. As a result, it also 
serves as a barrier for most therapeutic delivery into the brain. On the other hand, 
breakdown of this barrier is implicated in several neurological and neurodegenerative 
diseases, including cancer metastasis, Alzheimer’s disease, Parkinson’s disease, 
multiple sclerosis, and stroke [2–4]. The mechanisms of BBB breakdown, however, 
remain elusive. BBB disruption is reportedly associated with two phenomenon: (1) 
increased permeability (of proteins and molecules) and (2) massive cellular infiltration 
across the barrier [5]. In multiple sclerosis, for example, clinical symptoms have been 
found to correlate with a loss of junctional proteins at the BBB and an increase in 
adhesion molecules (e.g. ICAM-1, VCAM-1) on the surface of brain endothelial cells 
leading to elevated immune cell trafficking in the brain [5]. Still, in most diseases it 
remains unknown at which stage of progression (early versus late) the dysfunction 
occurs, which is critical for the development of therapeutics to prevent disease initiation 
or progression.  
The World Health Organization predicts that by 2040, neurodegenerative 
diseases will become the second leading cause of death, exceeding cancer [6]. Current 
therapeutics for many of these disorders strictly target symptom management, rather 
than serving as corrective measures. As such, significant focus in the field has shifted 




pathophysiology of this barrier and its related diseases to enable (1) more efficient 
development of barrier-penetrating therapeutics, and (2) mechanistic study of BBB 
dysfunction to identify targets for therapeutics development.  
 
The BBB is composed of brain microvascular endothelial cells (BMECs), 
which sit upon a basement membrane primarily consisting of laminin, collagen type 
IV, and fibronectin (Figure 1.1, recreated based on [7]) [8]. This unit is reinforced by 
physical and biochemical interactions with neural cells such as astrocytes and pericytes, 
further enhancing the selectively permeable barrier properties [9,10]. BMECs express 
tight junction proteins (e.g., occludins, claudins), which anchor to actin cytoskeleton 
via zonula occludens (e.g., ZO-1) (Figure 1.2) [11–13]. The tight junctions work 
cooperatively with adherens junctions (e.g. vascular endothelial cadherin, VE-
cadherin) to organize and stabilize the cell monolayer and regulate junctional tension 
[14]. The integrity of these junctions is required for the maintenance of normal 
Figure 1.1. Schematic of the Blood-Brain Barrier. Cerebral endothelial cells wrap 
around and form tight junctions with themselves to create the microvasculature of the 
brain. Pericytes and astrocytes within the brain microenvironment wrap around and 
support the capillaries, which are enclosed by the basement membrane or basal lamina. 
 
Figure 1.1 Schematic of 




physiological processes. Therefore, understanding the key players driving junction 
stability could hold significant promise for therapeutic discovery.  
 
Despite this, the mechanisms underlying junction disruption aren’t fully 
understood. This is largely due to the lack of efficient techniques to quantify the 
junctional proteins as they are presented at the cell edge. Importantly, previous studies 
have linked the edge-presentation of VE-cadherin with junction and barrier maturity. 
Specifically, linear VE-cadherin structures parallel to the cell boundary are considered 
to be stable and mature, while immature junctions take the form of discontinuous focal 
adherens presenting a punctate or serrated morphology [15]. Therefore, a useful 
parameter in evaluating monolayer integrity is the amount of mature (i.e., continuous 
Figure 1.2. Schematic of the Cell-Cell Junctions in the BBB. Simplified and 
incomplete schematic presenting the components of the tight and adherens junctions.  
Claudins and occludin form the tight junctions, in addition to the junctional adhesion 
molecules (JAMs) and the endothelial selective adhesion molecule (ESAM). The most 
important adherens junction protein in endothelial cells is vascular endothelial cadherin 
(VE-cadherin), but, the platelet–endothelial cell adhesion molecule (PECAM) is also 
present. Several first-order adaptor proteins interact with the junctions within the 
cytoplasm, including zonula occludens 1, 2, and 3, (ZO-1,2,3), p120, and β- and γ-catenin. 
These can bind to other proteins such as cingulin, α-catenin, vinculin, and α-actinin, which 










or linear) versus immature (i.e., discontinuous) junctions localized at the cell perimeter. 
Quantification of this parameter, however, remains cumbersome since most current 
methods rely on manual, tedious measurement techniques. Here, we aimed to address 
this gap by developing the Junction Analyzer Program (JAnaP), a semi-automated 
program capable of measuring the percent of a cell perimeter covered by continuous 
and discontinuous junction, or no junction, as well as other characteristic junction 
parameters.  
The overall objective of this dissertation was to investigate cell-cell junction 
phenotypes and their effects on endothelial barrier properties. We accomplished 
this by developing the JAnaP to quantify junction presentation, then applied this 
tool to understand the junctional changes involved in BMEC physiology and 
pathophysiology (Figure 1.3).  In Chapter 4, the establishment of standardized 
junction phenotypes is discussed, as well as the development and validation of the 
JAnaP to semi-automate the analysis and quantification of these junction presentations. 
In Chapter 5, the influence of basic culture parameters (e.g., culture time and substrate 
protein) on junction phenotype is investigated, as well as how junction patterns 
contribute to the permeability of the endothelial barrier. In Chapter 6, the effects of cell 
contractility and substrate stiffness on junction presentation are presented, and finally, 
in Chapter 7, the effects of breast cancer cell secreted factors on junctions in the context 





Figure 1.3. Dissertation Overview. 




 - Background 
2.1 Endothelial Cells and Cell-Cell Junctions 
2.1.1 Vasculature 
The vascular system provides the perfusion of nutrient-containing blood 
throughout the body, with blood vessels serving as the connection between all tissues 
and organs. Blood vessels are composed of endothelial cells (ECs) which line the inner 
surface and sit upon a basement membrane comprised of extracellular matrix (ECM) 
proteins (e.g. collagen type-IV, laminin, fibronectin, perlecan, agrin). The vasculature 
operates with selective permeability to mediate the transfer of ions, molecules, cells, 
and other materials from the luminal space to the adjacent tissues, and vice versa. It 
acts as a key regulator of immune responses and wound healing processes, and is 
implicated in the progression of several diseases [16]. Thus, there is significant 
motivation for the study of the vasculature and EC function.  
Vasculature is primarily categorized into arteries, veins, and capillaries (Figure 
2.1, from [17]). Arteries are thick-walled conduits that carry oxygenated blood away 
from the heart in a pulsatile manner. They contain long and narrow ECs that align in 
the direction of flow [18]. Veins are thin-walled conduits that carry de-oxygenated 
blood back to the heart, contain valves, and are not pulsatile [18]. They contain shorter 
and wider ECs that do not align in the direction of flow. Capillaries are thin, small 
vessels (less than 10 μm in diameter) with slow blood flow and are responsible for most 
of the diffusive exchange between the blood and the surrounding tissues. ECs also line 




Figure 2.1. Organization of the Vasculature. The vasculature is organized into hierarchical 
networks of arteries (red), veins (blue) and interconnected capillaries, as well as lymphatic 
capillaries and collecting vessels (green) that drain fluid into the venous circulation. 
Arterioles, capillaries and venules constitute the microvasculature, the site where most 
intercellular communication occurs. Large arteries and veins are characterized by a 
continuous lining of ECs, basement membrane (BM) and layers of smooth muscle cells 
(SMCs). Blood capillary ECs can be continuous, fenestrated or discontinuous, and they have 
varying extents of BM and pericyte coverage. Lymphatic capillaries consist of oak-leaf-
shaped ECs with specialized button-like junctions and anchoring filaments that pull the ECs 
apart and allow the entry of fluid under conditions of high interstitial pressure. Collecting 
lymphatic vessels have a sparse SMC coverage and luminal values that help with pumping 
and that prevent the backflow of lymph, respectively. The anatomy of capillary vessels is 
shown at the top of the figure and larger vessels are shown at the bottom. The tunica 
adventitia is the outer connective tissue covering of the vessel. Reprinted from Potente, M. 
& Mäkinen, T. Vascular heterogeneity and specialization in development and disease. Nat. 









comprised of lymphatic vessels, lymph nodes, and lymphoid organs [17]. Lymphatic 
vessels are also organized in a hierarchical manner, comprised of lymphatic capillaries, 
pre-collecting vessels and collecting vessels. Excess interstitial fluid is removed by the 
lymphatic capillaries, which also provide an entry site for immune cells residing in the 
tissue to enter the lymphatic system. Collecting vessels, on the other hand, are 
dedicated to the transport of fluid and lymph into ducts that ultimately return to the 
vascular system. The endothelial cells lining each of these vascular and lymph 
categories have different phenotypes and contain different protein and trafficking 
structures to reflect their respective function and surrounding mechanical environment. 
Endothelia are categorized as continuous or discontinuous, depending on the 
gaps and transport properties associated with the respective vascular bed. Continuous 
endothelium is further categorized as non-fenestrated or fenestrated, where increased 
filtration or transendothelial transport is observed [19]. The arteries, veins and 
capillaries of the heart, skin, lung and brain are non-fenestrated continuous 
endothelium, while the capillaries of, for example, the exocrine and endocrine glands, 
are categorized as continuous fenestrated endothelium. Fenestrae are transcellular 
pores, approximately 70 nm in diameter, that span the thickness of the EC and are 
typically covered by a 5 nm non-membranous diaphragm [19]. Discontinuous 
endothelium, on the other hand, contains much larger fenestrae, approximately 100 to 
200 nm in diameter, and are not covered by a diaphragm. This endothelial category 
comprises the liver and some sinusoidal vascular beds. These differences in endothelial 
barrier structure translate to different transport and permeability properties. It is 




small solutes, while transcellular shuttling via membrane-bound vesicles is used to 
move macromolecules across EC barriers.  Basal permeability is therefore governed by 
the presence or absence of fenestrae, the activity of the transcytotic machinery, and the 
properties of the junctional adhesion proteins mediating EC-to-EC interaction [19]. For 
the purposes of this dissertation, the focus will be specifically on cell-cell adhesions.       
Endothelial cell-cell adhesions include tight junctions (TJs), adherens junctions 
(AJs), gap junctions, and other adhesion molecules (e.g. PECAM-1) [20]. Tight and 
adherens junctions are involved in cell-to-cell contact, while gap junctions regulate the 
flow of water, ions, and small molecules between adjacent ECs [21]. Junction 
complexes are formed at sites of cell-to-cell contact by transmembrane proteins that 
form homophilic dimerized structures with the identical protein on neighboring cells. 
These proteins also link to various intracellular components, which tether to the 
cytoskeleton [22]. The integrity of these protein complexes is critical for vascular 
function since they play a key role in regulating cell behavior in both quiescent and 
activated (e.g., inflammation, angiogenesis) states, [21] influencing cell proliferation 
and apoptosis, the ability of cells to sense their positions, cell migration, cell polarity, 
and tubular structure formation [23]. Vascular dysfunction, including systemic loss of 
junctional integrity, is associated with several diseases including cancer, stroke, 
atherosclerosis, diabetes, hypertension, inflammation, ischemia, [20] Ebola 
hemorrhagic fever, [24] and bacterial sepsis [25,26]. Together, this emphasizes the role 
of junctional proteins in both physiology and pathology [27]. Since the focus of this 
dissertation is on cell-to-cell junctions, the discussion will primarily concentrate on TJs 




2.1.2 Endothelial Adherens Junctions 
 AJs are responsible for the initiation, maturation, and maintenance of cell-to-
cell contacts [23]. They are primarily composed of cadherins, a family of calcium-
dependent proteins. Included in this protein family is epithelial cadherin (E-cadherin), 
placental cadherin (P-cadherin), and heart cadherin (H-cadherin, or T-cadherin). 
Neuronal cells predominately express neural cadherin (N-cadherin), though N-cadherin 
is expressed in several cell types, including ECs and epithelial cells during epithelial-
mesenchymal transition [28,29]. VE-cadherin, also known as CD144, is uniformly 
expressed in ECs, while N-cadherin is more diffuse throughout the cell membrane. The 
two cadherins share the greatest homology in the cytoplasmic domains, containing the 
binding domains for intracellular transcription factors like β-catenin and p120 [28]. β-
catenin or γ-catenin (plakoglobin) connect the cadherins to the actin cytoskeleton, 
while p120 prevents endocytosis of the cadherins to maintain protein levels and 
mediate adhesion strength. These junctions therefore act as signal transducers through 
this tethering and retention of transcription factors, limiting their translocation to the 
nucleus, or by directly engaging signaling proteins or growth factor receptors [30].  
Both VE-cadherin and N-cadherin are important for inhibiting cell proliferation 
and apoptosis [31], but the differences in the extracellular domains contribute to 
differences in protein function, especially during angiogenesis. Specifically, VE-
cadherin is thought to mediate homotypic cell-cell adhesions between ECs, while N-
cadherin facilitates heterotypic interactions between ECs and vascular support cells 
(i.e. vascular smooth muscle cells or pericytes) [28]. Therefore, N-cadherin is up-




blood vessels, while VE-cadherin is increased with barrier maturation, accompanied by 
a down-regulation of N-cadherin. As such, AJs are important during development and 
angiogenesis, whereas TJs form later, requiring AJs for organization.      
 In addition to β-catenin and γ-catenin, AJs also bind to α-catenin which tethers 
to zonula occluden-1 (ZO-1). ZO-1, along with homologous proteins ZO-2/-3, belong 
to the membrane-associated guanylate kinase homologs (MAGUKs), which express a 
PDZ-binding domain responsible for the anchoring of transmembrane proteins to 
cortical actin [21]. There are two splicing variants of ZO-1, an α+ isoform which 
contains an 80-amino-acid α-domain, and an α- isoform that does not contain the α-
domain. While epithelial cells express the α+ isoform, the α- isoform is restricted to 
ECs. During early stages of junction formation, ZO-1 localizes to AJs. As junctions 
become more stabilized, the ZO-1 subsequently moves away to interact with TJs. In 
addition to actin and other transmembrane junctional proteins, ZO-1 is known to 
independently bind ZO-2 and ZO-3, as well as to various signaling molecules and 
transcription factors [32]. 
VE-cadherin can regulate the permeability of EC barriers in several ways. One 
mechanism increasing permeability is the internalization of VE-cadherin via clathrin-
dependent endocytosis. While this process is inhibited by the cytosolic binding of p120 
to VE-cadherin, increased internalization can occur by the activation of the small 
GTPase Rac via non-receptor tyrosine kinase protein, src [23]. Src can phosphorylate 
VE-cadherin, leading to the recruitment of components that drive VE-cadherin 
endocytosis. Notably, Rac can also be activated by VE-cadherin clustering, which can 




contractility is also modulated by various stimuli (e.g. histamine, thrombin), which can 
phosphorylate myosin light chain and activate p21-activated kinase (PAK), driving 
increased contraction and resultant increases in permeability [34]. This mechanism of 
contraction-induced permeability is the result of centripetal contraction of the 
actomyosin ring exerting a pulling force on the junctional complexes (including TJs), 
since the junction proteins link to the actin cytoskeleton via actin-associated proteins 
such as ZO-1 [35]. Finally, VE-cadherin can also be cleaved via enzymatic proteolysis 
to increase permeability [12]. This mechanism is especially important when 
considering the disruption of junctions for the transmigration of other cells such as 
leukocytes and tumor cells, which can secrete these enzymes to promote extravasation 
and vascular leakiness [23]. 
 VE-cadherin can also play a significant role in EC migration, proliferation and 
apoptosis. The inhibition of cell apoptosis is influenced by the interaction of p85, a 
component of the phosphatidylinositol 3-kinses (PI3K), to the VE-cadherin/catenin 
complex. Decreased VE-cadherin is associated with increased susceptibility of ECs to 
pro-apoptotic stimuli, since VE-cadherin clustering activates PI3K and Akt 
phosphorylation, which inhibits apoptosis. VE-cadherin also effects EC response to 
vascular endothelial growth factor (VEGF), influencing cell proliferation [36]. 
Association of VEGF-receptor 2 (VEGFR2) to the VE-cadherin/catenin complex 
contributes to density-dependent growth inhibition. VEGF induces clathrin-dependent 
internalization of VEFR2 where it activates mitogen-activated protein kinase (MAPK) 
and cell proliferation. This internalization process occurs more rapidly in the absence 




reducing VEGR2-signaling and limiting cell proliferation. Furthermore, the expression 
of VE-cadherin positively correlates with the activity of transforming growth factor-β 
(TGF-β), whose signaling influences anti-proliferation and anti-migratory responses in 
ECs [23]. Therefore, VE-cadherin influences EC stabilization by VEGFR2 inhibition 
and TGF-β activation, inhibiting cell growth and motility in mature EC barriers.  
2.1.3 Endothelial Tight Junctions 
 TJs regulate the paracellular flow of ions and solutes, and limit the diffusion of 
lipids and proteins between the apical and basal sides of the cell [23]. As such, they are 
sometimes referred to as the “fence” proteins of the cell-to-cell junctional complexes. 
They are typically located in the apical region of the intracellular cleft, and play an 
important role in establishing apical-basal polarity within the cell barrier [30]. TJs 
develop after AJ maturation, requiring AJ formation for structural organization. TJs are 
primarily composed of transmembrane proteins including occludin, claudins, and 
JAMs. Similar to AJs, these TJ proteins link to several intracellular components such 
as ZO-1/-2/-3 and cingulin [21]. TJs complexes are associated with several signal 
transduction molecules (e.g. G-proteins, protein kinases) and other molecules, and 
therefore play a role in the regulation of EC growth and survival.  
 The claudin protein family comprises more than 20 members, approximately 
22 kDa in size [32]. These proteins span the cell membrane four times, giving rise to 
two extracellular loops known to contribute to the para-cellular permeability. While the 
claudin family comprises several members, claudin-5 is specific to ECs [37]. Evidence 
in the literature suggests that expression of this protein is controlled by VE-cadherin, 




to regulate size and charge selectivity. For example, in the brain, claudin-5 has been 
shown to regulate the flow of small molecules (less than 800 Da) [37]. Furthermore, 
mutations in different claudins to alter their charge has been associated with changes 
in their permeability to different anions and cations, indicating their role as electrostatic 
barriers in the endothelium [39]. Intracellularly, claudins can directly bind the three ZO 
molecules, generating a link between the TJ protein and the actin cytoskeleton [32].        
 Occludin was the first transmembrane member of the TJ architecture to be 
identified [32]. It is approximately 65 kDa in size and spans the cell membrane four 
times, generating two extracellular loops with both termini located intracellularly. This 
protein is associated with cellular adhesion and its variable expression along the 
vascular tree correlates with the permeability of the tissue. It is thought to contribute to 
the passage of non-electrolyte solutes across the barrier, as well as the fence function 
of the TJ complex. Like claudin, it too directly binds the three ZO-1 molecules 
intracellularly, linking to the actin cytoskeleton [32].        
 The JAM family is composed of at least five members including JAM-A (or 
JAM-1), JAM- B, JAM-C, JAM-4, JAM-L, and the coxsackie adenovirus receptor 
(CAR) [20]. JAM-A, JAM-B and ESAM, another protein that has many similarities to 
the JAMs, closely associate with TJs in ECs. These proteins contain PDZ domains 
responsible for anchoring the junction complexes to the actin cytoskeleton and also 
associate with components such as ZO-1 [23]. JAMs and CAR influence EC cell-cell 
interaction, mediate leukocyte transmigration, establish and maintain cell polarity, and 




 The role of TJs in barrier permeability has been vastly studied. It is important 
to note, however, that the signaling pathways involved with TJs have been most 
extensively studied in epithelial cells, along with brain microvascular endothelial cells, 
likely due to the overexpression of these protein complexes in BMECs. Nevertheless, 
the most closely studied regulator of TJs and their role in EC barrier permeability is 
protein kinase C (PKC), the activation of which favors the assembly of nascent or 
growing TJs but weakens the barrier function of mature TJ complexes [38]. For 
instance, compounds that stimulate PKC generally induce the recruitment of ZO-1 [41] 
and occludin [42] in epithelial cells during junction assembly, but have been shown to 
disrupt TJs and increase paracellular permeability when applied to mature BMEC 
monolayers [43]. Activation of PKC has also been shown to decrease permeability by 
decreasing cell contractility via myosin light chain kinase inhibition [44]. Other 
kinases, such as tyrosine kinase and extracellularly regulated kinase 1 and 2 
(ERK1/ERK2) are also known to exert different effects on TJs. For example, inhibitors 
of tyrosine kinase have been shown to prevent reassembly of disrupted TJs, [45] while 
inhibitors of tyrosine phosphatase decreased barrier function when applied to 
established barriers [46]. Stimulation of the ERK1/ERK2 pathways by hydrogen 
peroxide was shown to increase permeability by rearranging occludin localization and 
altering its association with ZO-1, while inhibition of this pathway blocked these 
changes in response to hydrogen peroxide treatment [47].     
 Heterotrimeric G-proteins, which signal through cyclic nucleotides (e.g., cyclic 
adenosine monophosphate, cAMP; cyclic guanosine monophosphate, cGMP), have 




improved TJ structure, has been observed with cAMP elevation both BMECs and in 
vitro BBB models [48–50]. In contrast, elevated cGMP is evidenced to increase 
paracellular permeability, decreasing barrier function [51]. cGMP production is likely 
in response to nitric oxide, the signaling of which influences barrier permeability, since 
a nitric oxide donor is reported to enhance permeability while a nitric oxide inhibitor 
inhibits VEGF-induced permeability [52].  
 In addition to PKC and heterotrimeric G proteins, GTPases of the Rho family 
have also been shown to influence TJs and barrier function. Importantly, these effects 
require a delicate balance, since TJs have been shown to be sensitive to both excessive 
and insufficient levels of GTPase activity [38]. Notably, one effector of this activity is 
Rho-associated kinase (ROCK), which regulates paracellular permeability by myosin-
mediated cellular contractility [53,54]. Together these examples demonstrate the 
numerous mechanisms by which TJs influence EC stability and barrier properties and 
illustrate the overlap between TJ and AJ function.  
2.1.4 Junction Function and Vascular Beds 
 Many of the AJ and TJ proteins described above are universally found along 
the vascular tree. For example, VE-cadherin and claudin-5 are present in most blood 
vessels and in confluent EC in culture [21]. It is important to note that junction 
organization and distribution between vessels in vivo and in vitro is comparable in most 
vessel types [21]. The structure and composition of some junctional complexes, 
however, vary based on the vascular bed to which it belongs, driven by organ-specific 




The endothelium of large arteries display strong junctions since they experience 
high rates of pulsatile blood flow [19]. ECs of the microvasculature, however, display 
varying junction structure. Arterioles typically display the tightest junctions, then 
capillaries, and then venules display junctions “loosest” in nature, likely resulting from 
the need of this vessel type to mediate increased transport of immune cells and plasma 
constituents in response to inflammatory signaling. The microvasculature of the brain, 
Figure 2.2. Example of Junctional Differences Between Vascular Beds. Representation 
of three types of endothelial junctions (left) and the corresponding electron micrographs 
(right). In small arterioles (a,b), EC junctions are tight, probably being formed by TJs 
intermingled with AJs to limit exchange between blood and tissues. In venules (c,d) 
junctions are formed by AJs, and small areas of TJs are frequently concentrated at the 
apical side of the intercellular cleft. In initial lymphatics (e,f), in which intercellular 
junctions control entry (intravasation) and drainage of fluid and cells from tissues, 
junctions are permeable, and endothelial borders have discontinuous button-like junctions 
with intermingled flaps resembling valve-like structures. AJ and TJ proteins are 
concentrated at the buttons and allow the flaps to open freely without disrupting overall 
vascular organization. The most distal collecting lymphatic vessels have continuous 
zipper-like junctions similar to those of blood vessels (not shown). In addition to AJ and 
TJ proteins, other junctional adhesive proteins and intracellular partners are present at 
endothelial junctions but, for simplicity, are not reported here. (scale bars = 1 µm) 
Reprinted from Dejana, et al., Organization and signaling of endothelial cell-to-cell 
junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res. 












however, is extremely unique (Figure 2.3, from [5]). Here, TJs are overexpressed for 
tighter regulation of permeability between the blood and the central nervous system. In 
areas where a more dynamic exchange between blood and tissue is required (e.g., in 
post capillary venules), the junctions are structured to allow for more leakage [21]. 
Another unique junction structure is found in lymphatic vessels, since they require a 
high volume of solute and leukocyte passage. To allow for this, the lymphatic ECs 
contain intermingled “flaps” and “buttons”. The “button-like” regions contain 
concentrated TJs and AJs, while the “flap regions” contain PECAM, known to promote 
leukocyte trafficking. This allows the “flaps” to open without disruption of the 
junctional structures [55]. Notably, as lymphatic vessels become more distal, the 
junctions begin to resemble the blood vessel endothelium with more continuous 
“zipper-like” junctions.  
Figure 2.3. Image of BBB Junctions. Left: Electron microscopy of rat brain section 
showing a tight junction (TJ) between two cerebral endothelial cells. Right: Schematic 
view of cerebral TJ. Cerebral endothelial cells have close intercellular contacts due to the 
presence of TJs constituted by transmembrane proteins: occludin, claudins (claudin-3 and 
-5) associated with actin cytoskeleton via cytosolic proteins, such as the ZO family. 
Peripherally to TJs are localized JAMs and proteins of Adherens Junctions (AJs), such as 
VE-cadherin which is also associated with actin cytoskeleton via catenins. Reprinted from 
Weiss, N., et al., The blood-brain barrier in brain homeostasis and neurological diseases. 
Biochim. Biophys. Acta - Biomembr. 1788: 842–857, 2009 with permission from Elsevier.  






2.1.5 Relevance to Dissertation 
 The focus of this dissertation is on the microvasculature of the brain. Disruption 
of the BBB, and specifically, alterations in junctional protein expressed within the 
endothelium, is implicated in many neurogenerative diseases [2]. As such, 
understanding the mechanisms driving these dysfunctional states could lead to 
therapeutic discovery for these otherwise often untreatable ailments. On the other hand, 
because the junctions of this barrier are overexpressed to tightly regulate permeability, 
most brain-targeted therapeutics are unable to penetrate the intact brain capillaries. This 
simultaneously drives the need to understand how to modulate junction presentation to 
circumvent this, to inform new treatment delivery methods.  
Here, VE-cadherin, ZO-1, and to some extent, claudin-5, have been the focus 
of study. Many of the current techniques to study cell-cell junctions rely on the 
measurement of “bulk” barrier properties, rather than the junction proteins at the 
individual cell level in situ. The following section will discuss these current techniques 
in detail and discuss the limitations we sought to address by developing the JAnaP. 
While our focus here is on those specific proteins in BMECs, we believe that the 
developed tool is relevant to other junctional proteins and ECs from other vascular 
beds.  
In addition to JAnaP development, we utilized the tool to gain new 
understanding about junctional proteins in BMECs. Throughout the dissertation, the 
use of agents known to elevate cAMP have been used, since these agents are known to 
increase junctional architecture and barrier properties (section 2.1.3). This provided a 




biochemical and mechanical contexts. In chapter 6, we investigate the role of 
contractility in ZO-1 junctional presentation. While it is widely accepted that cell 
contractility can influence barrier properties (section 2.1.2 and 2.1.3), we explicitly 
investigate its role in ZO-1 junction localization and phenotype, and the modulation of 
this response by mechanotransduction. Finally, in chapter 7, we study the role of breast 
cancer secreted factors, and VEGF (section 2.1.3), on BMEC junction presentation.  
2.2 Barrier Assessment and Junction Phenotyping  
2.2.1 Evaluating Barrier Integrity 
The current experimental tools for monitoring the dynamics of endothelial 
systems has been recently reviewed [56]. The two most closely studied parameters, 
include: 1) Permeability – which measures the permeability of molecular probes, and 
2) Trans-endothelial electrical resistance (TEER) – which measured the permeability 
of small inorganic ions. The “gold standard” methods for measuring these parameters 
typically involve ECs grown on highly porous membranes that separate two fluid-filled 
compartments, commonly known as a Transwell insert or a Boyden chamber (Figure 
2.4) [56]. Both methods, as well as their pros and cons, are discussed below.  
Figure 2.4. Transwell Assay for Permeability and TEER. Schematic of a Transwell 
insert depicting ECs grown on a permeable membrane separating two fluid-filled 
compartments (A). Permeability assay applying a molecular probe of known 
concentration to the top “donor” compartment then measuring the concentration of the 
probe in the “acceptor” compartment after a specific time has passed (B). TEER assay 
using “chopstick” electrodes to measure the resistance across the EC monolayer (C). 




 2.2.1.A Permeability Coefficient of Molecular Probes  
 To measure the permeability of molecular probes, Transwell assays are 
typically used (Figure 2.4.B) [56]. This setup requires that any solute transfer from one 
compartment to the other must cross the cell layer. Typically, a highly water-soluble, 
non-membrane permeable molecular probe that is not actively transported by the cells 
(e.g., dextran) is then placed into the “donor” compartment and the concentration of 
the probe in the other “acceptor” compartment is subsequently sampled. The probes are 
often radio- or fluorescently-labeled for ease of sample measurement [57]. This data 
enables the calculation of the permeability coefficient of that system, which is 
dependent on the functional properties of the ECs and is specific for the given probe. 
As such, use of probes of different molecular weight and charge can provide different 
insights into the size- and charge-dependent transport properties of the EC barrier. 
Notably, the size and permeability of the porous membrane itself (although typically 
negligible) must be considered [56].  
 While this assay can provide useful information about the cell-cell junctions, 
and a global reading of the overall barrier properties, it is easily compromised by 
defects in the monolayer. Small disruptions in the barrier can serve as short-cuts for the 
probes and significantly increase the overall permeability result. Additionally, this low-
throughput assay requires an accumulation time prior to measurement, prohibiting real-
time measurements of the barrier status and junction integrity [56]. Furthermore, this 
setup does not allow for the incorporation of mechanical cues, such as shear stress, 
which have been shown to influence EC function (discussed more in Chapter 3) [58]. 




monolayer, and does not provide measurement of any local parameters, thereby 
neglecting information about single-cell heterogeneities. Despite these limitations, this 
assay remains a popular technique to assess barrier integrity in vitro due to its ease of 
experimental use and co-culture capabilities.   
 To address some of the drawbacks associated with the traditional Transwell 
setup, several techniques have been developed. A common approach to enable real-
time analysis, and the induction of shear stress, is to use microfluidic-based systems. 
One such example of this uses integrated microfluidic and laser technologies to 
establish a method with automated and time-resolved measurements of permeability 
coefficients [59]. To do this, ECs were seeded on a porous membrane separating two 
levels of a microfluidic channel. Laser-induced fluorescence (LIF) was used to detect 
fluorescently tagged bovine serum albumin as it permeated across the cell layer, 
enabling high-throughput and shear-based permeability studies. Expansion of this 
technology has the potential for pharmacological applications, given the in vivo-like 
drug screening approach, and could be coupled with additional parameter 
measurements for basic mechanistic studies.  
 To incorporate spatial resolution of barrier permeability, other approaches have 
been developed. One of the first techniques reported utilized ECs grown on a permeable 
membrane exposed to inhomogeneous flow fields. The membrane was then placed 
upon an agarose gel and 70 kDa FITC-dextran was allowed to diffuse across the 
monolayer, where it accumulated in the underlying gel matrix [60]. The membrane with 
the cells was then removed, leaving the gel containing dextran entrapped at the sites of 




the flow field and the fluorescence was measured to provide an indication of 
permeability relative to flow. While this setup provided enough resolution to show 
differences in EC permeability with differing flow regimes, the overall lateral 
resolution remained low due to diffusion of the dextran in the agarose gel away from 
the permeation site and well beyond the single-cell scale [56].     
 The development of an assay incorporating cells onto macroporous silicon 
chips further improved lateral resolution capabilities [61]. Notably, this system was 
reported for use with epithelial cell cultures but commented on its suitability for EC 
cultures. The silicon chip contained an array of densely populated and highly ordered 
pores of sub-cellular size (approximately 1 μm in diameter, located every 4 μm), open 
only towards the cell monolayers (approximately 10 μm deep). These pores enabled 
the collection and retention of the permeability marker at the site of permeation, the 
amount and location of which was quantifiable by confocal microscopy. Simultaneous 
immunostaining of cells enabled the visualization of cellular characteristics in 
conjunction with permeability analysis. This technique enables measurement of sub-
cellular permeability, since it can discriminate between sites of transcellular permeation 
and paracellular diffusion. Development of the “XPerT” assay, however, further 
improved lateral resolution [62]. This assay made use of the biotin-avidin complex to 
decrease lateral diffusion away from the permeation site. For this method, gelatin was 
doped with biotin and used as the EC substrate. The permeating probe, FITC-labeled 
avidin, was then applied and subsequently immobilized to the biotin at sites of 
permeation, conserving the permeation route for subsequent analysis via microscopy. 




permeability with various EC parameters (e.g., junction architecture). The lateral 
resolution of this system was controlled by the biotin-density of the gelatin substrate. 
The disadvantage of this method, however, is the restriction to avidin (or streptavidin) 
as the permeation probe, which limits systematic studies investigating the effects of 
probe size, charge, etc.    
 A completely different approach for the measurement of local permeability has 
also been reported, making use of scanning electro-chemical microscopy (SECM) to 
measure the transfer of a redox-active molecule across the cell barrier [63]. For this 
technique, a redox molecule is applied to the sample and a small working electrode, 
roughly hundreds of nanometers in size, applies a constant potential as it scans across 
the system. At the tip, a measurable current is generated by the oxidation/reduction 
reactions occurring in proportion to the local concentration of the redox-active species. 
To measure permeability using this setup, ECs are grown on a permeable membrane 
and the abluminal chamber is doped with the redox-species. This compound can then 
permeate across the cell barrier as the luminal EC surface is continuously scanned by 
the electrode, generating a “permeability map” based on the measured redox current at 
every pixel. This system is advantageous because it can differentiate between trans- 
and paracellular transport routes and can provide lateral resolution on the order of 
hundreds of nanometers. One disadvantage, however, is the length of time for data 
collection since one sample can take several minutes to be scanned. Additionally, the 
molecular probe is limited to electrochemically active molecules capable of redox-
activity at potentials safe for cell viability and function. As such, the temporal 




parallel with other imaging modes, however, could enable exciting parameter analysis 
for EC function.     
 2.2.1.B Trans-Endothelial Electrical Resistance (TEER)  
 For TEER, ECs are also plated on a porous membrane and placed between two 
fluid compartments, each containing an Ag/AgCl electrode to use direct current (DC, 
I) for measuring the voltage drop (V) across the barrier (Figure 2.4.C). Using Ohm’s 
Law (V=IR), the resistance can be calculated to represent the ionic permeability (when 
corrected for the resistance contribution of the empty filter and the area of the 
membrane). One popular setup is the commercially available chopstick system, which 
allows the user to place the electrode pair into each compartment of a Transwell insert 
and simply record the resistance readout. While TEER is beneficial because it is non-
invasive and can be performed in real time with high time resolution, there are several 
limitations to this method [56]. First, it is a global measurement, like the molecular 
probe permeability assay, such that any defect within the monolayer can create a short-
cut to current flow and significantly decrease resistance measurements. Another 
challenge is that it requires a homogeneous electrical field throughout measurement, a 
requirement that even commercially available systems do not always meet [56]. With 
point-based electrode setups, like the chopstick system, the current often only flows 
through an unknown portion of the cell monolayer but is still corrected by the size of 
the entire area. This leads to an overestimation of the barrier tightness and is especially 
important when membranes with larger surface areas are used. Moreover, TEER results 




contributors, not just junction protein expression. Nevertheless, TEER remains a 
commonly used tool for understanding ECs function and barrier properties.  
 To address some of the limitations to TEER measurements, the field has moved 
towards impedance spectroscopy (IS, or electrochemical IS, EIS) which instead uses 
alternating current (AC). In this approach, a sinusoidal voltage is applied, and the 
resulting steady-state current is measured. The relationship between these values can 
be described by the amplitude ratio of the voltage and current, and the phase shift 
between them. These are then fit to an equivalent circuit model (i.e. sequences of 
capacitors and resistors) and used to deduce information about the system. This 
technique allows one to distinguish between the  resistance of the medium and the 
TEER across the cell-cell junctions, preventing the need for blank measurements of the 
empty setup. A benefit of this type of measurement is the ability to use coplanar gold-
film electrodes, which allows the system to remain closed during measurement [64]. 
The electrodes are very thin (approximately 50-100 nm) so they remain transparent, 
enabling parallelization with microscopic methods. Importantly, the fabrication 
techniques of these micro-electrodes remain feasible, with the ability to generate small 
electrodes down to the single cell scale. One advantage to this type of electrode-chip is 
the spatial resolution associated with each electrode-pair, providing insight into the 
distribution of parameters rather than the average over the entire cell population. In 
some cases, electrodes have been integrated into the wells of 384-well devices, also 
enabling high-throughput readout capabilities.  
An even further extension of local resistance measurements with lateral 




uniform clamp current is established across an entire monolayer, while the potential is 
measured locally at the cell surface by a scanning electrode to generate a “resistance 
map” of the sample. This allows for recognition of local defects and can distinguish 
between, and separately quantify, the para- and trans-cellular current pathways, 
enabling the specific study of cell-cell-junction changes. Unfortunately, similar timing 
limitations exist as the SECM method described above.       
 Notably, one thing to consider when comparing the Transwell insert method 
versus the gold-film electrode-chips, is the difference in substrate permeability [56]. 
The electrodes serve as an impermeable surface, such that cells are only exposed to 
nutrients on the apical side, compared to the membranes, where both the apical and 
basal sides of the cells are exposed. On one hand, this makes the insert a more 
biomimetic system. On the other hand, it should be considered that most routine cell 
culture is still performed on impermeable surfaces, such as petri dishes and culture 
flasks. Therefore, while the insert acts as a more biologically relevant surface for 
transport purposes, one could argue for the use of ECIS and electrode-surfaces when 
performing structure-function studies and functional barrier analysis relative to the 
other substrates used for cell culture.        
 Another consideration is that while TEER can reflect the junctional tightness of 
ECs, alterations in cell morphology, without changes to the junctional structure, can 
also change the output values [56]. The amount of current following through the 
paracellular pathway will depend on the specific resistance of that pathway and the 
amount of available pathway [66]. One factor influencing the amount of pathway is the 




paracellular pathway, increasing the number of regions available for current to pass. 
Accordingly, TEER will be higher larger cells when the resistance per length of 
junction is the same. For cells of the same size, however, elongated cells will likely 
have lower TEER values, attributed to the higher perimeter to surface area ratio 
compared to more circular cells.  Indeed, shear-stress-induced elongation of ECs has 
been associated with decreased TEER values without changes to cell-cell integrity or 
junctional architecture [67]. Importantly, this relationship is consistent for all 
parameters describing paracellular barrier function, motivating the study of cell-cell 
junctions and paracellular transport properties in conjunction with cell morphology.  
2.2.2 Junction Phenotype 
 Tight and adherens proteins present themselves in several patterns when 
localized at the cell-cell junctions. These diverse patterns have been described in many 
EC types in the literature, resulting primarily from visualization via immunostaining 
techniques. While the names for categorical phenotyping differs slightly between 
reports, the two overarching patterns that consistently emerge are the continuous, 
“linear-like” junctions, and the discontinuous, “interrupted” junctions. These 
discontinuous (or “zigzag” [68]) junctions are separated by regions where no apparent 
junction is localized to the cell edge, where the image intensity is equivalent to the 
cytoplasmic background, representing a “free cell border” [69]. Continuous lines of 
adherens junctions are considered characteristic of in vivo vessels [70]. In vitro, these 
types of junctions are also found in highly confluent cultures, [71] and after stimulation 
with biochemical agents, such as hydrocortisone [72], or mechanical cues, such as shear 




hand, are characteristic of subconfluent cultures, in migrating ECs (e.g., during wound 
healing) and in response to inflammatory mediators (e.g., TNF-α) [24,68,73]. For VE-
cadherin, these are the sites of junction remodeling and are termed focal adherens 
junctions, molecularly identified by the association of vinculin at their attachment point 
to radial actin bundles [54]. In each case where discontinuous junctions are observed, 
the mechanism for cellular response involves changes in cell shape, increased motility, 
and the transition of actin from junction-associated filaments to stress fiber formation  
[71,74].  
Alterations in actin fibers have been directly linked with VE-cadherin 
presentation, where linear VE-cadherin is observed in cells with low tension and active 
Rac, whereas discontinuous focal adherens junctions are observed in cells experiencing 
high tension and active Rho [75]. Immature junctions are presented as punctate regions 
or have a serrated morphology approximately perpendicular to the cell edge. As 
junctions mature, they become larger and form more linear structures parallel to the 
cell boundary [15]. Functionally, linear junctions are associated with decreased 
permeability, [76] whereas junction disassembly and increased permeability have been 
linked with increased transmigration of leukocytes and breast cancer cells through 
BMECs, resulting from increased contractility via the Rho/ROCK signaling pathway 
[77]. In this specific example, linear patterns of tight junctions were present at the cell-
cell border of BMECs, but shifted to a “discontinuous, segmented and dotted” 
phenotype within 8 hours of co-culture with a human small cell lung cancer cell line 
[77]. Similarly, treatment of human umbilical vein ECs (HUVECs) with endothelial 




stable/mature” junctions to “perpendicularly orientated remodeling cell-cell junctions”, 
mediated through a Rho/ROCK-actomyosin contractility mechanism [54]. 
Interestingly, though, others have reported that increases in permeability resulting from 
TNF-α are the result of decreased occludin and re-distributed ZO-1, rather than the 
contractile mechanisms mediated by Rho/ROCK, since inhibition of this pathway but 
not MLCK prevented the effects of TNF-α [73].  
In one example, a model of brain injury (via cell stretching) showed 
redistributed ZO-1 into a punctate pattern at the cell edge with diffuse presentation 
across the cell body in BMECs [78].  In another example, the pattern of claudin and 
occludin were described “frayed” in iPSC-derived BMECs, a presentation that shifted 
to “continuous” upon treatment with retinoic acid, known to improve BBB properties 
in various BMEC types [79].    
Another group described VE-cadherin junctions as displaying linear, reticular, 
interrupted and plaque morphologies (Figure 2.5, from [69]). The dynamics of these 
adherens junction clusters are thought to be regulated by fusion and fission [67]. 
Nascent cell junctions are mediated by actin-drive lamellipodia which bring adjacent 
cells together to promote adhesion receptor binding and cell adhesion complex 
formation [80]. The lamellipodia then transition to filopodia which generates highly 
dynamic and discontinuous adherens junction patterning in growing cell cultures. 
Time-lapse imaging has shown consistent transitions between discontinuous and 
continuous patterning, though these transitions decreased with increasing cell density, 
as the continuous phenotype became more persistent [71]. The mechanism of gap 




cell adhesion and ARP2/3-controlled and actin-driven junction-associated intermittent 
lamellipodia (JAIL) formation [69]. JAIL are small plasma membrane protrusions that 
exist between VE-cadherin junctions to form new adhesion plaques that then become 
incorporated into junctions [71]. More JAIL is observed in regions of discontinuous 
junction while continuous junctions reduce their size. This process constitutively 
remodels VE-cadherin patterns and maintains the integrity EC  junctions.    
2.2.3 Current Methods to Quantify Junction Phenotypes 
 Despite the plethora of evidence regarding junction phenotypes, only a handful 
of methods have been described for the quantification of these parameters. One 
example of a method for junction quantification simply counted the occurrence of each 
Figure 2.5. Demonstration of VE-cadherin structures in HUVEC cultures.  (a) 
Confluent and (b) subconfluent HUVEC cultures are labeled with antibodies against human 
VE-cadherin. Confluent cells display mostly reticular (cropped area I) or linear (cropped 
area II). Plaque-like structures are seen in both confluent and subconfluent conditions (here 
shown in confluent cells). (cropped area III) structures along the junctions. In contrast, in 
subconfluent cultures, VE-cadherin appears overall interrupted (cropped area IV). This 
diversity in VE-cadherin appearances is a challenging task for image analyses. Reprinted 
from Seebach, et al., “The CellBorderTracker, a novel tool to quantitatively analyze 
spatiotemporal endothelial junction dynamics at the subcellular level.” Histochem. Cell 










individual junction to report the discrete number of tight junctions localized to the cell 
border [81]. Another approach commonly used is to measure the pixel intensity of the 
junctional protein compared to the brightness of the cytosolic-background to gauge the 
relative expression in various experimental conditions [71,82]. As described by Fan et 
al., this method calculates the corrected cell membrane intensity for each junctional 
protein by subtracting the average noise intensity for multiple random regions for each 
image from the raw intensity profile of the entire cell junction [82]. In this example, 
they went on to perform subsequent analysis such as the “staining percentage” which 
calculated the percent of pixels with positive intensity values localized around the cell 
boarder. Additionally, this group reported the count and area of gaps in the junctional 
staining, as manually traced in ImageJ, which they reported as the number and 
percentage per area. While these methods provide insight into how frequently junctions 
are present, and the relative comparisons between experimental conditions, they do not 
provide any information about junction morphology. 
One approach to quantify junction characteristics is to measure the width of the 
junctions (or junction gaps) around the cell edge by drawing a line across the junction, 
perpendicular to the cell perimeter [53,54,83,84]. The intensity profile of the line is 
then fit to a Gaussian (or two-gaussian, in the case of junction gaps) curve. The width 
measurement is then determined as some parameter of the Gaussian fit, such as the full-
width-at-half-max (FWHM) [85] or the width of the fit 20% above background pixel 
intensity [84]. One disadvantage to this approach is that it only provides measurements 
at discrete locations, selected by the user. As such, it does not calculate the width 




for measurement. Another approach to measure junction size was described by Ting, 
et al., who developed a custom-written MATLAB code to measure pixel intensity along 
the cell borders [86]. To do this, disconnected regions between adherens junctions were 
joined via pixel dilation and the boundaries were isolated from the background by 
subtracting the pixels below 30% of the maximum intensity. The cell boundaries were 
then defined using the watershed algorithm and a ribbon of interest was identified 
around the boundaries with a width of 10 pixels. Within this ribbon, the total pixel 
intensity was calculated, then divided by the total ribbon length and the number of cells 
to generate the amount of junctional protein per length per cell. Notably, this 
measurement was reported as a ratio relative to the control value rather than per cell 
quantified output. For both examples, the phenotypic detail on a per cell basis is limited.  
To instead measure “how linear” a junction is, one group reported the 
calculation of the “junctional linearity index” [87]. This parameter is calculated by 
dividing the length between two vertices or cell junction points, as measured using the 
Straight-line tool in ImageJ, by the length of the junction, as measured using the 
Freehand-tool. An index value of 1 indicates a perfectly straight junction, while lower 
values indicate a more tortuous phenotype. This clarifies the shape of continuous 
junctions that span the full length between cell vertices, however, it does not provide 
information on any discontinuities present at the cell borders.  
To measure the extent of junction coverage, the calculation of the “area fraction 
index” has been reported [88,89]. For this, images are corrected for background signal 
using ImageJ and a threshold value is applied to the gray scale intensity profile to 




ImageJ outline filter to determine the perimeter of junction staining. The total perimeter 
is then normalized by the square root of the cell number within the image, and the value 
is typically normalized to the value of the control condition. For this parameter, an 
index of 1 represents fully continuous junctions while decreased values indicate more 
discontinuous or non-existent junctions. While this method provides a useful tool to 
gauge overall junction coverage, it only provides relative measures and calculates 
results on a per image basis. This inherently provides an average measurement of the 
monolayer, without providing details about cell-cell variability.  
The measurement of phenotypic detail on a per cell basis has been reported as 
a purely manual technique [15]. In one example, the fraction of cells expressing a 
“frayed” junction phenotype, defined by any cell-cell contact point with discontinuous 
junction, was calculated by manually counting the number of cells presenting this 
pattern [79]. In another example, the percent of the cell perimeter covered by linear 
junctions was calculated by tracing regions of linear VE-cadherin, identified by the eye 
of the user, in ImageJ. The values were then summed and compared to the whole cell 
perimeter to provide a fraction of linear versus non-linear coverage. While this method 
provides more details about cell-to-cell variations in linear junction presentation, it 
neglects the presentation of any other junction phenotype. Admittedly, the same 
approach could be used to trace the regions of discontinuous junctions and calculate a 
comparable parameter but given that this method is completely manual in nature, that 
would be an extremely tedious and time-consuming task.   
To prevent the need for completely manual border tracing, some automated 




method which enabled semi-automated boundary extraction [90]. This method used a 
segmentation algorithm to convert an image into a weighted graph that assigns a cost 
value to each pixel based on features typically associated with an object edge (e.g., 
high-intensity gradients). Using a mouse click to seed a point near the object boundary, 
the algorithm can compute the path between that and the next point following the 
minimal cost pixels, thereby reflecting part of the object boundary. Subsequent seeding 
points allows for complete boundary tracing. This approach is more efficient and 
enables high reproducibility and accuracy compared to a solely manual process [69]. 
However, while this method allows for semi-automated boundary identification, it is 
not tailored to cells or their junctions, and as such, requires adaptation to quantify edge-
localized protein phenotypes.  
One benefit of the live wire method is that the point seeding enables the control 
and monitoring of segmentation by the user. This level of interaction, though, is not 
ideal for more automated image processing, especially for cellular networks, where 
weak gradients are often present. To build on this limitation, the CellBorderTracker 
(CBT) was developed [69]. This package enables dynamic tracing of cell junctions 
within a time-lapse sequence. While this is generally automated, it does require an 
interactive cell boarder extraction step where seed points are generated to identify the 
cell boarders in the first image of every sequence. This program can output the protein 
distribution patterns and junction dynamics, including gap formations, as well as cell 
shape changes and migration velocities, over time. This program holds significant 




basis the data is provided (i.e., per cell or per image) and to what level of detail the 
protein distribution patterns are reported.     
Overall, the current methods in the field suggest a desire to quantify junction 
localization and a need to characterize phenotypic parameters in situ. The current 
approaches enable one to gauge junctional protein characteristics, though not without 
significant limitation. An improved technique combining several of the parameters 
described above, calculated in an efficient manner, could provide significant insight 
into the function of junction phenotypes and the response in physiological and 
pathophysiological applications.  
2.2.4 Relevance to Dissertation 
Phenotypic differences in junction presentation are apparent in the literature and 
significant evidence suggests that these differences relate to various stages of junction 
maturity, thereby influencing EC function. Importantly, these diverse patterns of 
junction proteins are widely heterogenous even within one single cell, thus significant 
non-uniformities are present in any one given monolayer [69]. As such, it seems clear 
that better standardization and quantification of these parameters is needed to 
collectively understand the mechanisms driving these alterations and how they 
influence the barrier-specific properties of the endothelium. The current methods in the 
field for characterizing junctions in situ, however, are lacking phenotypic classification 
on a full-cell and per-cell basis. As such, we developed the JAnaP (Chapter 4) to 
quantify the percent of the cell edge presenting various junction phenotypes. To begin 
to understand the influence of junctional architecture on barrier properties, we then 




global permeability, as described above in section 2.2.1 (Chapter 5). Finally, we 
characterized junction presentation the BMECs in several contexts, as examples of 







 - Vascular Endothelial Cell Mechanosensing: New 
Insights Gained from Biomimetic Microfluidic Models† 
 
3.1 Introduction 
In vivo, cells of the vascular system are subjected to various mechanical stimuli 
(Figure 3.1, citations refer to: [1]-[16], [2]-[91], [3]-[8], [4]-[92], [5]-[93]) and have 
demonstrated the ability to adapt their behavior via mechanotransduction. 
Mechanotransduction is the process by which cells convert biophysical or mechanical 
stimulation in the local cellular microenvironment into intracellular or biochemical 
signaling which regulates the cell response [94,95]. Recent advances in microfluidic 
and “on-chip” techniques (e.g. 3D printing) have provided the technology to study 
these alterations in cell behavior. Contrary to traditional in vitro cell culture, these 
microfluidic devices (MFDs) provide the opportunity to integrate multiple mechanical 
cues (e.g. shear stress, substrate stiffness) with in situ quantification capabilities (Figure 
3.2). Additionally, they provide precise geometries towards physiological dimensions 
and length scales, allowing for decreased cell numbers and material quantity for 
synthesis and experimentation. Thus, they can be used to recapitulate the in vivo 
mechanical setting and systematically vary microenvironmental conditions, using 
minimal resources, for improved mechanobiological studies of the endothelium. MFD 
types and various design considerations have been recently reviewed in detail [96], and  
as such, will not be explicitly discussed here.  In Table 3.1, we highlight unique features 
† This chapter was adapted from K.M. Gray and K.M. Stroka “Vascular Endothelial Cell 
Mechanosensing: New Insights Gained from Biomimetic Microfluidic Models”. Seminars 
in Cell and Development Biology 71, 106-117 (2017). Permission was not required by 




of MFDs that have allowed for discovery of new biological information and 
mechanisms of mechanosensation, as we review here. 
Figure 3.2. Mechanical Cues Presented to ECs. Biophysical stimuli that have been 
integrated in MFDs for in vitro mechanosensing experiments. Blue arrows represent 
direction of each mechanical stimulus (e.g., in case of shear stress, transmural flow, 
interstitial flow, cyclic strain, and bifurcations), while black arrows indicate contractile 
forces in endothelial cells (e.g, in case of matrix stiffness). These biophysical cues may be 
active (e.g., shear stress, transmural flow, interstitial flow, and cyclic strain), or passive (e.g., 
confinement, matrix composition, matrix stiffness, curvature, bifurcations, and topography). 
Wavy lines represent extracellular matrix and basement membrane components. 
Figure 3.1 Mechanical Cues Presented to ECs 
Figure 3.1. In vivo Data for Vascular Stimuli. The major types of vasculature in the 
body, and the types of biophysical cues they are exposed to in healthy microenvironments 
in vivo. Values collected from human samples, except **bovine samples. I–intima, M-
media, A–adventitia, VSMC–vascular smooth muscle cells, d.n.a.-data not available.  







Adequate EC and vascular modelling provides for enhanced understanding of 
disease progression, design of cell separation [97] and drug delivery systems, and the 
development of biomaterials for tissue engineering applications (Figure 3.3 [98]). As 
such, several reviews have recently been published which nicely outline the advances 
in MFDs for mechanobiology and mechanotransduction [95,99,100]. These reviews 
broadly cover multiple cell and tissue types and discuss the suitability of the devices to 
mimic the physiologic environment. Other reviews describe the use of MFDs for 
specifically studying angiogenesis and the microvasculature [101–104], but focus on 
specific organ microvasculature or non-mechanosensing aspects of EC function. MFDs 
have been particularly useful in studying the role of EC mechanobiology in the 
transmigration of immune and/or tumor cells, and have been reviewed elsewhere [105–
107]. Here, we will discuss the advances in knowledge about EC mechanosensing 
resulting from the design and application of biomimetic on-chip and microfluidic 
platforms. Specifically, we will focus on the novel reports within the last five years 
from using devices designed to study EC mechanobiology, rather than technical 
fabrication approaches or mechanosensitive properties learned using alternative 
techniques. 
3.2 Shear Stress & Hydrodynamic Forces 
 When the heart beats, blood is pumped throughout the body due to cycles of 
contraction and relaxation of the ventricles and atria [108]. This flow results in shear 
stress experienced by ECs, the magnitude of which is dependent on many in vivo 
factors. As such, several on-chip systems, capable of a range of shear stresses, have 




3.2.1 Elongation, Cytoskeletal Realignments, & Junctional Relocation  
Numerous reports have shown that in straight vessels, ECs elongate and align in 
the direction of flow, and redistribute junctional proteins. These (and other) responses 
depend heavily on the magnitude [109–112], and the laminar (versus pulsatile) 
continuity [113], of the shear stress applied. This well-characterized shear-induced 
response has conveniently come to serve as a “proof-of-concept” feasibility check in 
many new device designs, particularly useful for organ-on-chip systems [108,114] 
(recently reviewed in [16,115–118]). 
Mechanistically, the ability of cells to sense the direction and strength of shear 
stress is still largely unknown and has been suggested to occur via mechanisms 
involving the glycocalyx, PECAM-1, stretch-activated ion channels, receptor tyrosine 
Figure 3.3. The Process of Designing MFDs to Study EC Mechanobiology. MFDs allow 
for unique capabilities in engineering a model system, including the incorporation of multiple 
mechanical cues, electrodes for sensing, imaging modalities, and spatiotemporal introduction 
of biochemical cues. These MFDs can be used to understand endothelial cell mechanobiology 
through exploration of the role of various proteins, pathways, processes, and ultimately 
functionality, in the cells. Revelation of new biological information could help re-engineer the 
model system to enhance physiological relevance or could help inform design of new 




kinases, VE-cadherin, and VEGF-receptor. Recent work has also provided evidence 
that shear stress mechanotransduction can occur through the hydrodynamic drag 
applied to EC nuclei [119]. Tkachenko et al. showed that HUVECs developed spatial 
polarity of organelles at a rate proportional to the shear stress, with the golgi apparatus 
and microtubule organizing center biased to the upstream side of the nucleus, and that 
flow-induced polarization was resisted by the acto-myosin cytoskeleton. This result 
suggests that relocation of nuclei downstream of applied force prompts EC 
polarization.  
Interestingly, flow-induced elongation reportedly depends on EC-type. HBMECs, 
for example, do not transition from a cobblestone morphology in response to shear (16 
dyn/cm2) [120]. In this study, actin fibers remained randomly oriented, and while 
junctional ZO-1 decreased, western blot analysis suggested increased ZO-1 (and beta-
catenin) expression under shear stress. These results suggest an evolutionary advantage 
for ECs of the BBB to resist shear-induced shape alterations. This is particularly 
relevant, as MFDs have shown significant promise in BBB-on-chip applications, which 
has been thoroughly reviewed in [121,122]. This difference in response based on EC-
type, however, should be thoroughly considered when planning MFD-based studies. 
Helms, et. al. nicely presented the detailed differences reported in the literature of the 
approximately thirty different EC types and co-cultures reported for in vitro BBB 
evaluation [121]. In general, we urge researchers to consider the EC source in 
combination with a physiologically-relevant shear stress for that type of micro- or 
macro-vessel. As shown in Table 1, the majority of MFDs in recent literature have 




ECs, with only a few studies utilizing microvascular ECs. As the field moves forward, 
MFDs will be useful tools to study the effects of physiologically-relevant mechanical 
cues on a wide range of ECs from different tissue sources. 
3.2.2 Calcium  
Intercellular calcium serves as an important messenger that regulates an abundance 
of spatiotemporal cellular signals. As such, the calcium ion (Ca2+) concentration within 
the cell is tightly controlled through various machineries (e.g. ion transporters, 
cytosolic calcium-binding proteins) [123]. Multiple calcium regulators have been 
implicated in mechanosensitive mechanisms, so several microfluidic approaches have 
been developed to study the response of intracellular Ca2+ to mechanical stimuli. 
ECs are exposed to ATP contained in the blood. Both shear stress and ATP serve 
as regulators of EC function (e.g. proliferation, migration, apoptosis), and have been 
identified as regulators of dynamic Ca2+ signaling [124]. Their synergistic influence 
was recently studied using adhesive micropatterns to modulate the elongation and 
orientation of BAECs exposed to shear stress [125]. Flow induced retraction upstream 
of the cell, while lamellipodia formation was observed downstream. Ca2+ increase was 
reported in BAECs patterned orthogonal to flow; however, the direction of intracellular 
Ca2+ waves were more heavily influenced by cell polarization (versus flow direction). 
The group speculated that the orientation of Ca2+ waves is due to the organized actin 
filaments within the polarized cell, since waves are correlated with ATP release from 
caveolae-rich regions [126] associated with actin microfilaments [127,128]. Chen et al. 
reported a single peak Ca2+ response in HUVECs under steady shear, with a second 




introduced to the system [124]. These results suggest that a combination of shear and 
ATP signals play a significant role in EC Ca2+ signal transduction induced by blood 
flow. 
Several reports indicate that mechanotransduction involves mechanosensitive ion 
channels [129]. Transient receptor potential vanilloid 4 (TRPV4), for example, is a 
mechano-activated cation channel [130] that has been implicated as a signal transducer 
of shear stress. The effects of the TRPV4-selective agonist, GSK1016790A, in 
response to a range of shear stress (up to 63 dyn/cm2) was recently reported [131]. A 
reduction in EC response time was observed with increasing shear stress, while 
increasing GSK1016790A at each shear stress level reduced the peak response time, 
suggesting that a shear stress-dependent sensitization exists for GSK1016790A-evoked 
Ca2+ signaling. In BAECs, increases in intracellular Ca2+ were proportional to shear 
stress magnitude, reportedly due to an influx of Ca2+ from the extracellular space rather 
than release from intracellular storage [129]. Activation of the TRPV4 channel was 
necessary for this flow-dependent response, as use of its antagonist, HC067047, 
reduced Ca2+ influx, thus supporting the possibility of a shear stress sensitization 
mechanism involved in TPRV4 function. 
Interestingly, Compton et al. exposed HUVECs to hydrodynamic shear at the 
microscale via micro-bubble bursts termed “microtsunamis” [132]. While this is not a 
microfluidic approach, this technology provides for extremely high-throughput 
capabilities to determine the key regulators of mechanotransduction involved in Ca2+ 
signaling. Microtsunami-induced Ca2+ signaling was attenuated by dose-dependent 




endoplasmic reticulum via G-protein-coupled receptor signaling. Thus, there seem to 
be conflicting reports about whether the cell response relies on Ca2+ release from 
intracellular versus extracellular space. Together, these results support that mechanical 
stimuli play a role in EC Ca2+ signaling and suggest the importance of incorporating 
and controlling shear stress into experiments for mechanistic study.  
3.2.3 Surface Proteins & mRNA 
Shear stress has been shown to influence surface receptor expression and other 
signaling proteins in the endothelium. The role of mechanosensitive microRNAs in EC 
responses to shear stress and redox state was recently reviewed [133]. Here, we will 
outline the influences of shear stress on protein and mRNA expression as determined 
via MFDs. Notably, several groups have developed MFDs to simultaneously expose 
ECs to varying magnitudes of shear stress and biochemical cues, and evaluated the 
resultant expression of surface marker proteins and mRNAs (e.g. ICAM-1, VCAM-1, 
endothelial-to-mesenchymal transition markers), often in comparison to previous 
literature [134–136].  
To investigate the effects of localized cytokine exposure, a model was developed 
to deliver TNF-α to the middle section of a blood vessel from the “tissue side” [137]. 
As expected, BAECs in the middle section (i.e. cytokine-activated) exposed to 12 
dyn/cm2 exhibited significant ICAM-1 increase. Interestingly, ICAM-1 expression was 
also increased downstream of activation (compared to upstream) even though the cells 
themselves were not activated, thus introducing the concept of spatial resolution in EC 




Vasculoprotection, via high laminar shear stress (HLSS), is reportedly modulated 
through Kruppel-like factor 2 (KLF2), a transcription factor involved in endothelial 
homeostasis via nitric oxide (NO) production  [138]. Connexin37 (Cx37) is a gap 
junctional protein highly expressed in healthy endothelium, but not in regions of 
atherosclerosis [139]. Pfenniger et al. reported increased Cx37 and KLF2 expression 
after ECs were exposed to HLSS but found that KLF2 silencing significantly reduced 
Cx37 expression. This result suggests that Cx37 may be involved in the protective 
effects of HLSS, as increases in its expression, via KLF2 activation, provides for 
increased intercellular gap-junctional communication and EC synchronization. More 
recently, the modulation of aquaporin-1 (AQP1), a transmembrane NO-transporter, by 
HLSS-induced KLF2 expression and inflammatory stimuli was reported. Since 
inflammatory conditions decreased AQP1 expression, while atheroprotective KLF2 
expression increased its expression, AQP1 is thought to be characteristic of non-
inflamed vessels [138]. KLF2 was also found to play a role in lung injury, as its 
expression decreased in response to pathologic cyclic stretching and inflammation, and 
pulmonary vascular integrity became dysregulated when EC KLF2 was disrupted 
[140].  
Effects of shear stress are also implicated in diabetes mellitus (DM). Using a model 
mimicking healthy and partially blocked vessels, increased rates of apoptosis were 
reported in HUVECs subjected to increased glucose concentrations and shear stress 
magnitudes [141]. Apoptotic rates were further increased after exposure to 
hyperglycemic plasma from DM patients. Interestingly, no change in apoptosis was 




static conditions, suggesting a flow-mediated mechanism involved in hyperglycemic-
driven apoptosis.  
Additionally, arterial hemodynamics are reported to play a role in atherosclerotic 
plaque formation [142]. Low shear stress (2 dyn/cm2) resulted in TNF-α-induced 
upregulation of VCAM-1, a biomarker of atherogenesis, and IRF-1, a transcription 
factor involved in immune responses and inflammation, in human aortic ECs. To 
evaluate the effects of high-fat foods, ECs were exposed to triglyceride-rich 
lipoproteins, which augmented the response, indicating a synergistic effect. 
Intriguingly, IRF-1-silencing eradicated this effect on VCAM-1 expression, 
demonstrating that VCAM-1 production is IRF-1-dependent. Together, these results 
elucidate a mechanism that may contribute to spatial atherosusceptibility via 
hemodynamic- and high lipid blood content- regulated VCAM-1 expression.  
3.2.4 Angiogenesis 
Angiogenesis is the formation of new blood vessels derived from existing 
vasculature, requiring several aspects of EC function (e.g. migration, proliferation) 
[101]. It is driven by the need to supply surrounding tissues with oxygen and nutrients 
and is therefore essential to both normal development (which we will discuss), as well 
as many pathological processes, including cancer (which we do not focus on here). 
Several reports indicate that angiogenesis is heavily influenced by the dynamic 
mechanical environment experienced by ECs. This has motivated the design of MFDs 
to include hydrodynamic forces such as luminal- (over ECs), transmural- (through 
ECs), and interstitial- (through ECM) [143] flow to decode their effects on EC behavior 




using traction force microscopy for was recently reviewed by Boldock et al. [144] so 
traction forces will not be discussed here. Notably, a sophisticated technique was 
recently reported to elucidate new characteristics of how stalk versus tip cells interact 
with the surrounding ECM for evaluation of mechanotransduction pathways 
involved in angiogenesis [145].  
The effects of luminal versus transmural flow was investigated by Galie et al. 
[146]. Regardless of flow type and EC-junctional maturation, 10 dyn/cm2 served as the 
threshold to induce sprout formation. Interestingly, matrix metalloproteinase 1 was 
found to be upregulated with flow, and its inhibition arrested flow-induced sprouting, 
demonstrating the role of matrix degradation in angiogenic progression. The direction 
of transendothelial flow (i.e. apical-to-basal, A-B, versus basal-to-apical, B-A) was 
also reported to affect angiogenesis [147]. Only B-A flow promoted capillary 
morphogenesis, increased VE-cadherin localization, and focal adhesion kinase 
phosphorylation; suggesting that the transition of ECs to a more invasive phenotype is 
mediated by a direction-dependent mechanism.   
To study the effects of interstitial flow (IF), Kim et al. developed an MFD to 
evaluate angiogenic [148] and lymphangiogenic [149] sprouting of HUVECs (co-
cultured with fibroblasts) in response to biochemical cues and IF. In both cases, sprout 
growth was significantly augmented in the direction opposite of flow, while sprouting 
was suppressed downstream. Collectively, these results implicate IF as a key 
mechanical regulator of tissue vascularization, the mechanism of which was recently 
investigated by Song et al. [150]. IF-induced EC sprouting was reported to occur in a 




by tip cells, but not VEGF gradients. Thus, RhoA-signaling is involved in mechano-
driven neovascularization.  
These studies highlight the importance of using on-chip systems to 
independently modulate flow-induced mechanical cues and biochemical signals to 
understand the mechanistic interplay involved in EC mechanosensing during 
angiogenesis. 
3.3 Subendothelial Matrix Mechanics  
In vitro cell culture requires functionalized surfaces (e.g. protein or bioactive 
hydrogel coatings) for cellular engagement and binding-ligands. The properties of 
these bioactive coatings reportedly affect EC behavior, since ligand composition and 
abundance present within the coating can alter cell-matrix interactions and affect the 
stiffness and topography of the underlying matrix. Several groups have worked to 
decouple the effects of these parameters to evaluate their individual roles in EC 
responses.   
3.3.1 ECM Composition & Structure 
In vivo, blood vessels interact with several ECM proteins (e.g. collagen type 1, 
laminin, fibronectin). The presence of these and other ECM proteins have been 
investigated to understand their role in EC behavior. Shamloo et al. reported that 
VEGF-induced angiogenic sprout paths were dependent on the density of the 
surrounding collagen/fibronectin matrix [151]. Relative to the VEGF-gradient, dense 
matrices induced parallel sprout formation, compared to less dense matrices where 




reorganized parallel to the gradient. More recently, the group integrated computational 
methods and determined that a matrix of intermediate collagen density (1.2–1.9 mg/ml) 
is optimal to induce long, stable sprout formation [152]. Unstable sprouts were reported 
in low concentration collagen matrices (0.7 mg/ml) while high concentration collagen 
matrices (2.7 mg/ml) inhibited cell migration and sprout growth as a result of increased 
collagen fibril entanglements. Despite this report, other results suggest collagen 
crosslinking does not hinder vascular stability or function [153]. Chan et al. presented 
stable EC tube formation in both uncrosslinked and crosslinked gels in response to 10 
dyn/cm2. In fact, when tubes were subsequently exposed to decreased shear (~5 
dyn/cm2) they only remained stable in crosslinked gels, suggesting a potential 
advantage. In another study, optimal vasculogenesis was observed on 3.0 mg/ml 
collagen gels compared to lower concentrations, but pure fibrin matrices (2.5 mg/ml) 
improved mature network formation compared to collagen or collagen/fibrin 
combinations, and were suggested as the optimal scaffold for in vitro modelling 
[154]. HUVECs co-cultured with fibroblasts reportedly increased the number of 
branches, and decreased the average branch length and diameter, of angiogenic sprouts, 
with increasing fibrin concentration [155].  
The effects of matrix properties have also been studied at the pericellular level using 
a magneto-microfluidic system [156]. Collagen fiber deformations were induced local 
to the site of magnetic beads embedded in the matrix, without altering the bulk material 
properties. Angiogenic activity of HMECs increased under magnetic force exposure, 




gradients. This supports prior results of increased area and motility with increased 
matrix stiffness.  
Overall these results encourage use of MFDs to probe fundamental aspects of 
matrix effects on angiogenesis, and EC behavior in general, and highlight the 
importance of gel concentration and composition, and the interplay between 
biophysical and biochemical factors, in promoting the maturation of microvascular 
networks. An important consideration moving forward is the possible turning over of 
exogenous ECM and replacement with endogenous ECM laid down by the ECs. While 
this effect is likely also at play in traditional assays, it may be even more pronounced 
in MFD studies, where cells may be cultured over longer time periods. Researchers 
should be aware of this potential effect and plan for evaluation of, or control of, ECM 
production by ECs within the MFDs. 
3.3.2 Matrix Rigidity  
Mounting evidence indicates that ECs are capable of mechanosensing matrix 
rigidity [76,157,158]. To independently study the effect of substrate stiffness on ECs, 
a new method to immobilize proteins on polyacrylamide hydrogels has been developed 
[159]. Micropatterns of fibronectin-coated rectangles were used to control the 
spreading and morphology of single HUVECs on different stiffness. Soft hydrogels 
(2.5 kPa) led to a lower actin fiber density, a rounded nucleus, and lower Young’s 
modulus compared to HUVECs on stiffer hydrogels (25 kPa). The observed 
reorganization of actin suggests that internal tension is modulated by matrix stiffness, 




The effects of matrix rigidity are particularly relevant in age-related arterial 
stiffening, which is implicated in the pathology of cardiovascular disease (reviewed in 
[160]). The combined effects of shear stress (12 dyn/cm2) and vessel stiffening were 
recently investigated [161]. BAECs on “young” hydrogels (2.5 kPa) exhibited typical 
flow-induced EC elongation and increased junctional tightness, decreased RhoA 
activation, and increased NO production, relative to “old” hydrogels (10 kPa). This 
demonstrates that substrate stiffness and shear stress signaling are coupled, and that 
compliant matrices, mimicking young blood vessels, can induce a flow-activated 
atheroprotective phenotype.   
Evidence of crosstalk between stiffness and shear stress signaling was also provided 
by Galie et al. who showed that the magnitude of shear stress required to induce an EC 
response was different depending on the underlying substrate rigidity [162]. Their 
studies indicated that the interplay is Rho/ROCK-mediated. Cell surface receptor CD44 
is upstream of this pathway and is known to bind hyaluronan (HA), a 
glycosaminoglycan present in the EC glycocalyx. Under static conditions, HA 
degradation induced no change in cell morphology or response to TNF-α on stiff 
matrices, but prevented cell spreading on soft substrates. With shear stress, HA 
disruption eradicated the flow-induced NF-κB decrease observed in ECs on soft 
matrices. This suggests that HA plays a role in EC mechanosensing and the 
inflammatory response on soft matrices specifically. 
Collectively, these results suggest that subendothelial matrix stiffness, independent 
of protein coating and cellular morphology, can modify the cytoskeleton, and impact 




effects with shear stress, on EC function, might elucidate the mechanisms involved in 
response to vascular stiffening in aging and disease.   
3.4 Topography  
Protein fibers in the basement membrane (BM) present biophysical cues to cells in 
the form of topography. Surface topography of a physiologically relevant size-scale has 
been recapitulated in MFDs in vitro and has been shown to effect EC mechanobiology, 
particularly under simultaneous shear stress exposure.  
To study the effect of topography on wound-healing, an MFD with 1 μm gratings 
was developed [163]. Increased HUVEC regeneration was observed in wounds 
perpendicular to flow, when cells were on gratings (versus flat surfaces) oriented 
parallel to flow. Shear stress (14 dyn/cm2) and wounding activated junctional Src 
activity leading to phosphorylation of VE-cadherin, decreasing adhesion strength. 
Grated substrates, and Src-inhibition on flat surfaces, decreased phosphorylation, 
which enhanced wound healing, likely due to improved mechanical connection and 
junctional integrity, rendering improved collective coordination and motility. The 
device was later used to test the interplay of topography and flow [164]. Under 
supraphysiological shear stress (up to 100 dyn/cm2), gratings induced polarization and 
ECs oriented themselves perpendicular to flow, leading them to withstand shear levels 
over 100% of those withstood on flat substrates. Topographical cues have also been 
found to dominate HUVEC migration on electrospun HA fibers under a VEGF gradient 
[165]. ECs were most persistent when fibers were aligned in the gradient direction, 
indicating a combinatorial effect of topographical and chemical cues. Meanwhile, no 




orientation and elongation is also reportedly affected by topographical cues provided 
from the apical versus the basal surface [166]. Delivery of apical flow (20 dyn/cm2) 
combined with basal exposure to ridge/groove topography parallel to flow had 
synergistic effects, while perpendicular flow resulted in less alignment, and increased 
migration tortuosity.  
In another approach, a synthetic ECM designed to mimic native structures was 
developed by depositing BM material, laminin, onto nanofibers of collagen I [167]. 
On COL1-only nanofibers, discontinuous VE-cadherin, and EC-detachment after 5 
days, was observed. On BM-COL1 nanofibers, however, densely localized VE-
cadherin was reported, and viable cell culture was maintained for several days. 
Evidence suggested that this improved attachment was due to integrin-α6, which has 
a high affinity to laminin and plays a role in “outside-in signaling”. BM-COL1 fibers 
enhanced laminin-integrin-α6 binding and stabilized focal adhesion integrin 
clustering via connections with actin cytoskeleton and suppression of junctional 
diphosphorylated myosin light chain II.    
Collectively, these results demonstrate the directional role of surface topography, 
and the apical versus basal application of, in guiding EC behavior. While simultaneous 
topographical and chemical signals may have combined effects, evidence suggests that 
topographical cues may be more influential.  
3.5 Geometry  
Similar to topographical cues that regulate cell phenotype, the slightly more macro-
scale parameter of vessel geometry reportedly influences EC behavior. ECs migrate 




branch-shaped blood vessel structures of varying diameters (see Figure 2). MFDs 
provide the capability to study the independent role of each of these geometries as 
mechanical inputs to the endothelium.  
3.5.1 Confinement  
The study of cell behavior in constricted environments is particularly relevant to 
our understanding of the mechanisms of cell invasion, where cells must move through 
ECM proteins in 3D to invade other tissues. In this regard, MFDs serve as promising 
platforms that “provide well-controlled physical, chemical and confined environments 
to study cell phenotype and behavior”, as noted by Spuul et al. who developed a device 
to study confinement of varying height [168]. No cells were observed in 1.28 μm 
fibronectin-coated slits. Interestingly, ECs exhibited cytoskeletal reorganization and 
podosome formation in 3.13 μm environments, and the fraction of podosome-forming 
cells decreased with increased slit height (up to 7.3 μm). Since ECs are typically devoid 
of podosomes, the experiments demonstrate that a confined cellular microenvironment 
can induce podosome formation. 
3.5.2 Curvature  
Vessel or fiber-like curvature has been shown to improve EC monolayer formation. 
As such, several groups have introduced this geometry into their MFDs. A 
methacrylated gelatin-alginate composite was engineered to construct double-layer 
hollow microfibers to simulate complex tissues such as the osteon  [169]. The vascular 
vessel was mimicked via ECs, and osteoblast-like cells were seeded in the outer layer 




synthesis of cell-laden multilayered microfibers for osteon-like fiber formation [170]. 
In both cases, the fiber geometry induced robust growth of the cells and enhanced 
vasculogenic and osteogenic expression. 
The effects of curvature are reportedly dependent on EC-type. In contrast to 
peripheral ECs, HBMECs have been shown to resist elongation in response to curvature 
and shear stress [171]. HBMECs were seeded onto glass rods with diameters ranging 
10–500 mm, spanning the range from brain capillaries to larger vessels. On 10 mm 
rods, only HBMECs wrapped around to form junctions with themselves. While 
HUVEC orientation, aspect ratio, and actin stress fiber distribution were extremely 
sensitive to vessel diameter and shear stress, HBMECs exhibited only weak 
dependencies. In both EC-types, actin fibers were noticeably aligned with the long-axis 
of the rod, suggesting that vessel shape may impact cytoskeleton organization.  
Alternative to the standard vessel-like geometry, increased angiogenic 
sprouting was observed at the corners of a microchannel embedded in collagen I, 
independent of a biochemical gradient [172]. The authors speculated that the 
mechanism involved was mechanically-driven, where geometric asymmetry may lead 
to increased matrix stiffness via cell-mediated ECM alterations. This in turn, would 
elevate cell contractility thereby altering sprout localization. While square vessels are 
not physiologically relevant, branch points and tortuous, tumor-associated sprouts, 
represent irregular vascular shapes in vivo, where enhanced angiogenesis is observed. 
Since geometry and cell density were key, these results indicate that biophysical cues 





3.5.3 Bi-furcation Angles & Protrusions 
Deviations from standard tubular-shaped vessels are present in vivo (e.g. 
bifurcations, aneurysms, stenosis), so a perfusable vasculature model was developed 
to recapitulate these structures [173]. Geometric alterations were shown to manifest 
as local changes in shear stress, which induces change in EC physiology (see section 
2). Here, VCAM-1 expression correlated with shear stress variations due to vascular 
geometries. In particular, geometries mimicking stenosis decreased platelet adhesion 
while bifurcation-like geometries escalated adhesion of sickle cell disease 
erythrocytes. Similarly, an MFD was designed to mimic the flow conditions in a 
stenotic artery to study the effects of plaque geometries [174]. Again, geometric 
alterations induced alterations in shear stress magnitude, which here, was shown to play 
a role in the activity of von Willebrand Factor (vWF), a glycoprotein involved in 
platelet aggregation. Geometry-induced shear increase upregulated vWF secretion by 
ECs thereby promoting platelet aggregation and thrombus formation. These results 
implicate vWF as a shear-sensitive protein involved in regulating thrombogenesis via 
hydrodynamic force recognition in the local microenvironment.   
Overall, these results demonstrate the importance of geometrical considerations in 
MFD design and highlight the capability of these systems to study EC mechanosensing 
of their geometrical environment. 
3.6 Mechanical Strain  
Within the body, ECs are routinely exposed to cyclic stretch resulting from blood 




investigated by integrating stretch capabilities into MFDs to characterize EC behavior 
[175].   
For instance, a microfluidic flow-stretch chip to study shear stress (26 dyn/cm2), 
cyclic stretch (5%, 1 Hz), and the combined effects on ECs was developed [176]. 
Increased HUVEC adhesion and spreading was observed in all conditions relative to 
static experiments. Stress fiber alignment was weakly induced by shear stress, but 
strongly organized parallel to flow with the addition of stretch, suggesting a synergistic 
effect. This synergy was further studied in MFDs which provided various orientations 
of biaxial strains and flow combinations [177]. Maximal HUVEC alignment was 
observed with increased ratios of maximum:minimum principal strain, typically 
aligning opposite of the maximum principal strain direction. Stretch-induced alignment 
and elongation was also observed in lymphatic ECs cycled between 0% and 10% strain 
at a 0.1 Hz frequency in a dielectric elastomer actuator based deformable bioreactor 
[178]. Furthermore, increased axisymmetric and nonuniform strains have been shown 
to increase inflammatory mRNAs and proteins (e.g. MCP-1, IL-8, IL-6, and ICAM-1) 
in a HUVEC cell line, providing insight into the inflammatory and mechanical 
mechanisms involved in vascular disease [179].  
Mechanical strain is of particular interest for lung applications since cells in the 
lung experience breathing-induced cyclic mechanical strain in combination with flow 
within the lung alveoli. These strains were found to play a crucial role in barrier 
permeability [180] and vascular leakage in a lung alveolar-capillary interface device 
used to mimic complex disease pulmonary edema [181]. While cyclic strain alone had 




often prescribed to cancer patients, lead to a threefold increase in leakiness compared 
to IL-2 treatment alone. Subsequent evaluation of a TRPV4 ion channel inhibitor 
suggested its role as potential therapeutic, highlighting the importance of evaluating 
drug efficacy and toxicity in appropriate biomimetic models. These devices provide 
simple and useful tools for in vitro investigation of the mechanotransduction involved 
in healthy tissue and in disease progression, and suggest mechanical strain significantly 
affects EC behavior. 
3.7 Microfluidic Platforms & Endothelial Cell Mechanosensing to Inform 
Therapeutic Applications 
One of the major goals of in vitro EC culture, particularly in the form of 
biomimetic organ- or vessel- on-chip systems, is for use in drug scanning, toxicity 
testing, and drug evaluation. In vitro, drug delivery is reportedly affected by the shear 
stress, pressure, and geometric conditions exhibited in the testing device. This evidence 
motivates the design of new devices to vary these parameters to appropriately study 
drug delivery in conditions specific to each application. The incorporation of 
physiological shear rates and hydrostatic pressure levels have been shown to alter 
nanoparticle uptake, sedimentation onto cells, cytotoxicity, and EC surface protein 
expression, relative to static or non-physiological conditions in MFDs [182–184]. 
Larger bifurcation angles were also shown to increase adhesion of neutrophils and 
microparticles to ECs, with larger and more rigid particles adhering preferably to the 
cell-cell junctions [185].  
MFDs have also been used to inform therapeutic design, providing the 




with different properties. For instance, while low shear stress (0.5 dyn/cm2) has been 
shown to maximize cationic micro-particle uptake; intracellular uptake of anionic 
particles seems unaffected by flow [186,187]. However, others have reported 
maximized uptake of negatively charged, nanoparticles with low shear [188].  
These studies demonstrate the mechanotransduction involved in EC responses 
and highlight the importance of incorporating the in vivo-like mechanical properties 
relevant to each application in MFD design. Optimization of particle physical and 
chemical properties are required for improved cellular distribution and targeted 
delivery of parenteral drug delivery systems. Government agencies including the 
federal Defense Advanced Research Projects Agency (DARPA) and the National 
Institutes of Health (NIH) have developed several initiatives to further explore the 
potential of these organomimetic platforms. For example, the NIH has an ongoing 
program titled “Tissue Chip for Drug Screening” aimed at streamlining development 
to eliminate toxic drugs earlier in the process and improve the success rate of promising 
medications [189]. The Food and Drug Administration (FDA) has even developed 
partnerships to develop microsystems aimed at evaluating organ-response to possible 
chemical hazards present in foods, supplements, and cosmetics in a more efficient and 
precise manner than current technologies [190]. It seems clear, from our perspective, 
that the benefits of MFDs, and likely the biomimetic mechanical cues they impart, are 
widely recognized in the field and that the use of these devices for standardized testing 




3.8 Conclusion and Outlook  
MFDs provide unparalleled tools for systematic incorporation of multiple 
mechanical cues, imaging modalities, electronics and sensors, as well as spatiotemporal 
introduction of biochemical cues into in vitro vascular models, in order to study cell 
mechanosensing capabilities. Indeed, mounting evidence demonstrates that the 
mechanical environment drastically alters EC signaling, protein and mRNA 
expression, cytoskeletal organization, morphology, migration, barrier function, and 
angiogenesis, and MFDs should continue to be used to study these functions. The 
ability of MFDs to incorporate shear stress on the microscale has tremendously 
impacted the progression of the mechanobiology field. In particular, the interplay of 
shear stress and other mechanical cues such as matrix stiffness, vessel geometry, 
topography, and mechanical strain, as well as biochemical cues, are illuminating 
interesting combinatorial effects. We expect that MFDs should continue to be 
developed and utilized to not only provide new correlative information, but also more 
detailed mechanistic insight into what mechanosensitive molecules are at play, and 
through which signaling pathways they act. 
A major challenge lying ahead will be the determination of what should be 
considered “state of the art” for best mimicking the physiological properties of the 
vasculature. While many designs have been reported, the question still remains what 
success criteria should be required for device characterization and which mechanical 
stimuli are truly needed to most accurately recapitulate the in vivo cellular responses. 
Until then, the systematic evaluation of each stimulus should continue to be explored 




functions. We suggest that, at minimum, physiologically-relevant shear stress and 
matrix stiffness should be simultaneously included in vascular models moving forward, 
since these mechanical cues significantly alter not only cellular response and function, 
but also the activation of various mechanosensors. Furthermore, the MFD, and the EC 
type, must critically reflect the specific in vivo setting which the researcher is trying to 
explore. It is likely that these advances will be aided by the integration of, or 
augmentation with, additional quantification capabilities, such as embedded electrodes 
for trans-endothelial electrical resistance measurements or optogenetic techniques for 
biosensor and photo-control capabilities. Nevertheless, increased understanding of EC 
mechanosensing will likely lead to enhanced future therapeutic design, and it is 
expected that MFDs incorporating physiologically relevant biophysical and 
biochemical cues will find increased applications in drug scanning, toxicity testing, and 
drug evaluation. 
 
Table 3.1. Summary of new fundamental information about EC response to various mechanical 
stimuli (alone or in combination, as noted in the first column) gained from MFDs, along with 
the extent to which mechanisms of mechanosensing are known. Unique features of MFDs that 
allowed for this new insight are also described in the second column. Composed by KM Stroka. 
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 - Junction Analyzer Program (JAnaP) 
Development† 
4.1 Introduction 
 The integrity of cell-cell junctions is required for the maintenance of normal 
physiological processes. Indeed, disruption of these junctions in, for example, the brain 
endothelium, is linked with  numerous neurodegenerative diseases including 
Alzheimer’s disease and multiple sclerosis [2]. Therefore, understanding the key 
players driving junction stability could hold significant promise for therapeutic 
discovery. Furthermore, the ability to modulate junction integrity holds important 
potential for drug delivery purposes.   
Despite this, the mechanisms underlying junction disruption aren’t fully 
understood. This is largely due to the lack of appropriate BBB models and efficient 
techniques to quantify the junctional proteins as they are presented at the cell edge. 
Importantly, previous studies have linked edge-presentation of VE-cadherin with 
junction and barrier maturity. Specifically, linear VE-cadherin structures parallel to the 
cell boundary are considered to be stable and mature, while immature junctions take 
the form of discontinuous focal adherens presenting a punctate or serrated morphology 
[15]. Therefore, a useful parameter in evaluating monolayer integrity is the amount of 
mature (i.e., continuous or linear) versus immature (i.e., discontinuous) junctions 
localized at the cell perimeter. Quantification of this parameter, however, remains 
† This chapter was adapted from K.M. Gray, D.B. Katz, E.G. Brown, K.M. Stroka. 
“Quantitative Phenotyping of Cell-Cell Junctions to Evaluate ZO-1 Presentation in Brain 
Endothelial Cells.” Annals of Biomedical Engineering 47(7), 1675-1687 (2019). 
Permission was obtained from Springer Nature to use this material in this dissertation. 




cumbersome due to a lack of efficient techniques for analysis. Here, we aimed to 
address this gap by developing the Junction Analyzer Program (JAnaP), a semi-
automated program capable of measuring the percent of cell perimeters covered by 
continuous and discontinuous junction, or no junction. 
4.2 Program Workflow 
To quantitatively analyze cell-cell junction presentation, we developed a 
Python-based program to analyze immunofluorescent images of junctional protein. We 
integrated the ability to calculate junction data in conjunction with cell morphology to 
streamline the analysis processes. This program was originally developed and validated 
using images immunostained for ZO-1. Therefore, the example images provided in this 
section depict ZO-1 phenotyping, except in section 4.2.4, where the analysis of multiple 
proteins is discussed. The JAnaP source code, guided user interface, and detailed 
instructions have been made available on the Stroka Lab GitHub account 
(https://github.com/StrokaLab/JAnaP) for practitioners to download and use. The 
detailed user guide is attached in Appendix A.  
4.2.1 Image Processing and Cell Waypointing 
The first step when using the JAnaP is to load images of EC monolayer (ideally 
collected using a 60x objective) into the program. Figure 4.1.A presents one example 
image. Each image is then converted to grayscale using the formula for effective 
luminescence, p_i = 0.2989*r + 0.5870*g + 0.1140*b, where r=red, g=green, and 
b=blue. This algorithm converts the color value of each pixel to an intensity (p_i) 




their maximum intensity values and a White Tophat filter is applied with a 5-pixel disk-
shaped structuring element to correct for the non-uniform background noise. To avoid 
over-filtering, the original image is normalized to 10% of this modified image and 
added to the modified image to generate a “cost image” used to trace the cell perimeter. 
For perimeter tracing, the user marks the edges of each cell fully contained within the 
image with a small number (typically 5-10) of single-pixel dots (Figure 4.1.B). This 
process is termed “way-pointing” and is similar to the livewire method described in 
Chapter 2. As the user adds each waypoint on the original image, the program uses the 
cost image to generate a “minimum cost path segment” between each waypoint using 
the Scikit path-finding algorithm. This essentially generates the path between each 
waypoint based on the maximum intensity present in the original image (i.e. follows 
the perimeter based on junction presentation). Conveniently, each path segment is 
generated in real time, so the user can adjust the waypoints, if needed, to accurately 
capture the cell edge. Each path segment is subsequently stitched together to create a 
full loop or “path” around the cell edge (Figure 4.1.B). This waypoint process generates 
an ordered set of points that is specific to every cell, each identified by their center 
coordinates (Figure 4.1.C). Note that this process allows the user to select only the cells 
in which the junction detail is visible around the entire perimeter of the cell. As such, 
only cells that are fully attached to and spread out on the substrate should be analyzed, 





4.2.2 Cell Morphological Parameter Calculation 
To calculate the cell shape parameters, the cell path generated in section 4.2.1 
is used. A numpy array representing the polygon bounded by the path is generated 
using the scikit Python module. This binary two-dimensional array is used with the 
scikit measure module to calculate a more accurate measure of the cell perimeter by 
accounting for diagonal lengths across pixels, the value of which is then converted to 
μm-scale and used to calculate cell area (Figure 4.2.A). Cell circularity can then be 
calculated using the formula 4𝜋𝜋(𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎) 𝑝𝑝𝑎𝑎𝑎𝑎𝑝𝑝𝑝𝑝𝑎𝑎𝑝𝑝𝑎𝑎𝑎𝑎2⁄ . Next, a convex hull is fit to the 
cell path using the Scipy library (Figure 4.2.B). The area of this hull is calculated via 







Figure 4.1. JAnaP Cell Identification. An example monolayer is presented in (A) 
with the cell of interest denoted in the white hashed box. (B) presents that cell after 
the waypointing process. The white arrows point to each waypoint seeded around the 
perimeter, with a zoomed-in clip in the top corner. The thin white line presents the 
perimeter traced by the program by connecting each waypoint (purple) using the A* 
search algorithm. The entire monolayer after the waypointing process is presented in 





(𝑐𝑐𝑎𝑎𝑐𝑐𝑐𝑐 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎) (𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑎𝑎𝑐𝑐 ℎ𝑢𝑢𝑐𝑐𝑐𝑐 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎)⁄ . The cell presented in Figure 4.2 has a perimeter, 
area, circularity, and solidity of 132 µm, 771 µm2, 0.55, and 0.93, respectively. 
 
4.2.3 Junction Phenotyping 
The junction phenotype categories are presented below in Figure 4.3. To 
quantify each junction into one of these categories, a threshold value is first identified 
to differentiate between regions with and without immunofluorescently tagged protein. 
The identification of this threshold value is described below in the validation section 
(Section 4.3.1). In this example, a threshold value of 15 was used. The JAnaP then 
compares the intensity of each pixel along the cell path to this threshold. Any pixel 
above this value is categorized as a “junction”, while “no junction” is any pixel below 
this threshold. Figure 4.4.A presents the isolated junctions of the example cell after the 
threshold has been applied and Figure 4.4.B depicts the regions of the cell path 
designated to the “no junction” category.  
To categorize the individual junction pieces, a feature mask is generated by 
creating a matrix equal to the image size. A “feature” is a contiguous region within the 
image (i.e., junction). Every feature is labeled by assigning each element of the matrix 
to a unique integer based on the feature it is a part via a fully connected structuring 
Figure 4.2. JAnaP Cell Shape Parameters. An example perimeter (white) generated 
by the JAnaP is presented in (A). This is used to calculate cell area and circularity. The 
generated convex hull (black) is presented in (B). This is used to calculate cell solidity. 




element. This feature mask can then be filtered down to include only the features which 
lie on the perimeter of the cell of interest. Then, junctions can be categorized into 
continuous or discontinuous by measuring the length of the cell path that passes through 
the feature, termed “Path Length”, and comparing it against a “Continuous Minimum 
Length”, determined here to be 15 pixels (for a 1024-pixel x 1024-pixel image, ~2.7 
µm). Determination of this value is described in the validation section (Section 4.3.2). 
If the Path Length is greater than the Minimum Length, that junction feature is 
considered continuous; otherwise, it is grouped as discontinuous (Figure 4.5). The 
Figure 4.4. JAnaP Generated Images of Isolated junctions. (A) Presents ZO-1 
junctions isolated by applying the threshold value (here 15) to the image in the JAnaP. 
(B) Presents the regions of the cell path classified as “no junction” (i.e. regions where 
there are no isolated ZO-1 junctions). (scale bar = 20 μm, applies to A and B)  
Figure 4.3 JAnaP Generated Images of 
l d  
Figure 4.3 Junction Phenotypes. Examples of each junction presentation 








cumulative sum of the path length of all junctions divided by the entire cell perimeter 
provides the total ZO-1 coverage (i.e., overall edge-localization) for that cell. In Figure 
4.4, 57.9% of the cell edge is covered by ZO-1 junction, while 42.1% has no junction 
localized at the perimeter. On the other hand, the cumulative sum of the path length of 
each junction type divided by the entire perimeter of the cell provides a measure of the 
fraction of the cell edge presenting each junction type. For the cell presented in this 
example, continuous junctions are expressed at 34.1% of the cell edge (Figure 4.6 –
dark blue color), while 23.8% of the perimeter is covered by discontinuous junctions. 
The discontinuous junctions can be further categorized into punctate or 
perpendicular, based on the “relative aspect ratio” of that feature. This is calculated by 
dividing the “tip-to-tip distance” (thickness measure) by the “Path Length” (Figure 
4.5). A threshold value of 1.2 was determined (described in the validation section 
Figure 4.5 Criteria for Phenotype Categorization. The dotted black line represents 
the edge of the cell while the green represents a single junction. The path length (red) 
represents the distance that the feature coincides with the cell path. If this distance is 
greater than the minimum length (min. length), the junction is considered continuous. 
Otherwise, it is grouped as discontinuous. The tip-to-tip distance (Tip-to-tip Dist.) 
(purple) is calculated first by finding the locations of the junction piece that are 
furthest away from the cell path (in both directions). The sum of the perpendicular 
distances from those points to the cell path is designated as the Tip-to-tip Dist. Since 
the path length and tip-to-tip distance provides measures of junction length and width 
(or thickness), respectively, dividing the tip-to-tip distance by the path length 
provides a relative aspect ratio with respect to the cell path that can be used to 









(Section 4.3.3), such that any feature with a relative aspect ratio less than 1.2 would be 
categorized as punctate, while any larger ratio would render the feature perpendicular. 
For the cell in this example, 21.7% of the cell edge is covered by punctate junction 
while 2.1% is covered by perpendicular junction (Figure 4.6 – light blue and magenta 
colors).    
 
4.2.4 Multi-Protein Analysis 
An additional capability of the JAnaP is to analyze more than one junction 
protein for the same cell. This requires that samples are immunostained for more than 
one protein, that sufficiently co-localize with one another, and that the images used 
capture each channel for the same location within the sample. This process allows the 
user to generate waypoints on one protein image, following the same steps as in Section 
4.2.1. These waypoints are then projected onto the other channels, and the path between 
each waypoint is generated based on the intensities of the other channels. A threshold 
value is identified for each channel and the remainder of the analysis continues as 
previously described in sections 4.2.1 - 4.2.3. This eliminates the need to re-waypoint 
Figure 4.6 Example of JAnaP Categorized Junctions. The isolated 
junctions of the example cell have been classified as punctate (magenta), 
perpendicular (light blue), or continuous (blue) based on the 









(i.e., re-trace) cells for each immuno-stain, thus streamlining the analysis process. This 
capability was quantitatively validated as described in Section 4.3.4.  
4.2.5 Quantification and Statistical Analysis 
 Throughout this dissertation, the analysis of the data generated using the JAnaP 
has been primarily on a per-cell basis (unless otherwise noted in the method section or 
figure caption), pooled together over three biological replicates or trials. This has been 
done to account for cell heterogeneities and allow for easy visualization  (e.g., via dot 
plot) of the spread of the data. However, this also means that the total N value, or 
number of data analyzed, is relatively large in most cases. This could skew the 
statistical results, since the standard error of the mean (SEM, used here) is the standard 
deviation divided by the square root of N. Another approach could be to pool the 
average of each trial, creating an N value of three, representing the result of each 
biological replicate. While this could minimize any over-estimation of significant 
differences, and represent inter-trial differences, it could also diminish the 
heterogeneities present within each trial. As such, we have chosen to present pooled 
data here.        
4.3 JAnaP Validation 
4.3.1 Intensity Threshold Identification 
 The threshold value is used to isolate the junction pieces from the background 
noise within the uploaded immunostained images. This value is identified by the user 




Figure 4.7 presents an example process for identifying the threshold value for a set of 
images. The images in this figure are representative of cells within one image set and 
were selected to span the range of cells presenting bright, medium and dim junctions 
at their edge. The “original” images in the figure were filtered using a range of threshold 
values (5, 10, 15, 20, 25). The post-filtered images were then qualitatively compared 
to the original image to identify the threshold value that isolated the junctions to best 
reflect their presentation in the original image. The lower threshold values do not 
remove enough background for the bright cells, while the higher threshold values over-
filtered the junctions in the dim cell. This narrowed the threshold to approximately 15. 
To probe the effects of smaller changes in threshold, we then compared the images 
filtered using threshold values ranging from 12 to 18. Only slight changes were 
observed within this range. This process identified 15 as the optimal threshold value 






4.3.2 Continuous Minimum Length Determination 
The continuous minimum length (CML) is the value that determines whether 
junction features are categorized as continuous or discontinuous. The cell presented in 
Figure 4.8 represents one example used to determine the CML. Each junction was 
color-coded based on the category to which it was assigned when using the specified 
CML value (and a relative aspect ratio of 1.2). Each image was then reviewed to 
determine which CML value most accurately categorized the junction pieces as we 
Figure 4.7 Intensity Threshold Identification. Post-filtered images of cells 
representing bright, medium, and dim junctions were compared at various 
thresholds to identify a value that adequately isolated the junctions for all 
cells. A value of 15 was identified for this image set.  





would have qualitatively categorized them. The arrows point to example junction 
pieces that are mis-categorized using the respective CML value. The white arrows 
present regions where the CML is too low and thus discontinuous junction pieces are 
coded as continuous, while the yellow arrows indicate junctions that are mis-coded as 
discontinuous because the CML threshold value is too high. This process identified 15 
as the optimal CML value for this and several other cells evaluated, leading to the use 
of this value as the default value for the JAnaP.   
 
 
Figure 4.8 Continuous Minimum Length (CML) Threshold Determination. The 
threshold length for the categorization of continuous versus discontinuous junctions. White 
arrows indicate junctions that were incorrectly marked as continuous but should be 
discontinuous when the respective CML was set too low. Yellow arrows indicate regions 
that were incorrectly categorized as discontinuous but should be continuous due to the CML 









4.3.3 Relative Aspect Ratio Determination 
The relative aspect ratio (RAR) is the value that determines whether 
discontinuous junction features are categorized as punctate or perpendicular. The cell 
presented in Figure 3.9 represents two examples used to determine the RAR. Each 
junction was color-coded based on the category to which it was assigned when using 
the specified RAR value (and a CML value of 15). Each image was then reviewed to 
determine which RAR value most accurately categorized the junction pieces as we 
would have qualitatively categorized them. The arrows point to example junction 
pieces that are mis-categorized using the respective RAR value. The white arrows 
present regions where the RAR is too low and thus punctate junction pieces are coded 
as perpendicular, while the yellow arrows indicate junctions that are mis-coded as 
punctate because the RAR threshold value is too high. This process identified 1.2 as 
the optimal RAR value for this and several other cells evaluated, leading to the use of 




4.3.4 Quantitative Validation of JAnaP Calculations 
The JAnaP program was qualitatively and quantitatively validated by selecting 
10 cells that included a mix of junction types and shape factors. The cells were traced 
in ImageJ and the shape descriptors were directly compared. The line tool was used to 
manually calculate the percentage of the cell perimeter covered by each junction type. 
The percent difference calculated between the JAnaP results and ImageJ calculations 
Figure 4.9 Relative Aspect Ratio (RAR) Threshold Determination. The threshold 
length for categorization of punctate versus perpendicular junctions. White arrows indicate 
junctions that were incorrectly marked as perpendicular but should be punctate when the 
respective RAR was set too low. Yellow arrows indicate regions that were incorrectly 
categorized as punctate but should be perpendicular due to the RAR value being too high.    
 





were within 1% for cell area, 2% for perimeter and solidity, and 3% for circularity and 
all junction types (Table 4.1). 
 
4.3.5 Quantitative Validation of Multi-Protein Calculations 
This capability was first tested on images co-stained for ZO-1 and VE-cadherin. 
The waypoints were generated on the ZO-1 image and were projected onto the VE-
cadherin-tagged image. To validate this approach, cell morphology and junction 
coverage results were calculated based on waypoints generated on the same image and 
the image of the different stain, for both proteins. A threshold value of 15 was used to 
isolate ZO-1 junctions while a threshold of 5 was used to isolate VE-cadherin junctions. 






Note that the cells used in the study are from section 5.3.2 below and were selected due 
to the variations observed in protein co-localization with some treatments (Figure 4.10). 
For the shape factors (Figure 4.11), the values for each condition returned the 
same, non-significantly different result regardless of what image was used to calculate 
it. This means that waypointing a cell in ZO-1 to measure the cell in that image returned 
the same shape factor output when those waypoints were (1) projected on the VE-
cadherin staining and used to re-trace the same cell, (2) generated on the same cell on 
the VE-cadherin staining and used to measure the cell in the VE-cadherin image, (3) 
generated on the same cell on the VE-cadherin image, projected onto the ZO-1 image, 
and used to re-trace the ZO-1-stained cell.  
 
Figure 4.10 Immunostaining of 
Example Image in Multi-Protein 
Validation. Immunofluorescence 
image of HBMECs on fibronectin,  
cultured for 7 days with 3 days of 
cAMP treatment, stained for ZO-1 
(green), VE-cadherin (red), and 











For the junction coverage (Figure 4.12), the values for each protein again 
returned the same, non-significantly different result regardless of what image was used 
to calculate it. For junction coverage, though, differences between ZO-1 and VE-
cadherin would be expected. Therefore, this means that waypointing a cell in ZO-1 to 
measure the ZO-1 coverage returned the same coverage value when those waypoints 
Figure 4.11 Shape Factor Calculations via Multi-Protein Method. Perimeter 
(A), Area (B), Solidity (C), and Circularity (D) of HBMECs cultured for 7 days with 
0, 1, 3, or 6 days of cAMP treatment (see Chapter 5). Naming indicates the channel 
that the values were calculated for and / the channel the waypoints were generated in. 
Therefore, ZO-1 / ZO-1 and VE-cad / VE-cad indicate that the values were calculated 
using the same channel as the waypoint generation. ZO-1 / VE-cad indicates that the 
waypoints generated in the VE-cad channel were projected onto, and the cells were re-
traced using, the ZO-1 image. VE-cad / ZO-1 indicates the opposite. 15 ≤ N ≤ 21, 
where N is the number of cells. The Kruskal-Wallis test with Dunn’s multiple 
comparison tests were used to calculate significant differences for each parameter, 
where ns = no statistical significance.    
Figure 4.11 Shape 





were generated for the same cell on the VE-cadherin image and projected onto the ZO-
1 image, and vice versa for the VE-cadherin.  
 
Together, these results indicate that (1) ZO-1 and VE-cadherin are sufficiently 
overlapped within the cell-edge, such that using the stain of either one was adequate to 
measure the shape based on the other, and (2) the method of projecting waypoints 
within the JAnaP to trace at least two proteins is sufficient for generating consistent 
cellular outlines and measured results. Importantly, this type of analysis should be 
performed for every set of proteins intended for use, at least visually or via the method 
performed here, to ensure that the co-localization of the two proteins is acceptable. If 
Figure 4.12 Junction 
Calculations via Multi-
Protein Method. Total 
(A), Continuous (B), 
Punctate (C), and 
Perpendicular (D) 
coverage of ZO-1 (left) and 
VE-cadherin (right) in 
HBMECs cultured for 7 
days with 0, 1, 3, or 6 days 
of cAMP treatment (see 
Chapter 5).  Color coding 
indicates the channel used 
to generate the waypoints. 
15 ≤ N ≤ 21, where N is the 
number of cells. The 
Mann-Whitey test was 
used to calculate 
significant differences for 
each parameter, where ns = 
no statistical significance.    
 






the proteins are not sufficiently colocalized, the waypoints of one protein will be 
projected onto the other but may be inconsistently connected due to insufficient 
alignment with the second protein. If they appear too spread or the shape factors are 
different depending on which protein was used to generate the waypoints, then each 
protein image should be traced individually.  
4.4 Discussion 
The expression of EC junctional proteins plays a vital role in the physiology 
and pathophysiology of vascular barriers [191]. However, the ability to quantitatively 
measure the protein presentations as localized in a cellular monolayer has been 
significantly lacking in the field, limiting analysis of how various parameters involved 
with homeostasis or pathology influence junctional expression. Here, we developed a 
program that calculates edge-localized junction presentations in conjunction with cell 
morphological parameters. The program provides a streamlined analysis process in a 
semi-automated fashion, since the user only needs to identify the perimeter of each cell 
via waypointing and the remainder of the calculations are performed automatically. 
This helps to minimize human error beyond that which exists when identifying the cell 
perimeter, though, use of the Scikit path-finding algorithm further helps to minimize 
human error during this step. Note that this program is limited by image and microscope 
resolution; however, this same limitation exists in current manual analysis techniques. 
While others have manually calculated the percent of the cell perimeter covered by 
linear junctions,[15] to our knowledge, this is the first program that allows for a 
streamlined and automated approach to this otherwise tedious task. Additional reports 




junctions around the cell edge. Although not explicitly presented here, the JAnaP also 
measures these parameters in its overall calculations. Importantly, this program could 
theoretically be expanded to study virtually any cellular system in which 
immunofluorescent staining or fluorescent protein-tagging of cell-cell junctional 
proteins is feasible. Indeed, the program could also prove useful for analyzing 
dynamics of cell-cell junction presentation in real-time in response to drug treatments, 
mimicked disease conditions, or other relevant processes using fluorescently-tagged 
junctional proteins and live cell imaging.  
The JAnaP has important implications in the field of biomedical engineering 
and can serve as a tool to gain fundamental biological information about cell-cell 
junctions, as well as to help inform therapeutic strategies that require knowledge of 
drug transport mechanisms across vascular barriers. In particular, the JAnaP generates 
quantitative data that can undergo statistical analysis on cell-cell junctions, rather than 
relying on a person’s subjective interpretation of qualitative images. For example, the 
JAnaP could provide quantitative measures of continuous, punctate, and perpendicular 
tight junction protein alterations in ECs in response to interactions with tumor or 
immune cells,[77,192,193] inflammatory cytokines,[68] ischemia,[194] VEGF or 
thrombin treatment,[54,195] or even in response to mechanical injury such as traumatic 
brain injury [78,196]. Additionally, it could be used to quantify the extent of barrier 
opening when investigating new techniques for therapeutic delivery via BBB-
penetration (e.g., ultrasound,[197–199] photodynamic therapy,[200] photothermal 






 - Junction Phenotypes and Barrier Integrity 
5.1 Introduction 
 As described in Chapter 2, cell-cell junctions, especially within the blood-brain 
barrier, are extremely important for maintaining normal physiological processes. They 
regulate numerous cell functions (e.g., migration, proliferation) and paracellular 
transport across the barrier, such that decreased junctional protein is associated with 
dysregulated transport and leaky vasculature. Despite the important role of cell-cell 
junctions and the BBB, the mechanisms involved in barrier formation and disruption 
aren’t fully understood. Furthermore, the specific influence of different junction 
presentations on BBB properties remains largely understudied. One reason for this lack 
of quantification was the lack of efficient quantification methods to assess junction 
phenotype. The development of the JAnaP (Chapter 4) has since addressed this gap, 
enabling quantitative phenotyping of junction presentation in situ.  
 One difficulty in studying the BBB in vitro, is the challenge associated with 
recapitulating the in vivo BMEC properties, [202] such as the overexpression of the 
tightly structured network of cell-cell junctions. To address this, however, many 
approaches have been reported for various brain EC types. One technique to improve 
tight junction formation and barrier properties, evidenced by junction immunostaining, 
Transwell permeability studies, and TEER, is the co-culturing of ECs with neural cells 
(e.g., astrocytes) or their conditioned medium [203,204]. This not only improved BBB 
properties, but also provided insights into the roles of biochemical and physical 




biomimetic approach has been the use different matrix proteins that (at least partially) 
recapitulate the in vivo basement membrane or the brain microenvironment. The 
basement membrane is known to have an important role in maintaining vascular 
function [205]. As such, is it unsurprising that constituents of this matrix (i.e., 
fibronectin, collagen type IV, and laminin; or combinations of the three) are reported 
to elevate TEER values relative to type I collagen in porcine brain capillary ECs, [206] 
and  promote adhesion and spreading of iPSC-derived brain ECs [83]. Additionally, 
hyaluronic acid is a primary component of the brain microenvironment, [8] and has 
been shown to induce tube formation in a mouse-derived brain capillary EC line [207]. 
A mixture of hyaluronic acid and gelatin is reported to improve cell spreading of 
endothelial progenitor cells and HUVECs [208] and has been used for in vitro models 
of the BBB [209,210]. 
Another approach towards improving brain EC phenotype is the activation of 
cyclic 3’-5’-adenosine monophosphate (cAMP)-dependent protein kinase (PKA) via 
cAMP, dexamethasone or hydrocortisone, which is linked with improved barrier 
function [49,72,211]. Specifically, 8-(4-chlorophenylthio) adenosine-3’,5’-cyclic 
monophosphate sodium salt (CPT-cAMP) and 4-(3-butoxy-4-methoxybenzyl) 
imidazolidin-2-one (RO-20-1724) have been shown to decrease permeability and 
increase tight junctions in various EC types [48,212]. These supplements: (1) inhibit 
myosin light chain phosphorylation which decreases EC contraction, and (2) activate 
Rac1 to increase cortical actin stabilization and decrease actin stress fiber formation; 




confluency and maturity are also reported to influence junction presentation within the 
endothelium [15,71].  
Using the JAnaP to quantify junction presentation, we aimed to understand the 
influence of each junction phenotype in terms of contribution to overall barrier 
properties, such as permeability and barrier tightness (measured by TEER). To do this, 
we investigated what in vitro factors most influence junction presentation in HBMECs, 
then systematically varied those parameters to vary junction phenotype. Specifically, 
we studied substrate protein coating, culture time, and treatment with cAMP 
supplements to identify conditions driving altered states of junction presentation. We 
then aimed to correlate these junction phenotypes with measures of barrier integrity.  
5.2 Materials and Methods 
5.2.1 Cell Culture 
Ethics approval for all studies were obtained from the University of Maryland, 
Institutional Biosafety Committee (Protocol Number ESSR #15-06). HBMECs were 
purchased from Cell Systems and cultured as previously described [214].  
5.2.2 Substrate Coating and Experimental Conditions 
On Day 0, glass bottom 24-well plates (Greiner Bio-One, 662892) were coated 
with 100 µg/ml collagen I (CN) (Sigma Aldrich, C3867), 100 µg/ml fibronectin (FBN) 
(Sigma Aldrich, F2006), 100 µg/ml collagen IV (CIV) (Sigma Aldrich, C6745), 100 
µg/ml fibronectin: 100 µg/ml collagen IV: 2 µg/cm2 laminin (FCL), or 0.4% thiol-




min at 37 °C, or 2 µg/cm2 laminin (LN) (Sigma Aldrich, L4544) for 60 min at 37 °C. 
All constituents were resuspended per the manufacturer’s instructions, then diluted to 
the respective concentration in PBS (+/+ Ca2+/Mg2+). After coating the surface, the 
excess solutions were removed, the wells were rinsed with 37 °C PBS (+/+), 500 µl of 
warm HBMEC medium was added to each well, and the plate was incubated at 37 °C 
until HBMEC seeding (5E4 cells/cm2, 9.5E4 cells/well) (approximately 20 minutes). 
After the cells were seeded, 500 µl of warm medium was additionally added to each 
well, and the cells were cultured for 2, 4, or 7 days, with varying treatments with cAMP 
supplements. These “supplements” include 250 μM 8-CPT-cAMP (Abcam, ab120424) 
and 17.5 μM RO-20-1724 (Tocris Bioscience, 0415), which are routinely used in EC 
culture to improve junction localization barrier properties [215–219]. A summary of 
the culture conditions is presented in Figure 5.1. For all experiments, the medium was 
changed the day after cell seeding on Day 1, to “control” HBMEC medium or medium 
containing cAMP supplements. For 2-day experiments, the samples were fixed and 
stained on the subsequent day (Day 2), generating a sample with no cAMP treatment 
(2D/0d cAMP) or 1 day of cAMP treatment (2D/1d cAMP). For 4-day experiments, 
the medium was again changed two days later on Day 3, maintaining the cAMP 
supplements in the 4D/3d cAMP sample, adding the supplements to the 4D/1d cAMP 
sample, and maintaining no supplement in the 4D/0d cAMP sample. Those samples 
were then fixed the next day, on Day 4. For 7-day experiments, the medium was 
changed to add or maintain the respective supplement treatments on Day 3, Day 4, and 
Day 6. Those samples were then fixed the next day, on Day 7, to generate samples 




treatment (7D/3d cAMP), 1 day of cAMP treatment (7D/1d cAMP), or no cAMP 
treatment (7D/0d cAMP). Three biological replicates were performed for each 
experiment.      
5.2.3 Immunostaining  
HBMECs were rinsed with 37 °C PBS (+/+) and fixed with 1% formaldehyde 
(ThermoFisher Scientific, BP531) for 20 minutes. Note that all steps were performed 
under gentle rocking. Samples were then washed three times, 5 minutes each, with 
room temperature PBS (+/+), then permeabilized for 5 minutes with 0.25% TritonX-
100 (Sigma-Aldrich). The washing steps were repeated, then the samples were blocked 
for 1 hour at room temperature with 2% goat serum (Abcam). Primary antibodies 
against ZO-1 (rabbit polyclonal IgG, ThermoFisher Scientific, 61-7300, 1:500 dilution) 
and VE-cadherin (mouse monoclonal IgG, Santa Cruz, sc-9989, 1:50 dilution) in 2% 
goat serum were added to the cells overnight at 4°C. The next day, the wash and 
blocking steps were repeated, then secondary antibodies goat anti-rabbit Alexa Fluor 
488 (Abcam, ab150077, 1:100 dilution) and goat anti-mouse Alexa Fluor 568 
Figure 5.1 Cell Culture Conditions and Treatments. 






(ThermoFisher Scientific, A-11004, 1:100 dilution), plus 1:2500 Hoechst 
(ThermoFisher Scientific, H3570), were added to the cells in PBS (+/+) for 1 hour at 
room temperature. The wash steps were again repeat prior to imaging. For claudin-5 
staining (rabbit polyclonal IgG, Abcam, ab15106, 1:200 dilution), cells were instead 
fixed with 100% ice cold methanol (Sigma Aldrich) for 10 minutes and blocked with 
2% goat serum containing 0.3% TritonX-100 for 1 hour at room temperature.  
5.2.4 Junction Analysis 
This analysis was performed by Jae W. Jung (Stroka Lab). 
Junction presentation was quantified using the Junction Analyzer Program 
(JAnaP) previously described (Chapter 4, [215]). Briefly, the complete cells within 
each image were traced via “waypoints”. For ZO-1 and VE-cadherin quantification, 
this was performed on the images from the green fluorescent channel (i.e. ZO-1 
immunostaining), and the waypoints were projected onto the red fluorescent channel 
(i.e. VE-cadherin immunostaining). For claudin-5 quantification, the cells were traced 
using the red fluorescent channel (i.e. VE-cadherin immunostaining) and the waypoints 
were projected onto the green fluorescent channel (i.e. claudin-5 immunostaining), for 
improved cell-edge visualization. Threshold values of 15, 5, and 5, were applied to 
isolate the ZO-1, VE-cadherin, and claudin-5 junctions, respectively. The cell 
morphological parameters (e.g., area, solidity, circularity) were then calculated, as well 
as the percent of the cell edge presenting continuous, punctate, or perpendicular 
junction. The junction types were classified based on the length of the junction piece 




aspect ratio with respect to the cell path (> 1.2 for perpendicular junction, otherwise 
punctate).  
5.2.5 Transwell Permeability Assay 
Permeability measurement performed by Collin Inglut (Huang Lab). 
The Transwell permeability assay was performed per the 2-day treatment 
condition (Figure 1). On day 0, HBMECs were seeded (5E4 cells/cm2, 1.6E4 cells/well) 
into Transwell inserts (Falcon, 24 well format, 1.0 µm pore size) that had been coated 
with 100 µg/ml FBN for 30 minutes at 37 °C. The next day (day 1), the medium was 
changed to control medium (no supplements) or cAMP-medium. On day 2, solutions 
of 1 mg/ml FITC-Dextran (70 kDa, Sigma-Aldrich) were prepared in the respective 
medium formulations. Each Transwell was moved to a new well containing 800 µl of 
fresh medium (containing the respective cAMP treatment) and the top well medium 
was replaced with 400 µl of the dextran-medium. After 30 minutes at 37 °C, medium 
was collected, and the fluorescence was measured using a BioTek Synergy Neo2 plate 
reader (Excitation/Emission: 492/518 nm, Gain: 65). A standard curve was used to 
calculate the mass of dextran within the sample and the apparent permeability 
coefficient (P_app) was calculated as previously described by Tominaga et. al, [220]. 
𝑃𝑃_𝑎𝑎𝑝𝑝𝑝𝑝 = (𝑉𝑉𝑉𝑉 ∙ [𝐶𝐶𝑎𝑎𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑎𝑎𝑏𝑏]) ∙ 𝑉𝑉−1 ∙ [𝐶𝐶𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑎𝑎𝑏𝑏]−1 ∙ 𝑝𝑝−1 [=] 𝑐𝑐𝑝𝑝/𝑠𝑠 
𝑉𝑉𝑉𝑉 = 𝑐𝑐𝑐𝑐𝑐𝑐𝑢𝑢𝑝𝑝𝑎𝑎 𝑐𝑐𝑜𝑜 𝑎𝑎𝑎𝑎𝑐𝑐𝑢𝑢𝑝𝑝𝑝𝑝𝑐𝑐𝑎𝑎𝑐𝑐 𝑐𝑐ℎ𝑎𝑎𝑝𝑝𝑎𝑎𝑎𝑎𝑎𝑎 (0.8 𝑐𝑐𝑝𝑝3)  
𝑉𝑉 = 𝑝𝑝𝑎𝑎𝑝𝑝𝑎𝑎𝑎𝑎𝑎𝑎𝑐𝑐𝑎𝑎 𝑠𝑠𝑢𝑢𝑎𝑎𝑜𝑜𝑎𝑎𝑐𝑐𝑎𝑎 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 (0.33 𝑐𝑐𝑝𝑝2) 
[𝐶𝐶𝑎𝑎𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑎𝑎𝑏𝑏] = 𝑎𝑎𝑎𝑎𝑐𝑐𝑢𝑢𝑝𝑝𝑝𝑝𝑐𝑐𝑎𝑎𝑐𝑐 𝑑𝑑𝑎𝑎𝑐𝑐𝑝𝑝𝑎𝑎𝑎𝑎𝑐𝑐 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑎𝑎𝑐𝑐𝑝𝑝𝑎𝑎𝑎𝑎𝑝𝑝𝑝𝑝𝑐𝑐𝑐𝑐 (µ𝑔𝑔 𝑝𝑝𝑐𝑐−1) 
[𝐶𝐶𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑎𝑎𝑏𝑏] = 𝑝𝑝𝑐𝑐𝑝𝑝𝑝𝑝𝑎𝑎𝑐𝑐 𝑐𝑐𝑢𝑢𝑝𝑝𝑝𝑝𝑐𝑐𝑎𝑎𝑐𝑐 𝑑𝑑𝑎𝑎𝑐𝑐𝑝𝑝𝑎𝑎𝑎𝑎𝑐𝑐 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑎𝑎𝑐𝑐𝑝𝑝𝑎𝑎𝑎𝑎𝑝𝑝𝑝𝑝𝑐𝑐𝑐𝑐 (1000 µ𝑔𝑔 𝑝𝑝𝑐𝑐−1) 




Transwells were subsequently fixed and stained as described in the “Immunostaining” 
section above. The membranes were then removed from the inserts using an X-acto 
knife and sandwiched between two coverslips, luminal-side down. The membranes 
were then imaged, and the junctions were quantified, as described above. Three 
biological replicates were performed for this experiment.      
5.2.6 Local Permeability Assay 
To visualize areas of monolayer leakiness and correlate them with junction 
phenotype, we adapted the XPerT permeability assay developed by Dubrovskyi et al. 
[62]. Here, however, FBN was biotinylated (b-FBN) using EZ-Link NHS-LC-LC-
Biotin (ThermoFisher Scientific, 21343) according to the manufacturer’s instructions 
(instead of gelatin described in [62]). b-FBN was then adsorbed onto glass bottom 24-
well plates overnight at 4 °C. Excess protein was then removed, the wells were rinsed 
with PBS (+/+), and 500 µl of warm HBMEC medium was added to each well. The 
plate was incubated at 37 °C until HBMEC seeding (5E4 cells/cm2, 9.5E4 cells/well) 
(approximately 20 minutes). After the cells were seeded, 500 µl of warm medium was 
additionally added to each well, and the cells were cultured per the 2-day experiment 
in Figure 5.1. Prior to fixing, however, the samples were treated with 50 µg/ml FITC-
avidin (ThermoFisher Scientific, A821) for 3 min. This resulted in immobilized FITC-
avidin bound to the underlying b-FBN at permeable sites of the monolayer. The 
samples were then fixed and stained for ZO-1 and VE-cadherin per the 
“Immunostaining” section above, but each protein was immunostained separately and 
goat anti-rabbit Alexa Fluor 568 (ThermoFisher Scientific, A-11011) was used as the 




due to the immobilized FITC-avidin, and phenotyping of red junctions, via 
immunostaining. Three biological replicates were performed for each ZO-1 and VE-
cadherin.       
5.2.7 Local Permeability Analysis 
 To analyze the results of the local permeability assay, two primary steps were 
performed. An example monolayer image is presented in Figure 5.2.A to depict each 
step. First, image processing of the green-channel images of the bound FITC-avidin 
was performed in ImageJ (Figure 5.2.B). To do this, each image was converted to 8-bit 
and a threshold was applied to create a binary image showing the presence or absence 
of a permeated region (PR) (Figure 5.2.C). The second step was to process the red-
channel junctional protein images (Figure 5.2.D) using the JAnaP. This analysis 
differed from other JAnaP processing described in section 5.2.4, since every single cell 
border was waypointed, regardless of whether the entire cell was present in the image. 
The Jupyter Notebook was then used to generate several images of the categorized 
junctions, in some cases, overlaying them onto the PR threshold images (Figure 5.2.E-






Figure 5.2 Local Permeability Analysis – Image Processing. Composite image of 
VE-cadherin (red) and FITC-avidin (green), labeled to identify examples of the PR 
categories (A). Images of bound FITC-avidin (B) are processed in ImageJ to generate 
8-bit binary images of PRs (C). The raw junctional protein images (D) are processed 
in the JAnaP to generate images of categorized junctions, which can be overlaid onto 
the PR images (E) and separated into images depicting only junctions of a specific 
category (J-L). Cropped images depicting the regions in the gray-dotted box for (E, 
G-I) are presented in (F, J-L), respectively. (scale bar = 20 μm, applies to A-E, G-I)  




5.2.7.A PR Categorization   
PRs were categorized as Uni, Bi, Tri, Quad, or Multi, depending on the number 
of cells the PR was associated with (1, 2, 3, 4, 5+, respectively). Figure 5.2.A presents 
an example of most categories. To quantify PR area, the Analyze Particles function in 
ImageJ function was used on the PR threshold images (Figure 5.2.C). Images showing 
the cell edges on top of the PRs (Figure 5.2.E) were used to manually identify the 
number of cells that each PR was adjacent to. Five images from each of the 2-3 trials 
were measured, and the average count of each PR category per image was calculated. 
The PR area measurements were averaged over all PRs within the respective category. 
While this was performed for the PR images associated with both the VE-cadherin- and 
ZO-1-stained images, only the VE-cadherin-associated results are presented here. Note 
that the ZO-1-associated images showed similar trends.  
5.2.7.B Junction analysis along PR length 
To calculate the percent and count of junctions along the cell perimeters 
coinciding with PRs, images like Figure 5.3.A were used. These overlapped images 
were manually traced in ImageJ using the segmented line tool. Importantly, only PRs 
greater than 400 pixels2 were included in this analysis. For each blot (Figure 5.3.B), the 
length of the cell path(s) overlapping the PR was manually traced to calculate the PR 
length (Figure 5.3.C). Then, the number and length of each junction type was 
subsequently summed (Figure 5.3.D-F). The difference was taken to be the length of 
the no junction regions. The summed length of each junction type divided by the PR 
length was taken to be the % Junction Along the PR Path. For the continuous versus 




together as the measures of discontinuous junctions. Three images from the 2-3 trials 
were measured, with the values calculated on a per PR basis.  
 
5.2.7.C Co-localization Analysis  
For the co-localization analysis, the Jupyter Notebook was used to generate 
junction-categorized images that presented all the junctions for each category within a 
given image, on a black background without the cell path (Figure 5.4.top row). These 
images were uploaded into ImageJ, converted to 8-bit, and a threshold was applied to 
isolate the junctions. A selection was then created to measure the total area of each 
junction type present within the image (A_total). Next, the PR threshold images (Figure 
Figure 5.3 Junction 
Analysis Along PR 
Length. Junction 
categorization and cell paths 
overlaid onto PR threshold 
image (A). Gray-dotted box 
indicates blot cropped for 
this example (B). Tracing 
the length of the cell path 
that corresponds to the 
length of the PR (green) 
provides the PR length (C). 
Tracing the length of each 
junction type (green) 
provides the count and 
length of continuous (D), 
punctate (E), and 
perpendicular (F) junctions 
along the PR length. The 
numbers indicate a distinct 
junction piece. (scale bar = 








5.2.C) were again uploaded into ImageJ. A selection was created to isolate the PRs and 
was used as a mask applied to each junction image (Figure 5.4.middle row). The 
junctions present outside of the masked PR region were removed, leaving only the 
junction pieces corresponding to the PRs remaining (Figure 5.4.bottom row). Another 
selection was created to measure the area of each junction type that corresponded with 
PRs in the image (A_PR). The % Co-localization was taken as (A_PR/A_total)*100 
for each junction type.   
 
5.2.8 Trans-Endothelial Electrical Resistance (TEER) Assay 
TEER measurement performed by Jae Jung (Stroka Lab). 
For the TEER assay, cells were cultured on Transwell inserts (24-well) with a 
0.4 µm pore size (Falcon, 353047) according to the 4 Day schedule (Figure 5.1). On 
day 0, the inserts were coated with 100 µg/ml FBN and incubated for 1 hour at 37 °C. 
Figure 5.4 Co-
localization Analysis. 
Isolated junctions  used 
to calculate the total 
junction area (A_total) 
for each junction type 
(top row). A “selection” 
of the corresponding PR 
threshold image was 
used to create a mask 
applied to each junction 
type (middle row) and 
remove all junctions that 
did not colocalize with a 
PR. Area measurement 
of  remaining junctions 
(bottom row) provided 
the PR colocalized 
junction area (A_PR).  





Excess solution was then removed, and the inserts were rinsed with warm PBS (+/+). 
The top and bottom chambers of the system were then respectively filled with 100 µl 
and 800 µl of warm HBMEC medium and placed in the incubator during cell splitting. 
HBMECs were then plated at 5x104 cells/cm2 and the volume of the top chamber was 
then brought to 200 µl. The controls for this experiment were a blank insert and an 
insert with just the FBN coating for each condition. Starting on Day 1, resistance 
measurements were performed using an EVOM2 meter and performed every day for 
the duration of the experiment. Electrodes were rinsed in warm PBS (+/+) then 
HBMEC medium prior to measurement of each sample. On days on which a media 
change occurred, the TEER measurement was performed prior to the media change. 
After collecting the measurement on Day 4, the inserts were rinsed with warm PBS and 
fixed as described in section 5.2.3. Prior to imaging, the membranes were removed 
from the insert, inverted, and sandwiched between two glass coverslips with PBS. 
Junction analysis was then performed on the images as described in  section 5.2.4. 
5.2.9 Microscopy 
All samples were imaged using a 60x oil objective on an inverted IX83 
Olympus microscope and Olympus cellSens Software. For fixed-cell epifluorescence 
microscopy, images were simultaneously collected using the red, green, and blue 
filters. Images within the manuscript have been enhanced via ImageJ for improved 
visualization. For live-cell imaging, the imaging chamber was maintained at 37°C, 50% 
humidity, and 5% CO2. Images were collected every 5-10 minutes, then then image 
sequences were analyzed for junction presentation as described in the “Junction 




5.2.10 Statistical Analysis 
All statistical analysis and graph generation was performed using GraphPad 
Prism 8. For each data set, a D'Agostino-Pearson normality test was used to identity 
the normality of the data. If the data was normal, a one-way ANOVA with a Tukey’s 
multiple comparison post-hoc test was performed. More frequently, the data was non-
normal, in which case the non-parametric Kurskal-Wallis ANOVA with Dunn’s 
multiple comparison post-hoc testing was performed instead. For instances where only 
two groups were compared, a Mann-Whitney test was used. A linear regression was 
used to compare the junction presentation with global permeability and a two-way 
ANOVA was used to compare the experimental versus the control group for each set 
in the TEER study. No statistical significance (ns) was determined using p > 0.05, and 
statistical significance was indicated as * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p 
≤ 0.0001. Errors bars represent standard error of the mean. All data represents pooled 
values from three independent trials unless otherwise noted in the figure captions.  
5.3 Results 
5.3.1 cAMP supplements increase continuous ZO-1 and VE-cadherin 
junctions, independently of substrate coating 
Figure 5.5 respectively presents HBMECs cultured for 2 days with and without 
cAMP supplements on six different matrix constituents. Only minor differences in cell 
and junction morphology were apparent between each substrate coating. While no 
significant differences in cell area, solidity, or circularity were observed (Figure 5.6), 




Table 5.1). The addition of cAMP supplements generally decreased cell area but had 
only minor effects on cell circularity and solidity (Figure 5.6). On the other hand, 
cAMP supplements consistently improved barrier architecture, as expected. Significant 
increases in continuous junction were observed for every condition for both ZO-1 and 
VE-cadherin (Figure 5.7), with the greatest presentation observed on FBN (though, 
F:C:L and HA:G induced similar coverage). While only minor changes in punctate and 
perpendicular ZO-1 were observed, cAMP supplements significantly decreased 
punctate VE-cadherin and increased perpendicular VE-cadherin.  
Figure 5.5 Immunofluorescence Images of HBMECs in 2-day Culture. HBMECs on 
6 substrate coatings, cultured for 2 days with and without cAMP treatment, stained for 











Figure 5.6 Cell Morphology Analysis for 2-day Culture. Cell area (A), circularity 
(B), and solidity (C) of HBMECs cultured on the 6 substrate coatings for 2 days, with 
and without 1d cAMP treatment. 72 ≤ N ≤ 125, where N is the number of cells. The 
Kruskal-Wallis test was used to calculate significant differences for each parameter, 
where * p < 0.05, ** p < 0.01, and *** p < 0.001.   Figure 5.7 Cell Morphology 
     
Figure 
5 6 Figure 5.7 Junction Phenotype Analysis for 2-day Culture. Edge presentation of 
continuous (A, D), punctate (B, E), and perpendicular (C, F) junctions for ZO-1 and 
VE-cadherin, respectively. 72 ≤ N ≤ 125, where N is the number of cells. The Kruskal-
Wallis test with a Dunn’s multiple comparison test was used to calculate significant 
differences for each parameter, where * p < 0.05, ** p < 0.01, *** p < 0.001, and **** 





5.3.2 Extending cell culture requires increased cAMP treatment for 
similar junction coverage  
 While treatment with cAMP supplements led to increased junction coverage for 
both ZO-1 and VE-cadherin, the total percentage of junction presented at the cell edge 
(calculated by adding the junction presentation of each junction type) remained less 
than full coverage. We therefore investigated the effects of extended cell culture and 
cAMP treatment time to probe the ability of these parameters to further increase 
Table 5.1 Statistical Significance for Junction Phenotype Analysis for 2-day Culture. 
The comparison between each substrate protein with and without cAMP is presented, as 
calculated using the Kruskal-Wallis test with a Dunn’s multiple comparison test. A red box 
marked with “ns” signifies no significant difference. A green box signifies a significant 
difference,  where * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. Data 
corresponds to Figure 5.8.  Table 5.1 Statistical Significance for Junction 




junction coverage. Since we observed minimal differences between substrate protein 
coatings,  we investigated these effects only on FBN.   
First, we studied the effects of extending the time in cell culture to 4 days. 
Figure 5.8 respectively presents HBMECs cultured for this length of time with 0, 1, or 
3 days of cAMP supplements. No change in cell area, circularity, or solidity, were 
observed with cAMP treatment, though the cells were smaller compared to those 
cultured for 2 days, except for 4D/3d cAMP groups where increased area was observed. 
Increased cAMP treatment increased both continuous and perpendicular ZO-1 and VE-
cadherin. The greatest continuous junction presentation was observed with 3d cAMP, 
which covered approximately 38% and 61% of the cell edge for ZO-1 and VE-cadherin, 
respectively. These coverage values were similar to those observed in HBMECs 
cultured for 2 days with 1d cAMP, suggesting increased culture time required increased 
cAMP treatment to reach comparable junction presentation.  
Punctate junctions, on the other hand, displayed different responses for ZO-1 
versus VE-cadherin. While no chance in punctate ZO-1 was observed, punctate VE-
cadherin decreased with increased cAMP treatment.     
Next, we studied the effects of extending cell culture to 7 days with 0, 1, 3, or 
6 days of cAMP treatment on FBN (Figure 5.9).  While 1d cAMP treatment decreased 
cell area, increased cAMP treatment beyond 1d increased area, with the largest cells 
observed with 6d cAMP. Notably, the cell area with 7-day culture was comparable to 
the size of cells cultured for 2 days, versus 4-day culture where smaller cells were 
observed. Continuous ZO-1 increased with increased cAMP treatment up to 3d, while 









Figure 5.8 4-day HBMEC Culture. (A) Immunofluorescence images of HBMECs on 
FBN, cultured for 4 days with 0, 1, or 3 days of cAMP treatment. Stained for ZO-1 
(green), VE-cadherin (red), and DNA (blue). (scale bar = 20 μm) (B) Cell area, (C) 
circularity, and (D) solidity. Edge presentation of continuous, punctate, and perpendicular 
junctions for (E) ZO-1 and (F) VE-cadherin. 87 ≤ N ≤ 145, where N is the number of 
cells. The Kruskal-Wallis test with a Dunn’s multiple comparison test was used to 
calculate significant differences for each parameter, where ns = p > 0.05, *** p < 0.001, 





level of presentation with 3d treatment. For both junction proteins, however, 6d of 
cAMP treatment led to a significant decrease in continuous junction presentation, 
comparable to 1d treatment. While no change in perpendicular junctions was observed 
punctate ZO-1 increased with 1d cAMP treatment, and punctate VE-cadherin decreased 
with increased cAMP treatment up to 3d, then spiked up with 6d cAMP treatment.  
Cumulatively, the greatest total protein coverage observed during 7-day culture 
was with 3d cAMP treatment, with approximately 54% of the cell edge covered by ZO-
1 and 76% by VE-cadherin. These values were comparable to the total coverage 
observed during 4-day culture with 3d cAMP treatment, and 2-day culture with 1d 
cAMP treatment . This suggests that increased cAMP treatment is needed to maintain 
ZO-1 and to a lesser extent, VE-cadherin, with increased culture time. Importantly, 
there seems to be a limit to this trend since a decrease in continuous ZO-1 (and a spike 
in punctate VE-cadherin) was observed with 6d cAMP treatment. Furthermore, these 
studies suggest that FBN  is a suitable matrix to induce varied presentation of  ZO-1 





Figure 5.9 7-day HBMEC Culture. (A) Immunofluorescence images of HBMECs on 
FBN, cultured for 7 days with 0, 1, 3, or 6 days of cAMP treatment. Stained for ZO-1 
(green), VE-cadherin (red), and DNA (blue). (scale bar = 20 μm) (B) Cell area, (C) 
circularity, and (D) solidity. Edge presentation of continuous, punctate, and perpendicular 
junctions for (E) ZO-1 and (F) VE-cadherin. 74 ≤ N ≤ 115, where N is the number of 
cells. The Kruskal-Wallis test with a Dunn’s multiple comparison test was used to 
calculate significant differences for each parameter, where ns = p > 0.05, * p < 0.05, ** 
p < 0.01,  *** p < 0.001, and **** p < 0.0001.     




5.3.3 Increased culture time increases continuous claudin-5 junctions  
 Since TJs are known to assemble after AJs, we next investigated the effects of 
increased cell culture and cAMP treatment time on the phenotypic presentation of TJ 
protein claudin-5 on FBN coating. First, we cultured HBMECs for 4 days with 0d, 1d, 
or 3d cAMP, where we qualitatively saw increased edge-localization with cAMP 
treatment (Figure 5.10.A). Figure 5.10.B presents the quantified junction analysis, 
supporting this observation, showing that continuous and perpendicular claudin 
increased with cAMP treatment, independent of 1d or 3d treatment length, while 
punctate claudin remained unchanged.    
 
Figure 5.10 Claudin-5 Phenotype Analysis for 4-day Culture. (A) Immuno-fluorescence 
images of HBMECs on FBN, cultured for 4 days with 0d, 1d, or 3d cAMP treatment, 
stained for Claudin-5 (green), VE-cadherin (red), and DNA (blue). (scale bar = 20 μm). (B) 
Edge presentation of continuous, punctate, and perpendicular claudin. 19 ≤ N ≤ 47, where 
N is the number of cells. The Kruskal-Wallis test with a Dunn’s multiple comparison test 
was used to calculate significant differences for each parameter, where ns = no statistical 
significance, ** p < 0.01 and **** p < 0.0001.  
 





Next, we extended the culture time to 7 days, and observed minimal claudin 
presentation with 6d cAMP treatment, in line with our observations for ZO-1 and VE-
cadherin (Figure 5.11).  Maximal continuous claudin was found to be approximately 
35% with 1d cAMP, higher than the approximate 30% observed with 1d cAMP 
treatment during 4-day culture. Punctate claudin, however, was unchanged with cAMP 
treatment and was presented at comparable levels to those found during 4-day culture. 
With cAMP treatment, perpendicular claudin was found at similar levels between 4-
day and 7-day culture, though 6d cAMP treatment significantly decreased presentation 
to the approximate levels of 4-day culture with 0d cAMP.  
Figure 5.11 Claudin-5 Phenotype Analysis for 7-day Culture. (A) Immunofluorescence 
images of HBMECs on FBN, cultured for 7 days with 0d, 1d, 3d, or 6d cAMP treatment, 
stained for Claudin-5 (green), VE-cadherin (red), and DNA (blue). (scale bar = 20 μm). (B) 
Edge presentation of continuous, punctate, and perpendicular claudin. 21 ≤ N ≤ 52, where N 
is the number of cells. The Kruskal-Wallis test with a Dunn’s multiple comparison test was 
used to calculate significant differences for each parameter, where ns = no statistical 
significance, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. 





5.3.4 Transwell TEER and permeability assays are insufficient for 
correlative assessment of junction phenotype and barrier properties 
 In the literature, continuous, linear adherens junctions are indicative of stable, 
mature EC barriers, while immature junctions are presented as punctate or 
perpendicular regions of junction [15]. As such, discontinuous junctions are typically 
linked with decreased barrier function, such as increased permeability [76]. Since the 
conditions tested here generated varied presentations of continuous and discontinuous 
tight and adherens junctions, we aimed to use these treatments to gain an understanding 
of the influence of junction phenotype on barrier properties (e.g., TEER, permeability) 
using traditional measurement techniques (e.g., Transwell assays) .  
First, we performed a permeability assay by culturing HBMECs for 2 days on 
FBN-coated Transwell inserts, comparing the effects of 0d and 1d cAMP treatment on 
the permeability of 70 kDa FITC-dextran. Since 1d cAMP treatment significantly 
increased junction coverage in section 5.3.1, we expected decreased permeability with 
Figure 5.12 Transwell Permeability Analysis. Apparent permeability coefficient (P_app) 
of HBMECs cultured for 2 days with 0d or 1d cAMP treatment. N = 6, where N is the 
number of inserts measured over 3 trials. Significant difference of * p < 0.05 as determined 
using a Mann-Whitney statistical test. Correlation of each junction type for ZO-1 (B) and 
VE-cadherin (C) coverage with P_app, where a linear regression rendered the slope of all 
relationships non-significantly non-zero. N = 12, where N is the number of inserts pooled 
between the 0d and 1d cAMP conditions. Data collection for (A) was performed by Collin 
Inglut (Huang Lab).    
Figure 5.12 Transwell Permeability 




1d treatment. Indeed, the apparent permeability coefficient (P_app) decreased with 1d 
cAMP, as presented in Figure 5.12.A. To correlate these permeability values with 
junction presentation, the inserts were fixed, immunostained for ZO-1 and VE-
cadherin, and imaged for cell and junction morphology analysis using the JAnaP. The 
P_app values for each sample were then plotted against the junction coverage values 
(Figure 5.12.B,C). Surprisingly, no significant correlation was found between junction 
coverage and permeability, which could suggest that ZO-1 and VE-cadherin phenotype 
does not influence permeability. This result is very unlikely given the literary evidence 
suggesting otherwise [34,81,221–223]. It is important to note, though, that these reports 
are qualitatively correlative between immunostaining and permeability measurement, 
and not a quantitative correlation between permeability and junction presentation. 
Based on our results in section 5.3.1 and Figure 5.12.A, we could draw a similar 
conclusion that increased continuous junctions is linked with decreased permeability. 
This conclusion, however, assumes that the junction presentation of the cells within the 
two different experimental setups in consistent.  
To probe the validity of this assumption, we investigated the cell and junction 
characteristics on the Transwell inserts to compare them against the results from section 
5.3.1 when the cells were cultured on glass bottom plates (Figure 5.13). While cAMP 
decreased cell area from approximately 2000 μm2 to 1500 μm2 on glass (Figure 5.6), 
cells on the inserts were approximately 1700 μm2 in area and remained unchanged with 
cAMP treatment. In both cases, circularity and solidity were consistent with and 
without cAMP. While the treatment increased continuous junctions in both cases, the 





compared to glass. For example, continuous ZO-1 and VE-cadherin respectively 
reached approximately 20% and 51% on the inserts, compared to the approximate 32% 
and 66% coverage values observed on glass. These different trends for cell area and 
junction presentation with cAMP treatment suggest that the assay (e.g., treatment with 
FITC-Dextran, or cAMP supplements to both the apical and basal side), or the different 
mechanical environments (i.e., stiff glass versus softer membrane), could be altering 
the cells and/or their response to cAMP treatment. This could potentially explain the 
lack of correlation observed between junction phenotype and permeability, since one 
possibility is that the magnitude of change of each junction type did not vary enough 
to influence permeability. This would mean that significantly more (or less) junction 
Figure 5.13 Cell Morphology and Junction Phenotyping from Transwell Permeability 
Assay.  Cell area (A), circularity (B), and solidity (C) of HBMECs cultured on Transwell 
inserts coated with FBN, cultured for 2 days, with 0d or 1d cAMP treatment. Edge presentation 
of continuous, punctate, and perpendicular junctions for ZO-1 (D) and VE-cadherin (E). The 
Mann-Whitney test was used to calculate significant differences for each parameter, where ns 
= no significance, * p < 0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001. For (A-E), 53 











presentation would be required to alter the overall permeability of the barrier. 
Furthermore, the monolayer may not be homogenous throughout the entire insert. Any 
gaps or regions of heterogeneity could lead to increased permeability, significantly 
skewing the P_app results since it is a “bulk” measurement of the entire barrier.  
We next measured TEER to probe barrier integrity as a function of junction 
phenotype. The 4-day culture protocol (Figure 5.1) on FBN with 0d, 1d, and 3d cAMP 
treatment was selected to provide more sequential values of total junction coverage. 
The resistance measurements were performed on each day and the adjusted results are 
presented in Figure 5.14. We observed the expected outcome: increased TEER with 
increased cAMP treatment, though the changes were minor and insignificant.  
To examine the monolayer characteristics, the samples were again fixed and 
immunostained after the TEER measurement on the fourth day (Figure 5.15). Cell 
morphology and junction presentation were then characterized using the JAnaP (Figure 
5.16) and plotted against the TEER values for correlative analysis (Figure 5.17). Like  
Figure 5.14 TEER Assay. Resistance measurements of HBMECs cultured on FBN-coated 
Transwell inserts for 4 days with 0d, 1d, or 3d cAMP treatment. Control measurements 
without cells are also presented. N = 3, where N= number of trials. A two-way ANOVA 
indicated significant differences for each condition versus their FBN-only control , 
presented in the figure legend, where * p < 0.05 and **** p < 0.0001. Data collection for 
this assay was performed by Jae W. Jung (Stroka Lab).      





permeability, no correlations between junction presentation and resistance 
measurements were observed, which was not surprising since the TEER values 
themselves were insignificant between each condition. While the trends with cAMP 
treatment for area, circularity, and solidity were generally consistent with the previous 
findings in section 5.3.2, the cells were larger on the inserts compared to the glass-
bottom plates (Figure 5.6). In line with the observations from the permeability assay, 
the junction presentations of both ZO-1 and VE-cadherin were different on the inserts 
compared to glass and did not respond to cAMP treatment in the same manner. While 
continuous ZO-1 on FBN-coated glass increased from approximately 10% to 20% to 
40% with cAMP treatment of 0d, 1d, and 3d, respectively, the presentation on FBN-
coated inserts increased to approximately 35% with 1d and 3d cAMP from 
approximately 20% with 0d cAMP treatment. Similarly, while continuous VE-cadherin 
Figure 5.15 
Transwell Images 
from TEER Assay. 
Immunofluorescence 
images of HBMECs 
on Transwell inserts 
coated with FBN, 
cultured for 4 days, 
with 0d, 1d, and 3d 
cAMP treatment. 
Stained for ZO-1 
(green), VE-cadherin 
(red), and DNA 








increased from approximately 15% to 45% to 60% on FBN-coated glass with 0d, 1d, 
and 3d cAMP, respectively, the presentation on FBN-coated inserts increased to 
approximately 58% with 1d and 3d cAMP from approximately 50% with 0d cAMP 
treatment. This decreased response to cAMP in the Transwell system could explain the 
lack of significant difference in TEER values between each day, since the range of 
changes in junction might not be large enough to induce significant differences in 
resistance. The generally low values, however, suggest that small defects or 
heterogeneities in the monolayers may have been present, generating “shortcuts to 
current flow”, drastically decreasing the resistance measurement [56]. According to 
Wegener, et al., even just missing one in a hundred cells within a monolayer can 
decrease the TEER value by 50 Ω·cm2 [56]. 
Figure 5.16 Cell Morphology and Junction Phenotyping from TEER Assay.  Cell area 
(A), circularity (B), and solidity (C) of HBMECs cultured on Transwell inserts coated with 
FBN, cultured for 4 days, with 0d, 1d, and 3d cAMP treatment. Edge presentation of 
continuous, punctate, and perpendicular junctions for ZO-1 (D) and VE-cadherin (E). 53 ≤ N 
≤ 72, where N is the number of cells. The Kruskal-Wallis test with a Dunn’s multiple 
comparison test was used to calculate significant differences for each parameter, where * p < 
0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001.   
 
Figure 5.16 Cell Morphology and 




Overall, this motivated the use of a more localized assay to understand the 
effects of junction phenotype on local barrier function. Specifically, the ability to 
correlate local junction presentation with local barrier properties in situ was needed to 
mechanistically study the role of junction phenotyping.   
Figure 5.17 Junction Phenotype and TEER Correlation. Correlation of each junction 
type for ZO-1 (A-C) and VE-cadherin (D-F) coverage with TEER, where a linear 
regression rendered the slope of all relationships non-significantly non-zero. N = 9, 
where N is the number of inserts pooled between the 0d, 1d, and 3d cAMP conditions.   
 
Figure 5.17 




5.3.5 Local permeability assay reveals correlation between discontinuous 
junctions and barrier penetration 
 To circumvent the challenges faced in the Transwell permeability and TEER 
assays, we adapted the XPerT assay [62] to detect regions of local monolayer 
permeability in situ. This technique enables visualization of barrier permeation via 
FITC-avidin-binding to biotinylated-FBN, in parallel with junction immunostaining. 
Here, we used this assay in conjunction with the JAnaP to quantitatively study junction 
phenotype and site-specific barrier permeability. Figure 5.18 presents representative 
images of VE-cadherin (A-B) and ZO-1 (C-D) in HBMECs cultured for 2 days with no 
cAMP treatment. 
  To start, we characterized the permeated regions (PR) of the monolayers, 
indicated by substrate-bound green fluorescence, since the number of cells 
corresponding to PRs was not always consistent. We therefore categorized each PR 
based on the number of cells with which it correlated (i.e., Uni, Bi, Tri, Quad, or Multi). 
To quantify each of these instances, we averaged the number of times each category 
was present within each image (Figure 5.19.A). Bi-cellular PRs were the most 
consistent PR, with about 16 bi-cellular PRs per image. Larger PRs such as Quad or 
Multi were much less common, occurring less than or equal to one time per image. Size 
analysis indicated that PR area significantly increased with each additional cell contact, 






Figure 5.18 Local Permeability Assay. Immunofluorescence images of HBMECs 
cultured for 2 days on B-FBN without cAMP, treated with FITC-avidin (green), then 
stained for VE-cadherin (row A, red), ZO-1 (row C, red), and DNA (blue). Rows B and C 
provide a zoomed-in view of the region outlined in the white-dotted box in the respective 
images.  (scale bar = 20 μm, applies to rows A and C) 
 




 Next, we investigated the types of junctions present around the PRs. Here, we 
combined perpendicular and punctate junctions as discontinuous junctions. 
Qualitatively, we observed PRs primarily in regions of no junction or discontinuous 
junctions. To quantify this observation, we traced the length of each junction type 
present along the cell path overlapping each PR (Figure 5.20). The total junction count 
and coverage fraction was dominated by regions of no junction for both VE-cadherin 
and ZO-1. This suggests that in regions where FITC-avidin penetrated the barrier, the 
cell edge was most commonly covered by regions of “no junction”. For VE-cadherin, 
continuous and discontinuous junctions covered the same fraction of the PR, though 
the fraction of no junction was significantly greater. For ZO-1, however, continuous 
junction covered significantly less than either discontinuous or no junction. To gauge 
how frequently each junction type corresponded with a PR, we calculated the percent 
co-localization for each image (Figure 5.20.E-F). Interestingly, the co-localization was 
rather consistent between the VE-cadherin and ZO-1, with about 15% of the continuous 
Figure 5.19 Permeated Region Analysis. The average number of each PR 
type per image is presented in (A) while the average size of each PR type is 
presented in (B). N = 15 for (A) where N is the number of images. 11 ≤ N ≤ 
247 for (B) where N is the number of PRs. The Kruskal-Wallis test with a 
Dunn’s multiple comparison test was used to calculate significant differences 
for each parameter, where * p < 0.05, ** p < 0.01, and **** p < 0.0001. 
 




junctions and about 30% of the discontinuous junctions co-localizing with the PRs. 
Together this suggests that while discontinuous junctions are more likely to associate 
with a PR, the presence of either junction does not necessarily indicate a permeable 
region of the monolayer. 
Figure 5.20 Co-localization Analysis – Continuous vs. Discontinuous. Count (A-B) and 
percentage (C-D) of ZO-1 and VE-cadherin junctions along the cell edges co-localized 
with PRs. N = 126 for ZO-1 and 105 for VE-cadherin, where N is the number of PRs. The 
percent of co-localization of each junction type with PRs in each image is presented in (E) 
for ZO-1 and (F) for VE-cadherin. N = 9, where N is the number of images. The Kruskal-
Wallis test with a Dunn’s multiple comparison test was used to calculate significant 
differences for (A-D) and a Mann-Whitney test was used for (E-F), where ns = no 
statistical significance, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. 
Figure 5.20 
Co-




 Despite this, we were curious if the amount of any one junction type (or no 
junction region) would instead correlate with “how permeable” the permeable regions 
were. We measured the extent of permeability as the area of the PR and investigated 
the correlation between PR area and junction presentation (Figure 5.21). Note that these 
graphs have excluded 2-3 very large Multi PRs that were likely affected by more than 
just the local junction presentation of these proteins. Since the fraction of no junction 
regions dominated the PR length for both VE-cadherin and ZO-1, the magnitude of this 
line is greater than either continuous or discontinuous. For VE-cadherin, there was no 
statistically significant correlation between percent junction and PR area. For ZO-1, 
however, discontinuous junction showed a significant correlation (p < 0.05), though 
the R2 value was low (R2 = 0.039). Analysis of the junction counts, however, showed 
significant trends for almost every condition. Since the junctions are inherently 
categorized by size, looking at the number of junctions considers the smaller sizes of 
discontinuous junctions relative to continuous, that could inadvertently be skewing the 
percentage results. For both VE-cadherin and ZO-1, all junction types presented a 
significant correlation (p < 0.0001), with discontinuous and no junctions showing a 
much greater positive correlation compared with continuous junction. Together this 
suggests that the size of the PR, or how permeable the barrier is as permeable region, 
is  influenced by the presentation of discontinuous junction and no junction, with 






While the influence of junction protein localization and presentation at the cell-
cell borders of ECs on barrier properties has been significantly investigated, these 
studies have been performed in a primarily qualitative manner and lacked the 
quantification of junction phenotype. Development of the JAnaP (Chapter 4) has 
enabled the quantitative analysis of cell-cell junctions in situ, thereby permitting the 
study of junction phenotype on EC barrier properties in a calculated manner. In this 
Figure 5.21 Junction Presentation and PR Area – Continuous vs. Discontinuous. 
The correlation between PR area and the percent (A,B) and count (C,D) each continuous 
(Cont.), discontinuous (Disc.), and no junction (No Junct.) the cell edge co-localized with 
the PR for ZO-1 and VE-cadherin. All results were fit using a linear regression. N = 126 
for ZO-1 and 105 for VE-cadherin, where N is the number of PRs. The Cont., Disc., and 
No Junct. R2 values are as follows: 0.001, 0.039, 0.019 for (A), 0.008, 0.009, 0.007 for 
(B), 0.213, 0.617, 0.662 for (C), and 0.143, 0.451, 0.493 for (D).. 
Figure 5.21 Junction Presentation and 




study, we varied cell culture parameters to understand their influence on junction 
presentation, then used them to probe the effects on barrier permeability.  
Despite the different properties of the matrix proteins studied here, [205,224] 
use of different substrate coatings seemed to have little effect on cell and junction 
phenotype of HBMECs. CN, Fbn, F:C:L, and HA/Gtn, all induced similar levels of 
total junction coverage, though CIV and LN induced less junction localization in some 
cases. This result that LN induced a less optimal BBB phenotype was not surprising, 
since previous reports with iPSC-derived brain ECs reported the lowest TEER values 
and occludin expression on LN compared to other proteins, including several that were 
studied here [205]. This study also reported the greatest TEER values on FBN, 
supporting our result that, while marginal, FBN induced the greatest junction protein 
coverage [205].   
The addition of cAMP supplements was found to have the greatest effect in 
junction presentation, increasing continuous junctions in almost every case. This was 
not surprising given the significant evidence that these supplements improve barrier 
phenotype in ECs [48,212]. Of specific relevance, one study reported increased TEER 
and localization of ZO-1 and VE-cadherin, showing a more linear morphology 
(assessed qualitatively) in HUVECs treated with the same concentrations of cAMP 
supplements for 1 day, supporting our results in this study [217]. Interestingly, 
increasing culture time did not increase junction coverage, and required more cAMP 
treatment to reach similar presentation values observed in shorter experiments. This 
was surprising, since barrier maturity is thought to correlate with a more continuous, 




we did see presentation of claudin-5, which peaked with increased culture time, as 
expected, since TJs are known to form after AJs, requiring their structure for 
organization [23]. Interestingly, claudin responded differently to cAMP treatment time 
compared to VE-cadherin and ZO-1, possibly indicating different mechanisms 
regulating tight and adherens junction proteins.  
 To correlate barrier properties, we performed TEER and permeability 
measurements. As expected, our permeability coefficient decreased with cAMP 
treatment, to a similar value reported for the B.end3 brain EC cell line in comparable 
conditions with 70 kDa Dextran (approximately 1E-06 cm/s) [225]. The TEER 
measurements were on par with literature values, on the order of 10-30 Ω·cm2 for static 
monoculture of B.end3 cells, [225] primary rat brain ECs, [226] purified murine brain 
ECs, [227] as well as for HBMECs [218]. The resultant trends, however, were not 
expected, since no significant differences were observed with cAMP treatment. 
Furthermore, neither TEER nor permeability showed a correlation with junction 
coverage. While this was surprising, it was likely due to heterogeneities in the cell 
barrier skewing the readouts, or insufficient differences in junction coverage to 
generate measurable differences. Notably, continuous junction coverage alone spanned 
a range of about 20-30%, suggesting that more extreme coverage values such as less 
than 10% or greater than 60% might be required to affect the output measurements. 
Notably, other reports that qualitatively associate changes in junction phenotype and 
localization with barrier measurement often use treatments such as inflammatory 
cytokines (e.g., TNF-α) which could be altering other cell features that drive the 




Another important influence likely driving the unexpected results, are the differences 
in cellular response due to the different experimental setups (i.e., glass versus insert, 
apical versus basal nutrient accessibility). Often in literature, the immunofluorescent 
staining of cells is performed, the TEER or permeability measurement is performed 
separately, and the two results are then correlated to infer function. We’ve shown here 
that cells can respond differently in the different systems and as such, caution should 
be taken when comparing cellular responses. These results motivated the use of a local 
assay to measure site-specific permeability in a single system that enables direct 
correlative measures. Since ECs can sense and respond to their microenvironment, EC 
phenotypes are known to display spatial heterogeneity, further supporting the use of 
local studies to gain mechanistic insights into EC function [23]. Importantly, though, 
global assays still provide valuable understanding, since assessment of whole barrier 
function is important in, for example, in vitro modelling for the study of drug delivery 
systems.  
The local permeability studies showed that permeated regions were most 
affected by the number of discontinuous and no junction regions of coverage, showing 
a positive correlation with PR area. It’s important to note that this assay is only 
measuring permeability of FITC-avidin and as such, could return different results for 
the permeability of molecules of different size or charge; or for different cell types 
transmigrating across the barrier. Use of the JAnaP with other local permeability assays 
for different molecules [61] or live cell imaging for cell transmigration [228,229] could 
therefore provide additional insights into the effects of junctional phenotypes. This is 




perpendicular junctions, since the two were combined in this analysis. Also of note, is 
that these studies were performed in static culture, despite the evidence that suggests 
the significant influences of mechanical cues in EC function [230]. Therefore, 
performing these correlative local permeability or TEER studies in a system that 
enables the incorporation of biomimetic microenvironmental cues (e.g., shear stress 
[205], substrate stiffness [15]) to probe the interplay of these parameters on a local 
scale is an important future application. Notably, in Chapter 6 we investigate the effect 
of substrate stiffness on ZO-1 localization and phenotype in HBMECs.  
Overall, this study highlights the capabilities of combining junction 
phenotyping and assessment of barrier function for the mechanistic study of the BBB, 
and possibly other EC and epithelial barriers. Together, these data suggest that 
increased continuous junction presentation is associated with a less permeable barrier, 
with increased gaps or discontinuous junctions indicating increased permeability. 
Understanding what conditions influence junction presentations and how that affects 
barrier properties, could lead to therapeutic development for diseases associated with 
BBB dysfunction or delivery mechanisms capable of traversing healthy barrier 
systems. 
5.5 Conclusion 
 In summary, we investigated the influence of cell culture parameters such as 
matrix protein coating, culture time, and cAMP treatment, and used the JAnaP to 
quantify their role in cell and junction morphology. While protein coating seemed to 
have little effect on these parameters, cAMP treatment significantly increased 




presentation, but instead required increased cAMP treatment for protein coverage 
comparable to shorter culture time. No correlation between junction presentation and 
barrier permeability was found when comparing junction phenotype to Transwell-
based TEER and permeability experiments, motivating the use of an assay that could 
instead capture cell-to-cell inhomogeneities rather than a “bulk” barrier measurement. 
A local permeability assay identified that barrier permeability most closely correlates 
with the number of gaps with no junction coverage, and by extension, the number of  
discontinuous junctions, present at the cell edge. Together this promotes the use of local 
quantification techniques to quantitatively study barrier function in conjunction with 
junction phenotype to understand the mechanisms at play in functional and 





 - Role of Contractility in ZO-1 Presentation† 
6.1 Introduction 
In this chapter, we used the JAnaP to quantify the effect of cell contractility on 
ZO-1 presentation in HBMECs. Cell contractility and actin fiber formation have been 
directly linked with adherens junction presentation in several EC types, including 
BMECs [15]. Furthermore, this has been correlated with barrier permeability, where 
increased contractility drives junction disassembly, leading to vascular leakage [53] 
and increased transmigration of immune and cancer cells [77]. Additionally, we and 
others have previously shown that peripheral EC tension and adherens junction 
presentation can be modulated by altering the subendothelial matrix stiffness, a 
phenomenon driven by myosin II-mediated contractility [15,76,157,231,232]. 
Specifically, stable, linear adherens junctions are observed in cells on soft 
substrates,[15] or in cells with low tension and active Rac,[75] while discontinuous 
junctions and increased permeability are observed in cells on stiff substrates, [76] or in 
cells experiencing high tension and active Rho [75]. The link between myosin II-
mediated contractility and vascular barrier properties (e.g., cell-cell junctions, 
permeability) has been recently reviewed [233,234]. The effects of cell contractility, 
and specifically its modulation via substrate stiffness, on BMEC barriers and ZO-1 
junction formation, however, remains relatively understudied. The effects of matrix 
† This chapter was adapted from K.M. Gray, D.B. Katz, E.G. Brown, K.M. Stroka. 
“Quantitative Phenotyping of Cell-Cell Junctions to Evaluate ZO-1 Presentation in Brain 
Endothelial Cells.” Annals of Biomedical Engineering 47(7), 1675-1687 (2019). 
Permission was obtained from Springer Nature for use of this material in this dissertation. 




stiffness are of particular interest, as matrix modulation remains a tunable parameter of 
in vitro model design, and because vascular stiffening is associated with cardiovascular 
injury, disease and stroke [160,235–237]. Most in vitro BBB modeling is still 
performed on Transwell inserts, tissue culture plastic, and glass, with the approximate 
stiffness in the MPa-GPa range. This is much stiffer than the in vivo brain extracellular 
matrix (~1 kPa) and peripheral subendothelial matrices (~3-7 kPa) [92,238]. As ZO-1 
has been a suggested regulator of cell-cell tension and junctional assembly via 
actomyosin organization,[14] and actin reorganization is involved in the cellular 
response to substrate stiffness,[76] here we aimed to use the JAnaP to quantify ZO-1 
presentation in response to biochemical and physical cues associated with altered states 
of contractility.  
6.2 Materials and Methods 
6.2.1 Cell Culture and Treatments 
Ethics approval for all studies were obtained from the University of Maryland, 
Institutional Biosafety Committee (Protocol Number ESSR #15-06). HBMECs were 
purchased from Cell Systems and cultured as previously described [214]. Cells 
(passage 7-10; 5e5 per coverslip) were seeded onto collagen-coated glass coverslips or 
polyacrylamide gels (as described below) and grown for two days. For conditions with 
cAMP supplements, 250 μM 8-(4-chlorophenylthio) adenosine-3’,5’-cyclic 
monophosphate sodium salt (CPT-cAMP) (Abcam) and 17.5 μM 4-(3-butoxy-4-
methoxybenzyl) imidazolidin-2-one (RO-20-1724) (Tocris Bioscience) were added to 




because they are routinely used for culturing brain endothelial cells and are cited in 
many several previous studies [217–219,239]. Myosin II was inhibited with 50 μM (-
)-blebbistatin (Sigma-Aldrich) for 1 hour at 37°C after 48 hours of culture (with or 
without cAMP supplements). The vehicle control consisted of medium containing 
0.6% DMSO (Sigma-Aldrich). Alternatively, after 48-hour culture, protein 
phosphatases were inhibited via 0.1 nM calyculin A (Santa Cruz) treatment for 30 
minutes at 37°C. The vehicle control consisted of DMSO at an equal volume to that 
used in the calyculin conditions (0.1% final concentration). These concentrations were 
selected for blebbistatin and calyculin A because we have previously measured lower 
and higher cell traction forces, respectively, for these inhibitors, while still maintaining 
cell viability [98]. All experiments were repeated two to four times. 
6.2.2 Polyacrylamide Gel Preparation 
Thin polyacrylamide gels were synthesized on glass coverslips as first 
described by Wang and Pelham [240], and used in our previous publications 
[76,157,192,241].  Here, gels were composed of acrylamide and bisacrylamide (bis) 
(BIO RAD) at the following concentrations: 15% acrylamide + 1.2% bis, 8% 
acrylamide + 0.2% bis, 8% acrylamide + 0.07% bis, and 3% acrylamide + 0.2% bis. 
Gels were activated using sulfo-SANPAH (Thermo Fisher) and then coated with 100 
µg/mL collagen type 1 (Sigma-Aldrich) for 4 hours at room temperature (RT). For glass 
experiments, cells were plated on unactivated coverslips (22x22 mm, Fisher Scientific) 





6.2.3 Atomic Force Microscopy 
Atomic force microscopy (AFM) was used to measure the Young’s modulus of 
each polyacrylamide gel composition. Following polymerization of the 
polyacrylamide, unactivated gels were rinsed with PBS and the coverslip was adhered 
to the bottom of a 50 x 9 mm petri dish. The dish was then filled with PBS and atomic 
force microscopy (AFM) was performed using an Asylum MFP-3D-BIO Atomic Force 
Microscope with TR400PB(L) probes from Asylum Research. Asylum’s “Get Real” 
procedure was used to measure the spring constant of the cantilevers via the Sader 
method, as well as the inverse optical lever sensitivity via the thermal noise method. 
The spring constant of TR400PB(L) cantilevers was measured to be in the range 0.026-
0.032 N/m, which was within a factor of 1.62 to Asylum’s nominal value of 0.02 N/m. 
Three 100-curve force maps covering a 10 μm x 10 μm area were collected for each 
sample using a 1 μm force distance, a 1 V trigger point (~1.75 nN), and a scan rate of 
0.99 Hz. Force curves were fit to the Hertz model within Asylum’s Igor Pro-based 




∙ √𝑎𝑎 ∙ 𝛿𝛿3/2 , with 𝛿𝛿 as the measured 
indentation of the sample and Young’s modulus 𝐸𝐸 as the fitting parameter. The 
Poisson’s ratio 𝜐𝜐  of the sample was assumed to be 0.45 and the tip radius of curvature 
𝑎𝑎 was approximately 30 nm.  
6.2.4 Immunostaining 
HBMECs were rinsed with warm PBS, fixed with 1% formaldehyde (Fisher 
Scientific) for 10 minutes, and permeabilized in 0.25% TritonX-100 (Sigma-Aldrich) 




blocked in 2% goat serum (Abcam) for 1 hour at RT. Primary antibody (rabbit 
polyclonal IgG to ZO-1, Santa Cruz Biotechnology, sc-10804) was then added to cells 
at a 1:50 dilution in 2% goat serum and incubated overnight at 4°C. The next day, 
samples were washed with PBS, then blocked again with 2% goat serum for 1 hour at 
RT. Cells were then incubated in 1:100 secondary antibody (goat anti-rabbit Alexa 
Fluor 488, Abcam) and 1:2500 Hoechst (ThermoFisher Scientific), in PBS, for 1 hour 
at RT, then rinsed with PBS.  
6.2.5 Microscopy 
All samples were imaged on an Olympus IX83 inverted microscope using a 60x 
oil objective and Olympus cellSens Software. Images were collected to maximize the 
monolayer coverage within that image. Image analysis was performed on raw images 
such that the pixel intensities were comparable between groups; however, the images 
presented in this manuscript have been adjusted to improve visibility.     
6.2.6 Junction Analysis 
Junctions were analyzed using the JAnaP described in Chapter 4. A threshold 
of 15 was used to isolate the ZO-1 junctions from the background noise.  
6.2.7 Monolayer Coverage Quantification 
ImageJ (National Institutes of Health, Bethesda, MD) was used to quantify 
monolayer coverage of each image. Visible holes in the monolayer were manually 
traced and quantified in ImageJ, and the total void area was summed per image. 




total uncovered area divided by the total image area by 100 and then subtracting it from 
100%. When monolayer coverage was less than the void area, the covered area was 
traced instead, and the void area was calculated by subtracting the sum of the covered 
area from the total image area. While all other data presented is on a per-cell basis, this 
measure is presented on a per-image basis. Note that this parameter is the only variable 
in this manuscript that was not quantified using the JAnaP.  
6.2.8 Statistical Analysis 
For instances where two groups of data are compared (i.e., Figure 2), statistical 
analyses were completed used an unpaired t-test. For other shape factor group 
calculations, a one-way ANOVA with a post-hoc Tukey test for multiple comparisons 
was used. For grouped junction analysis, a two-way ANOVA with a post-hoc Tukey 
test for multiple comparisons was used. Outliers were identified using the Grubbs’ 
method with alpha = 0.0001 to remove only definite outliers. Measurements stated in 
this paper are presented in the format mean ± SEM. Note that only ***p≤0.001 and 
****p≤0.0001 have been included within the graphs due to the large cell numbers 
included in analysis, however the full statistical data has been included separately in 
tables following the figures. Unless otherwise marked with brackets, significance is 
with respect to the control within the same treatment group (e.g., control with cAMP 





6.3.1 cAMP supplements increase ZO-1 edge-coverage in HBMECs on 
glass 
Several previous studies, including our own (Chapter 5), have shown that CPT-
cAMP and RO-20-1724 increase tight junctions in various EC types [48,212]. 
Therefore, we first quantified the effects of these supplements in HBMECs on collagen-
coated glass, to probe the changes in junction architecture on an extremely stiff 
substrate routinely used in cell culture. Representative images of cells immunostained 
for ZO-1 comparing the use of cAMP supplements are shown in Figure 6.1.A, and an 
example cell analyzed by the JAnaP is presented in Figure 6.1.B. The addition of cAMP 
supplements decreased the average cell perimeter and area from 195.0 ± 6.1 to 156.5 ± 
3.6 μm and from 1185.0 ± 66.2 to 938.8 ± 37.0 μm2, respectively, but increased solidity 
and circularity, leading to smaller but more rounded cells (Figure 6.1.C-F). Monolayer 
coverage was approximately 47 ± 3% and was unaffected by cAMP supplements 
(Figure 6.1.G). Note that the same initial seeding density was used throughout the 
manuscript, and while here, monolayer coverage was low, the same seeding density in 
subsequent conditions led to a significant increase in monolayer coverage. While 
cAMP supplements did not influence monolayer coverage, the overall ZO-1 
localization increased from 15.2 ± 0.9% to 27.6 ± 0.9%, resulting from increased 
continuous and punctate junction presentation from 4.6 ± 0.5% to 11.3 ± 0.7% and 9.7 
± 0.5% to 14.3 ± 0.4%, respectively (Figure 6.1.H). These results suggest that while 




increases the edge-localization of ZO-1. These quantified results are in line with the 
large body of qualitative evidence that cAMP agents improve junction architecture in 
EC barriers. Since edge-localization of junctional proteins typically requires 
Figure 6.1 The effects of cAMP 
supplements on HBMECs on 
collagen-coated glass. (A) presents 
immunofluorescent images of ZO-1 
in HBMECs with and without cAMP 
supplement (scale bar = 20 μm). An 
example cell of interest is denoted 
with the white hashed box and is 
presented in (B) with the junctions 
categorized by the JAnaP. (C-F) 
presents the average cell perimeter, 
area, solidity, circularity as 
calculated using the JAnaP. N = 177 
cells without cAMP and N = 327 
cells with cAMP. The coverage of 
the monolayer within each image is 
presented in (G) while the coverage 
of each junction per cell perimeter is 
presented in (H). For (G), N = 36 and 
41 monolayer images for without 
and with cAMP, respectively. For 
(H), the bars represent the average 
results for N =  179 and 329 cells for 
without and with cAMP groups, 
respectively. Statistical analysis was 
performed using an unpaired t-test, 
***p≤0.001 and ****p≤0.0001. The 
colors of the statistics in (H) indicate 
the differences with and without 
cAMP for each junction type. (I-J) 
present the relationship between 
total ZO-1 coverage and monolayer 
coverage (I) without and (J) with 
cAMP supplements, with each dot 
representing the average of all cells 
within each image. Full statistical 
information is included in Table 6.1.        
 
Figure 6.1 The effects of cAMP 





homophilic interactions with an adjacent binding partner in regions of cell-cell contact, 
we investigated the influence of monolayer coverage on total ZO-1 presentation. A 
positive correlation was found between monolayer and junction coverage (r-
squared=0.6078) in the absence of supplements (Figure 6.1.I). However, this 
relationship was mitigated with the addition of supplements (Figure 6.1.J; r-
squared=0.0078), suggesting that cAMP additives increase and stabilize the level of 
edge-localized ZO-1 at these confluency levels. 
6.3.2 Biochemical inhibition of myosin II on stiff substrates increases 
continuous ZO-1 
 Despite the increase in junction localization with cAMP supplements on glass, 
the overall junction and monolayer coverage remained low. These cAMP supplements 
function to (1) inhibit myosin light chain phosphorylation which decreases EC 
contraction, and (2) activate Rac1 to increase cortical actin stabilization and decrease 
actin stress fiber formation [213]. Therefore, we investigated the interplay of 
blebbistatin, a myosin-II inhibitor, and cAMP supplements, to test the effects of further 
decreasing contractility on HBMEC barrier formation and junctional presentation. 
Representative immunostaining and JAnaP images are presented in Figure 6.2.A-B.  
Table 6.1 Statistical p-values 
for Figure 6.1. Analysis via an 
unpaired t-test comparing 
HBMEC parameters for 
conditions with and without 
cAMP on collagen-coated. Note 
that significant values are 
highlighted in green and non-
significant values (P > 0.05) are 
highlighted in red. 





The average cell area ranged from 1201 ± 64 to 1579 ± 83 μm2 and was 
unchanged with blebbistatin or cAMP treatment (Figure 6.2.C). Other morphological 
parameters can be found in Figure 6.3, with statistical comparisons presented in Table  
5.2. Monolayer coverage, however, increased over 20% when cells were treated with 
blebbistatin (irrespective of cAMP supplement) (Figure 6.2.D). Total ZO-1 edge-
Figure 6.2 The effects of blebbistatin treatment with and without cAMP supplement 
on collagen-coated glass. (A) presents immunofluorescent images of ZO-1 in HBMECs 
for each treatment (scale bar = 20 μm). An example cell of interest is denoted with the 
white hashed box and is presented in (B) with the junctions categorized by the JAnaP. (C) 
presents the average cell area calculated using the JAnaP (129 ≤ N ≤ 195, where N is the 
number of cells) and (D) shows the coverage of the monolayer within each image  (32 ≤ N 
≤ 35, where N is the number of images). The coverage of each junction per cell perimeter 
is presented in (E) (136 ≤ N ≤ 188, where N is the number of cells). Statistical analysis was 
performed using a one-way ANOVA for (C-D) and a two-way ANOVA for (E), both with 
a post-hoc Tukey test for multiple comparisons, ****p≤0.0001. The statistics represent 
differences between the experimental group and the control with the same cAMP treatment 
unless otherwise marked with a bracket. The color of the statistics in (E) indicate the 
differences for the corresponding junction type. Full statistical information is included in 
Table 6.2. 
  
Figure 6.2 The effects of blebbistatin treatment with and without cAMP 




coverage also increased from 14.2 ± 0.8% to 22.9 ± 1.0% with blebbistatin, and further 
to 43.3 ± 1.7% when treated with both blebbistatin and cAMP supplements (Figure 
6.2.E). This increase was driven by significant increases in continuous junctions, as no 
change was observed in punctate or perpendicular junctions. The increase in both 
monolayer coverage and continuous junctions indicate improved barrier formation with 
decreased myosin II-mediated contractility, especially when HBMECs were 
supplemented with cAMP. 
Table 6.2. Statistical p-values for Figures 6.2 and 6.3. A one-way ANOVA with 
a post-hoc Tukey test was used for multiple comparisons for HBMEC morphology 
and junction parameters on collagen-coated glass following blebbistatin treatment 
with and without cAMP (corresponds to data in Figure 3). Note that significant 
values are highlighted in green and non-significant values (P > 0.05) are highlighted 
in red. 
 
Table 6.2 Statistical p-values for Figures 6.2 and 6.3 
Figure 6.3 The effects of blebbistatin treatment on HBMEC morphology on 
collagen-coated glass with and without cAMP supplement. (A-C) presents the average 
cell perimeter, solidity, and circularity, respectively, calculated using the JAnaP (129 ≤ 
N ≤ 195, where N is the number of cells). Statistical analysis was performed using a one-
way ANOVA with a post-hoc Tukey test for multiple comparisons, ***p≤0.001 and 
****p≤0.0001.  Figure 6.3 The effects of blebbistatin treatment on HBMEC morphology on 




6.3.3 Decreasing matrix stiffness increases continuous ZO-1 coverage 
Previous results suggest that substrate stiffness modulates myosin II-mediated 
EC contractility [76] and monolayer traction forces [242]. Given the monolayer and 
junctional alterations observed with myosin II inhibition (Figure 6.2), we next 
investigated the mechanobiological effects of substrate stiffness on barrier formation. 
HBMECs were plated on collagen-coated polyacrylamide gels and immunostained for 
ZO-1 (Figure 6.4.A-B). The specific gel compositions were selected to span a wide 
range of physiologically- and pathologically- relevant stiffness. The brain extracellular 
matrix is approximately 1 kPa and peripheral subendothelial matrices range from 3-7 
kPa,[76] and hence our lower gel stiffnesses represent physiologically “healthy” 
matrices in terms of mechanical properties. Blood vessel stiffening is associated with 
vascular injury, and thus the 15 and 194 kPa gels represent a “diseased” stiffness range, 
as evidenced by previous studies where atomic force microscopy was used to quantify 
the mechanical properties of endothelial cell substrates in peripheral arteries ex vivo 
and found diseased models to increase in stiffness from 3-5 kPa to 10-15 kPa  
[243,244].  
The Young’s modulus of each gel composition was previously determined 
[241] and confirmed again in our lab using AFM  (Figure 6.5). Because our previous 
results suggested barrier improvement with cAMP, the results in Figure 6.4 present 
only conditions with cAMP supplement (see Figure 6.6 for results without supplement 
and full shape factor analysis). Note that the results on collagen-coated glass from 




Interestingly, cell area was consistent on all gels, despite the large stiffness 
range, and was roughly double the size of the cells cultured on glass (Figure 6.4.C). 
Monolayer coverage ranged from 92.2 ± 1.0 to 95.2 ± 0.6% on the gels, which was 
roughly 50% higher than the average monolayer coverage on glass (Figure 6.4.D). 
Total ZO-1 edge-localization increased on gels versus glass, with the greatest (55.8 ± 
1.3%) observed on 1 kPa gels. This resulted from increased continuous presentation on 
1 kPa, covering 35.5 ± 1.5% of the cell perimeter (at least 12% more than any other 
condition) (Figure 6.4.E). Without cAMP supplement, HBMECs also demonstrated 
higher junctional coverage on gels versus glass; however, the amplified enhancement 
of these parameters on 1 kPa gels was absent (Figure 6.6.C). No change in 
perpendicular junction coverage was observed, but punctate junctions increased 
between selective substrates. Overall, this suggests that while HBMEC morphological 
parameters are insensitive to matrix stiffness within a physiological (1 and 8 kPa) and 
even pathological (15 and 194 kPa) [76] range, they are affected by the orders of 
magnitude difference between polyacrylamide gels (kPa range) and glass (GPa). 
However, ZO-1 presentation seems to be more mechanosensitive, as more mature 









Figure 6.4. HBMECs on collagen-coated polyacrylamide gels of varying stiffness. (A) 
presents immunofluorescent images of ZO-1 in HBMECs with cAMP supplement on each 
gel stiffness (scale bar = 20 μm). An example cell of interest is denoted with the white 
hashed box and is presented in (B) with the junctions categorized by the JAnaP for each 
condition. (C) presents the average cell area calculated using the JAnaP (167 ≤ N ≤ 327, 
where N is the number of cells)  and (D) shows the coverage of the monolayer within each 
image (31 ≤ N ≤ 50, where N is the number of images). The coverage of each junction per 
cell perimeter is presented in (E) (228 ≤ N ≤ 343, where N is the number of cells). Statistical 
analysis was performed using a one-way ANOVA for (C-D) and a two-way ANOVA for 
(E), both with a post-hoc Tukey test for multiple comparisons, ****p≤0.0001. The color 
of the statistics in (E) indicate the differences for the corresponding junction type. Full 
statistical information is included in Table 6.3.       
 
Figure 6.4 HBMECs on collagen-coated 










Table 6.3 Statistical p-values for Figures 6.4 and 6.6. A one-way ANOVA with a post-hoc 
Tukey test was used for multiple comparisons for HBMEC parameters on collagen-coated 
polyacrylamide gels or glass with and without cAMP. 






Figure 6.5. Young’s modulus measurements of polyacrylamide gels as a function 
of acrylamide and bis acrylamide concentration. Each point represents the average 
Young’s modulus of a 100-curve force map covering a 10 μm x 10 μm area. Three 
measurements were taken across 3 different samples for each gel composition (N=9, 
































Figure 6.5 Young’s modulus measurements of 
       
Figure 6.6. HBMECs on collagen-coated polyacrylamide gels of varying stiffness. (A-
B) present the average cell area and monolayer coverage without cAMP supplement. For 
(A), 167 ≤ N ≤ 238, where N is the number of cells. For (B), 36 ≤ N ≤ 50, where N is the 
number of images. The coverage of each junction per cell perimeter without cAMP 
supplement is presented in (C). (D-F) presents the average cell perimeter, solidity, and 
circularity, respectively, with and without cAMP calculated using the JAnaP (167 ≤ N ≤ 
347, where N is the number of cells). See Table 6.3 for statistical analysis. 




6.3.4 Inhibition of protein phosphatases on soft substrates decreases ZO-
1 junction coverage 
Given the improved monolayer coverage and ZO-1 localization in conditions 
associated with decreased cell contractility (i.e., via blebbistatin treatment and soft 
substrate stiffness), we next investigated whether the opposite effect would be observed 
with increased contractility. HBMECs on collagen-coated 1 kPa gels or glass were 
treated with calyculin-A, a protein phosphatase inhibitor linked with increased cellular 
contractility,[245,246]  immunostained for ZO-1, and analyzed via the JAnaP (Figure 
6.7). In line with the section 6.3.3 results, cells were smaller and exhibited lower 
monolayer coverage on glass versus 1 kPa gels (Figure 6.7.B-C; see Figure 6.8 for 
additional morphological parameters). While calyculin treatment had no effect on cell 
area on the respective substrates, this treatment decreased monolayer coverage from 
89.5 ± 3.5% to 70.0 ± 3.3% on 1 kPa gels. Notably, this effect was not observed on 
glass. Similarly, total ZO-1 localization decreased from 30.8 ± 1.0% to 13.7 ± 0.9% 
with calyculin treatment on 1 kPa gels, while junctional coverage on glass remained at 
~19-20% for both conditions (Figure 6.7.D). This calyculin-induced decrease in ZO-1 
on 1 kPa resulted from a decrease in both continuous and punctate junction presentation 





Figure 6.7. HBMECs treated with calyculin on 1 kPa collagen-coated polyacrylamide gels or 
glass. (A) presents immunofluorescent images of ZO-1 in HBMECs on each gel with cAMP 
supplement and an example cell of interest (denoted with the white hashed box) with the junctions 
categorized by the JAnaP for each condition (scale bar = 20 μm). (B) presents the average cell area 
calculated using the JAnaP (131 ≤ N ≤ 236, where N is the number of cells) and (C) shows the 
coverage of the monolayer within each image (15 ≤ N ≤ 35, where N is the number of images). The 
coverage of each junction per cell perimeter is presented in (D) (131 ≤ N ≤ 215, where N is the 
number of cells). Statistical analysis was performed using a one-way ANOVA for (C-D) and a two-
way ANOVA for (E), both with a post-hoc Tukey test for multiple comparisons, ***p≤0.001 and 
****p≤0.0001. The color of the statistics in (E) indicate the differences for the corresponding 
junction type. Full statistical information is included in Table 6.4.      
 Figure 6.8 HBMECs treated with calyculin on 1 kPa collagen-coated polyacrylamide gels or glass 
Figure 6.8 The effect of calyculin treatment on cell morphology on collagen-coated 1 kPa 
polyacrylamide gels versus glass. (A-C) presents the average cell perimeter, solidity, and 
circularity, respectively, calculated using the JAnaP (131 ≤ N ≤ 236, where N is the number of 
cells). Statistical analysis was performed using a one-way ANOVA with a post-hoc Tukey test 
for multiple comparisons, ***p≤0.001 and ****p≤0.0001.       
 
Figure 6.7 The effect 





Since cell contractility has been previously been linked with barrier function 
and junction localizations, [15,53,77] our novel JAnaP was used to quantify the role of 
this phenomenon on junction presentation in HBMECs. First, the effect of cAMP 
supplements and substrate stiffness on ZO-1 presentation in HBMEC monolayers was 
investigated. The addition of cAMP supplements increased continuous junctions in 
every condition and also increased punctate and perpendicular junctions on glass. This 
was not surprising, based on our results in Chapter 5, and the significant evidence 
showing improvements in barrier properties with cAMP supplements. In ECs, cAMP 
reportedly blocks myosin light chain phosphorylation through Rho/ROCK signaling 
inhibition,[247] which has been linked with increased linear VE-cadherin 
formation,[14] and Beese et al. reported the supplements to improve continuous 
junction development in human umbilical vein ECs due to actin cytoskeleton 
reorganization [48]. Our results further support these points, since continuous ZO-1 
presentation was further increased when myosin II was inhibited via blebbistatin.  
Table 6.4 Statistical p-values for Figures 6.7 and 6.8. A one-way ANOVA 
with a post-hoc Tukey test was used for multiple comparisons for HBMEC 
parameters with calyculin treatment. 
Table 6.4 
Statistical p-




Onken et al., previously observed increased actin stress fibers in HBMECs on 
polyacrylamide gels of increasing stiffness and a correlation between decreased 
substrate stiffness and increased linear VE-cadherin junctions as measured manually 
[15]. This aligns with our data since we found increased continuous ZO-1 on all gels 
(versus glass), with the highest continuous presentation on the softest 1 kPa gels with 
cAMP supplements. In fact, total junctional coverage was lowest on glass, which 
increased with blebbistatin and further increased on 1 kPa gels. Consistent with this 
trend was the overall monolayer coverage with cAMP, which was lowest on glass, 
increased with blebbistatin, and further increased on hydrogels. Overall, this indicates 
improved barrier formation in cells cultured on gels of biologically-relevant stiffness. 
Importantly, however, monolayer coverage could be influencing the overall ZO-1 
presentation results, since junctional proteins typically localize to sites of cell-cell 
contact. We therefore investigated the relationship between total junction coverage and 
monolayer coverage for all conditions tested in this manuscript (Figure 6.9). Only a 
slight positive correlation emerged (r-squared=0.3007), suggesting that while 
Figure 6.9. The effect of monolayer coverage on total ZO-1 junction coverage. This 
graph represents the average cellular junction coverage for each image, including all 
experimental groups presented in the manuscript (N=610 images). Linear regression 
was performed to determine an r-squared value of 0.3007. 
 






monolayer coverage (and therefore, cell-cell contacts) play a role, it is not the only 
driving force regulating ZO-1 edge-localization. 
Given our previous result that substrate stiffness modulates EC 
contractility,[76] it is likely that cells on glass are highly contractile, inducing the 
poorest barrier properties of the conditions tested. Meanwhile, decreasing contractility 
on glass, via blebbistatin, led to improved barrier properties, though not to the extent 
that resulted from decreased substrate stiffness. This suggests that mechanical 
modulation of the cell’s microenvironment may adjust cellular contractility to a more 
optimal level. This was further supported by the final study, where calyculin 
significantly disrupted linear ZO-1 and increased discontinuous ZO-1 on 1 kPa gels. 
On 1 kPa, cells are likely minimally contracted such that calyculin treatment induced 
contraction, leading to disrupted junctional presentation. On glass, however, calyculin 
treatment did not affect ZO-1 edge-localization, likely because cells are already highly 
contractile, rendering calyculin ineffective in further enhancing contractility.  
Overall, these results indicated improved junctional ZO-1 localization, with a 
more mature, linear phenotype in conditions driving lowered states of cell contractility. 
Specifically, biomimetic substrate stiffness was shown to improve barrier formation, 
decreasing contraction via mechanotransduction. This motivates the use of matrices of 
physiological stiffness in vitro modelling of the BBB and provides insight into potential 
therapeutic targeting of cell contractility for enhanced barrier function in disease.      
6.5 Conclusion 
In summary, we investigated the role of matrix stiffness and myosin II-mediated 




quantitative measures of cell-cell junction morphologies. Interestingly, the highest 
percentage of mature junctions was observed on the 1 kPa gels, which was the most 
physiologically relevant to the brain microenvironment and within the range of reported 
values for subendothelial matrix stiffness in vasculature. This further suggests that 
mimicking the mechanical environment of the in vivo system may be an effective 
approach to optimizing endothelial barrier properties for in vitro study; however, 
further investigation into the effects of these parameters on other tight junction proteins 
(e.g. claudins, occludins) is needed to fully understand the effects on barrier phenotype. 
Furthermore, additional experiments are needed to understand the physiological role 
(e.g., local permeability to molecules and cells) of each junction presentation type. 
Expanded use of the JAnaP could provide insight into the role of tight and adherens 
junction presentation in BBB physiology and pathology and possibly enable the study 
of junctional protein presentation in peripheral endothelial and epithelial cell 
monolayers. Understanding what conditions (e.g., contractility states) influence 
specific junction presentation and how that affects barrier properties could lead to the 
development of therapeutics capable of traversing the BBB for delivery to the brain or 





 - Effects of Breast Cancer Cell Secreted Factors† 
7.1 Introduction 
Cancer metastasis occurs in approximately 20% of all cancer cases [248,249] and 
remains a devastating prognosis due to limited treatment options. Evidence in the literature, 
including in vivo imaging, has shown that tumor cells are capable of metastasizing to the brain 
through the circulatory and lymphatic systems [250], and that metastasis occurring through the 
circulatory system requires the tumor cells to traverse the BBB in order to reach the brain 
parenchyma [251]. The mechanisms governing how tumor cells cross the BBB, however, are 
not well understood.  
In one study, close physical contact with the abluminal surface of the blood vessel was 
crucial for the spread of tumor cells, which actively transmigrated through gaps in the vascular 
wall, but also engaged in vascular remodeling during extravasation [252]. Unique to the BBB, 
tight junction proteins (e.g., claudins, occludins) are overexpressed, and act in conjunction with 
adherens junctions (e.g., VE-cadherin) to regulate barrier integrity and permeability [253]. 
These junctional proteins link to the actin cytoskeleton through ZO-1, which has been shown 
to regulate cell and junctional tension, cellular migration, barrier formation, and angiogenesis 
[14]. Disruption of these junctions is linked with increased permeability of the BBB to cells 
and molecules and is implicated in several diseases [2], including cancer metastasis [254] and 
glioblastoma, where microvascular leakiness correlates with histological tumor grade [255]. 
Metastatic breast tumor cells reportedly secrete factors that promote increased tumor cell-BBB 
† This chapter was adapted from M.A. Pranda*, K.M. Gray*, A.J.L. DeCastro, G.M. 
Dawson, J.W. Jung, K.M Stroka. “Tumor cell mechanosensing during incorporation into 
the brain microvascular endothelium”. Cellular and Molecular Bioengineering 12(5): 455-
480 (2019)  (*, equal contribution). Reproduced with permission of Springer in the format 
of Thesis/Dissertation via Copyright Clearance Center. M.A.P. co-wrote several sections 
in this chapter, and performed and analyzed the experiments for Figures 7.1, 7.2, and 7.8, 




adhesion and disrupt or rearrange junctions, weakening the barrier and leading to tumor cell 
transmigration [256,257]. Junction disruption can be considered a decrease of junctional 
proteins present at the cell boundary, while junctional rearrangement is a change in the 
boundary presentation (e.g., phenotype or morphology) of the specific junctional protein. As 
described above in chapters 2, 4, and 5, junctional phenotype is thought to be linked with the 
stability and maturity of the cell-cell junction. For instance, a linear, continuous junction 
parallel to the cell boundary is reported as a stable junction, exhibited by cells with low tension 
[15,258]. On the other hand, increased levels of cellular tension or contractility is linked with 
unstable, discontinuous junctions, which can take the form of punctate (e.g., dotted) or 
perpendicular (e.g., serrated) morphologies. Use of the JAnaP allows us to quantitatively 
phenotype these cell-cell junctions in a healthy BBB and in disease-associated states. 
Tumor cell-derived biochemical cues and physical interaction with brain endothelial 
cells can alter brain endothelial cell-cell junctions in such a way that directs the mode of trans-
endothelial migration. For instance, melanoma cells are reported to disrupt junctions, 
presumably through protease secretion, and induce endothelial cell apoptosis leading to 
paracellular transmigration [259]. Other studies have shown that breast tumor cells can cross 
endothelial barriers utilizing both transcellular and paracellular pathways [260]. Tumor cells 
also secrete endothelial-altering substances that can lead to an influx of calcium [261], 
glycocalyx degradation [260], and increased contractility [77,262], of the targeted endothelial 
cells, all of which are associated with enhanced tumor cell transmigration at cell-cell junctions 
[77,260–262]. Furthermore, we and others have demonstrated that tumor cells can even 
physically displace endothelial cells and “incorporate” or “intercalate” into the endothelium 
[263–265]. We hypothesized that this process may also represent a distinct step in the 
extravasation of tumor cells through the brain endothelium. Hence, we aimed to quantify how 
breast tumor cell biochemical factors and physical contact with the brain endothelial cells affect 




 In addition to cell-secreted factors, cell functionality is profoundly influenced by its 
surrounding extracellular matrix (ECM) [266]. However, it is not yet well understood which 
aspects of the brain microenvironment play a role in cancer progression [267]. Hyaluronic acid 
(HA) is a glycosaminoglycan that serves as a major building block of the brain ECM, which, 
unlike other parts of the body, is not highly organized and consists mainly of loosely 
crosslinked networks [268]. HA in the brain is linked with small glycoproteins, as well as 
tenasins, the density of which plays a large role in the function of various neural processes. 
Thus, the disruption of these linkages [268] as well as ECM rearrangement [269] could play a 
large role in disease progression. Indeed, for other ECM models such as collagen gels, 
crosslinking (e.g., via lysyl oxidase) has been shown to increase ECM stiffness, making it more 
conducive to the progression of tumors and other diseases [270–273]. While HA has important 
biological functions related to joint lubrication and wound healing, it also plays a role in the 
invasion of tumor cells, and, in the case of primary glioma tumors, HA is highly upregulated 
in the surrounding ECM [266].  
Because ECM structure (e.g., arrangement, stiffness, etc.) is known to play a 
significant role in healthy and diseased states of the brain, here we have investigated how the 
crosslinking of a brain-like ECM affects brain endothelial cells, tumor cells, and the interaction 
between the two cell types. We have used an HA/gelatin-based system with varying degrees of 
crosslinking to mimic the brain ECM and used live-cell microscopy and immunofluorescence 
imaging to quantify cellular migration, morphology, cell-cell junction presentation, and tumor 
cell incorporation into brain endothelial monolayers, thus providing insight into the interplay 





7.2 Materials and Methods 
7.2.1 Cell Culture 
Human breast adenocarcinoma cells, MDA-MB-231s (American Type Culture 
Collection, Manassas, VA, USA) were cultured in Dulbecco’s Modified Eagle’s 
Medium (DMEM) with high glucose and L-glutamine supplemented with 1% 
Penicillin/Streptomycin 10,000 U ml-1 (Pen/Strep) and 10% Fetal Bovine Serum (FBS) 
(Thermo Fisher Scientific, Waltham, MA, USA) and used below passage 20 after 
purchase. HBMECs were purchased from Cell Systems and cultured as previously 
described,[214] and used below passage 12.  
7.2.2 HA/Gelatin film formation 
 HA/gelatin films were formed using the HyStem-C kit (ESIBIO, Alameda, CA, 
USA). The kit contained four components: DG water, Glycosil (thiolated HA), Gelin 
(thiolated Gelatin), and Extralink (thiol-reactive PEGDA crosslinker). Instructions 
from the kit were followed and were also described previously by Prestwich [274]. 
Briefly, all components were thawed for 30 - 60 minutes. Glycosil, Gelin, and DG 
water were then briefly heated at 37°C in a water bath to increase solubility. Glycosil 
and Gelin were then dissolved in 1 mL DG water, rocked for 1 hour at room 
temperature, then briefly re-heated in the water bath. Extralink was dissolved in DG 
water to 10%, then was further diluted into aliquots of 6, 4, and 1%. 24-well glass 
bottom plates (13 mm glass diameter) or 35 mm glass bottom dishes (14 mm glass 
diameter) (MatTek, Ashland, MA, USA) were plasma treated using a plasma cleaner 




“High” RF power setting (Harrick Plasma, Ithaca, NY, USA, PDC-001-HP (115 V)) to 
increase hydrophilicity. The plates were then treated with ultraviolet light for 5 - 10 
minutes for sterilization. Gelin and Glycosil were mixed in a 1:1 ratio and then the 
Glycosil/Gelin solution was combined in a 4:1 ratio with the appropriate concentration 
of Extralink. The final concentration of Extralink within the films were 0.2, 0.8, 1.2, 
and 2%. Twenty microliters of solution were plated in each well, spread, and covered 
for gelation, the time of which varied by Extralink concentration (2%: 2 - 5 minutes, 
1.2%: 3-6 minutes, 0.8%: 4 - 7 minutes, 0.2%: 6 - 9 minutes). Once crosslinked, 
medium was added, and the films were incubated at 37°C for at least 30 minutes or 
until cells were ready to plate.  
7.2.3 Atomic Force Microscopy 
To measure the stiffness of the HA/gelatin, films were formed on 50 x 9 mm 
petri dishes. After the films had polymerized, the dishes were filled with PBS and an 
Asylum MFP-3D-BIO Atomic Force Microscope was used to perform AFM. The “Get 
Real” approach provided by Asylum Research was used to calculate the inverse optical 
lever sensitivity and the cantilever spring constant of the TR400PB(L) probes used for 
measurement. The cantilever spring constants were within the nominal range of 0.01 
to 0.05 N m-1 (measured range: 0.026 to 0.028 N m-1) and within a factor of 1.37 to 
Asylum’s nominal value of 0.02 N m-1. Four film samples of each composition were 
measured via five 100-curve force maps each (20 force maps in total). The force map 
specifications were as follows: 10 μm x 10 μm area, 2 μm force distance, 1 V trigger 
point (~1.57 nN), and a 0.99 Hz scan rate. The Hertz model was used to fit the data 








𝛿𝛿3/2 where the fitting parameter, 𝐸𝐸, is the Young’s modulus, and 𝛿𝛿, is the measured 
indentation of the sample. The Poisson’s ratio, 𝜈𝜈, and tip radius of curvature, 𝑎𝑎, were 
assumed to be 0.45 and 30 nm, respectively. 
7.2.4 Tumor cell morphology and migration assays 
Written, performed and analyzed by Marina Pranda, with the help of Ariana DeCastro and Greg 
Dawson (Stroka Lab). 
HA/gelatin films were prepared as described above in 24-well glass bottom 
plates. After soaking with medium in the incubator, 5x104 MDA-MB-231 cells were 
plated on top of the films and set-up to image as soon as the cells settled to the bottom 
of the plate. Images were collected via time-lapse phase-contrast microscopy and 
analyzed as described below in the data analysis section.  
Tumor cell morphology was analyzed using ImageJ by manually tracing phase 
contrast images of live cells captured during or after time-lapse experiments in ImageJ. 
Cell circularity, solidity, and inverse aspect ratio were calculated as we have previously 
described [275]. To track tumor cell migration on bare films, phase-contrast time-lapse 
images were acquired in 5-minute intervals. The ImageJ Manual Tracking plugin was 
used to track the approximate centroid of each cell starting 5-6 hours post-plating and 
analyzed for up to the next 8-9 hours. Cells were not tracked if they went out of frame, 
divided during the tracking time, or were otherwise obstructed or hard to track. A 
custom Matlab (MathWorks, Natick, MA, USA) code was used to calculate cell speed, 
mean square displacement, and diffusion coefficient of the migrating cells, as we have 




used for speed calculation, while approximately 7 hours (80-90 frames) were used for 
MSD calculation.  
7.2.5 Tumor cell immunofluorescence staining 
Written, performed and analyzed by Marina Pranda, with the help of Ariana DeCastro and Greg 
Dawson (Stroka Lab). 
For CD44 staining, 2x104 MDA-MB-231 cells were plated on HA/gelatin films 
formed with 0.2, 0.8, 1.2, and 2% Extralink in glass bottom dishes, or on dishes 
incubated with 20 μg ml-1 type I collagen for at least 1 hour at 37°C then washed three 
times with PBS. The next day, the cells were fixed in 3.7% formaldehyde (Millipore 
Sigma) for 10 minutes at room temperature, washed three times with PBS for 5 minutes 
each with rocking, and permeabilized with 0.5% Triton-X 100 (Millipore Sigma) for 5 
minutes. The samples were then washed again three times in PBS for 5 minutes each 
and blocked in 2% Bovine Serum Albumin (BSA) (Millipore Sigma) for 1 hour at room 
temperature. Cells were then incubated at 4°C overnight with CD44 antibody 
(monoclonal CD44 antibody (156 3C11) Mouse mAb #3570, Cell Signaling 
Technologies, Danvers, MA, USA), which was dissolved in 2% BSA at a 1:100 ratio. 
Next, cells were rinsed with PBS and again blocked with 2% BSA for one hour at room 
temperature and washed with PBS. Cells were then incubated with 1:500 Phalloidin - 
Alexa Fluor 488 (Thermo Fisher Scientific), 1:100 of secondary antibody (Goat anti-
Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody Alexa Fluor 568, Thermo 
Fisher Scientific, A-11004), and 1:2500 of Hoechst 33342 (Thermo Fisher Scientific) 
diluted in PBS for 1 hour at room temperature. HBMECs transfected with the VE-




were also fixed for 10 minutes in 3.7% formaldehyde, washed with PBS, and stained 
with 1:2500 of Hoechst 33342 for one hour at room temperature. Finally, all samples 
were washed with PBS and stored at 4°C until imaging via confocal microscopy. 
7.2.6 Tumor-conditioned medium (TCM) preparation 
To prepare TCM, MDA-MB-231 cells were seeded at 25% confluency in a T-
75 flask and cultured in HBMEC medium for 72 hours. The medium was then 
collected, centrifuged at 300 x g for 10 minutes and the supernatant was filtered through 
a 40 μm cell strainer to remove any debris. This post-strained solution was then mixed 
at a 1:1 ratio with control HBMEC medium and designated as TCM. The TCM-free 
conditions consisted of HBMEC medium that was spun down and strained to the same 
degree as that collected from the MDA-MB-231 cells and mixed at a 1:1 ratio with 
fresh HBMEC medium.   
7.2.7 HBMEC immunofluorescence staining  
HA/gelatin films were prepared as described above in 24-well glass bottom 
plates. After soaking in medium at 37°C, 5x104 HBMECs were plated onto each film. 
Approximately 24 hours later, the cells were treated with TCM or TCM-free (Control) 
medium and cultured for an additional 24 hours. For the VEGF studies, HBMECs were 
treated with TCM containing 0.12 μg/ml VEGF monoclonal antibody (Thermo Fisher 
Scientific #26503) or mouse IgG2b isotype control (Thermo Fisher Scientific), or 
TCM-free medium 24 hours after cell-seeding and cultured for an additional 24 hours. 
For immunofluorescence staining, HBMECs were rinsed with warm PBS and fixed 




three subsequent 5-minute washes with PBS, the fixed HBMECs were then 
permeabilized with 0.25% Triton-X 100 (Millipore Sigma) for 5 minutes at room 
temperature. The samples were then washed again with PBS three times for 5 minutes 
each, then blocked for 1 hour at room temperature with 2% goat serum (Abcam, 
Cambridge, MA, USA). Primary antibodies (rabbit polyclonal IgG to ZO-1 antibody 
(H-300) and mouse monoclonal IgG to VE-cadherin antibody (F-8); Santa Cruz 
Biotechnology, Dallas, TX, USA, sc-10804 and sc-9989, respectively) were diluted 
1:50 in 2% goat serum and added to the cells overnight at 4°C. Samples were rinsed 
the next day with PBS, blocked again for 1 hour at room temperature with 2% goat 
serum and then treated with secondary antibody (goat anti-rabbit Alexa Fluor 488, 
Abcam, ab150077; and goat anti-mouse Alexa Fluor 568, ThermoFisher Scientific) at 
a 1:100 dilution and 1:2500 Hoechst 33342 (ThermoFisher Scientific), in PBS, for 1 
hour at room temperature. Samples were then rinsed with PBS and fresh PBS was 
added for imaging via fluorescence microscopy and analyzed as described below in the 
data analysis section.  
7.2.8 ELISA assay for VEGF detection 
 To quantify the concentration of VEGF in TCM and TCM-free conditions, a 
Human VEGF Quantikine ELISA Kit (R&D Systems, Minneapolis, MN, USA) was 
used per the manufacturer’s instructions. The medium samples were collected as stated 
in the “TCM Preparation” method above and quantified immediately following 




7.2.9 Tumor cell incorporation assay and analysis 
Written, performed and analyzed by Marina Pranda, with the help of Ariana DeCastro and Greg 
Dawson (Stroka Lab). 
HA/gelatin films were prepared as described above in 24-well, glass bottom 
plates with 0.2, 0.8, 1.2, and 2% Extralink as well as a 1:1 mixture of gelatin and HA 
without Extralink (0%). 5x104 - 1x105 HBMECs were plated on the HA/gelatin films. 
To investigate the percent incorporation of metastatic breast tumor cells into HBMEC 
monolayers, live MDA-MB-231 cells were first stained with CellTracker Orange 
CMRA Dye (Thermo Fisher Scientific) per the manufacturer’s instructions. Briefly, 
MDA-MB-231 cells were cultured in 6 well plates and equilibrated in HBMEC 
medium for two hours. The cells were washed with PBS and then incubated with 2 mL 
of 0.5 𝜇𝜇M CellTracker Orange dye in RPMI-1640 and 1% Pen/Strep for 15 minutes. 
Cells were then washed again with PBS and incubated for 30 minutes in full HBMEC 
medium. The stained cells were then trypsinized and 1x104 - 2.5x104 MDA-MB-231 
cells were plated on top of HBMECs that had been cultured to monolayer on 
HA/gelatin films for two days prior to MDA-MB-231 cell seeding. These samples were 
imaged using time-lapse phase-contrast and fluorescence microscopy as described 
below. 
 To quantify the time that tumor cells take to incorporate into HBMEC 
monolayers, and the percent of the tumor cells that incorporate into the monolayers, 
CellTracker-stained MDA-MB-231 cells were tracked on HMBEC monolayers by 
capturing images in 15-minute intervals. First, the total number of tumor cells per frame 




frames (585 minutes). Cells that went out of frame before frame 40 were excluded from 
analysis, as well as cells deemed “untrackable” due to clumping, visual obstructions, 
or migration to areas of large gaps in the monolayer. An incorporating cell was 
subjectively identified based on the disappearance of a white halo surrounding the cell 
and transition to a 2D-flattened morphology in phase contrast images. If a cell was 
spread, but retained a halo and 3D appearance, it was counted as not incorporating and 
instead was likely spreading on top of the monolayer. Percent incorporation was 
calculated by dividing the total cells that incorporated into the monolayer by the total 
number of cells tracked in each frame. The start time for a cell to incorporate was 
marked as the first frame where the cell appeared to be spreading into the monolayer, 
or the very first frame if it was already spread. If cells incorporated and then exited the 
monolayer, only the first instance of incorporation was counted. If a cell divided before 
incorporating or before frame 40, it was counted as two separate cells. If cells divided 
after incorporation, it was counted as one cell. Cumulative percent incorporation was 
calculated by averaging the total percent of cells that had incorporated at each 15-
minute timepoint out of the total number of analyzable cells.  
7.2.10 Microscopy 
Confocal and live-cell microscopy performed by Marina Pranda (Stroka Lab). 
Immunostained HBMECs were imaged on an Olympus IX83 inverted 
microscope using a 60x oil objective and Olympus cellSens Software. Images were 
collected in a manner that maximized monolayer coverage within the respective image. 




have been enhanced via ImageJ, to the same extent for each channel, for improved 
visualization within this manuscript. 
A PerkinElmer confocal spinning disk microscope (PerkinElmer, Waltham, 
MA) was used to obtain 3D images of fixed cells using a 40x water immersion 
objective. Vertical z-stacks were taken using appropriate filters using the Volocity 3D 
Image Analysis software. All acquisition settings were kept consistent between images 
within each experiment for CD44 imaging and slightly adjusted for best visualization 
for transmigration imaging. The ImageJ software (NIH; https://imagej.nih.gov) was 
used to reconstruct individual z-stack images into 3D, maximum-intensity and 
interpolated projections. Brightness of each channel in images of MDA-MB-231 cells 
stained for CD44 was adjusted separately but identically between each image to ensure 
that intensities could be compared. Brightness of each channel in images of MDA-MB-
231 cells incorporating into HBMEC monolayers were adjusted separately for best 
visibility of appropriate parts of the cells; thus, intensities cannot be directly compared 
for these images. 
Live-cell phase contrast and fluorescence images were captured using an IX83 
microscope (Olympus, Center Valley, PA, USA) with a 10x objective for tumor cell 
migration assays on bare films, and 20x objective for tumor cell morphology assays on 
bare films, and incorporation assays with HBMECs and CellTracker-stained tumor 
cells. The Olympus cellSens Software (Olympus) was used to acquire the images. 
Phase contrast images of tumor cells on bare films were collected every 5 to 15 minutes 
for migration analysis, and additional images were captured at the end of the time-lapse 




experiments were selected based on best monolayer coverage and the presence of 
MDA-MB-231 cells. The live-cell imaging chamber was maintained at 37°C, 50% 
humidity, and 5% CO2:95% air surrounding the microscope stage.  
7.2.11 HBMEC morphology and junction analysis 
To quantitatively analyze HBMEC morphology and cell-cell junction 
presentation, we utilized the JAnaP described in Chapter 3. Here, we utilized the ability 
to quantify an additional junction protein on the same cell. In addition to ZO-1, we co-
stained the HBMECs for VE-cadherin. The waypoints generated on the ZO-1 image 
were projected to the VE-cadherin-tagged image, but the path between each waypoint 
was generated based on the intensities of the VE-cadherin image. A threshold value of 
15 was used to isolate ZO-1 junctions while a threshold of 5 was used to isolate VE-
cadherin junctions. Continuous junctions are junction pieces coinciding with the cell 
edge for at least 15 consecutive pixels. Junctions coinciding with the cell edge for less 
than 15 pixels are categorized as perpendicular, if they have a relative aspect ratio 
greater than 1.2, or punctate, if they have a relative aspect ratio less than 1.2. The 
relative aspect ratio is calculated by dividing the tip-to-tip distance (Tip Dist.), or 
maximum thickness, by the length of the junction coinciding with the cell edge, termed 
“path length”. In this chapter, the percent of the junction coverage (calculated by 
dividing the cumulative sum of the path length of each junction type by the cell 
perimeter), as well as the tip-to-tip distance, are presented. The average tip-to-tip 
distance per cell for each junction type was calculated, providing a measure of the 
average maximum thickness of the continuous, perpendicular, and punctate junctions 




all cells from every trial pooled together (n is approximately 200 cells). The percent 
difference, however, was calculated based on the average of each junction type for 
every trial (n=3). The percent difference was calculated by taking the 
(%𝐽𝐽𝑢𝑢𝑐𝑐𝑐𝑐𝑝𝑝𝑝𝑝𝑐𝑐𝑐𝑐𝑇𝑇𝑇𝑇𝑇𝑇 − %𝐽𝐽𝑢𝑢𝑐𝑐𝑐𝑐𝑝𝑝𝑝𝑝𝑐𝑐𝑐𝑐𝑇𝑇𝐶𝐶𝑏𝑏𝐶𝐶𝐶𝐶𝐶𝐶𝑏𝑏) ∙ ((%𝐽𝐽𝑢𝑢𝑐𝑐𝑐𝑐𝑝𝑝𝑝𝑝𝑐𝑐𝑐𝑐𝑇𝑇𝑇𝑇𝑇𝑇 + %𝐽𝐽𝑢𝑢𝑐𝑐𝑐𝑐𝑝𝑝𝑝𝑝𝑐𝑐𝑐𝑐𝑇𝑇𝐶𝐶𝑏𝑏𝐶𝐶𝐶𝐶𝐶𝐶𝑏𝑏)/
2)−1 for each junction type, for both ZO-1 and VE-cadherin.  
7.2.12 Statistical Analysis 
GraphPad Prism 8 (GraphPad, La Jolla, CA, USA) was used for all statistical 
analysis and graph preparation. Data was tested for normality using a D'Agostino-
Pearson normality test, and some data within the same set did not follow a normal 
distribution. Thus, non-parametric tests were used for statistical analysis. If there were 
not sufficient values for a D’Agostino-Pearson test, a non-parametric test was used for 
consistency. If data was normally distributed in all comparison groups, a one-way 
analysis of variance (ANOVA) without assumed equal variances was used. For data 
that was not all normally distributed, a non-parametric Kruskal-Wallis ANOVA test 
with a Dunn’s multiple comparison post-hoc test was used and for data that was all 
normally distributed a Brown-Forsythe and Welch ANOVA with Games-Howell post-
hoc test was used. All tests were carried out with P > 0.05 indicating not statistically 
different, * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, **** P ≤ 0.0001. A linear regression 
was used to compare the number of tumor cells at the start versus monolayer quality, 
the percent difference in HBMEC junction presentation between TCM and control 
treatments, and the effect of Extralink concentration on junction tip-to-tip distance. A 
Mann-Whitney test was used to compare the TCM versus TCM-free conditions for 




VEGF concentration in TCM versus TCM-free conditions. Errors bars represent 
standard error of the mean. All data represents pooled values from three independent 
trials unless otherwise noted in the figure captions. 
7.3 Results 
7.3.1 MDA-MB-231 cells become smaller and slower with increased 
HA/gelatin crosslinking 
ECM crosslinking has been shown to alter tumor cell phenotype and 
invasiveness, and HA is known to be one of the primary components of the brain’s 
ECM [268,270,271,273]. Hence, we aimed to evaluate the migration and morphology 
response of MDA-MB-231 tumor cells to varying degrees of HA/gelatin film 
crosslinking by altering the concentration of Extralink, a PEGDA-based crosslinker, 
during film formation [276,277]. We found that with increased Extralink concentration 
from 0.2% to 2%, MDA-MB-231 cells became significantly smaller (Figure 7.1.A,B) 
and more circular (Figure 7.1.A,C) and increased in inverse aspect ratio, circularity, 
and solidity (Figure 7.1.A,C). Furthermore, MDA-MB-231 cells plated on HA/gelatin 
films with increased Extralink concentrations demonstrated more homogeneous 
morphologies as evidenced by a decreased spread of the data with higher Extralink 
concentrations (Figure 7.1.B,C). Additionally, MDA-MB-231 cell speed decreased 
with increased crosslinking of HA/gelatin films (Figure 7.1.D). Plots of mean squared 
displacement vs. time indicated that MDA-MB-231 cells explored smaller areas with 
increased crosslinking of HA/gelatin films (Figure 7.1.E). Because a mesenchymal, 




[278,279], these changes in cell morphology and migration could be relevant to the 
cells’ functionality.  
Figure 7.1 MDA-MB-231 morphology and migration parameters on HA/gelatin films 
with varying degrees of crosslinking. A) Phase contrast images of MDA-MB-231 cells 
on HA/gelatin films with 0.2, 0.8, 1.2, and 2% Extralink. Scale bar is 50 μm and applies to 
all images. B) Areas, C) inverse aspect ratio, circularity, and solidity, D) speed, E) mean 
squared displacement of MDA-MB-231 cells on HA/gelatin films with 0.2, 0.8, 1.2, and 
2% Extralink. Means of columns that do not share a lower-case letter are significantly 
different with P < 0.05 via a non-parametric Kruskal-Wallis ANOVA test with a Dunn’s 
multiple comparison post-hoc test. B,C: 529 ≤ N ≤ 582, D: 142 ≤ N ≤ 228 where N is the 
number of cells. E: N = 3, where N is the number of trials. All error bars represent standard 
error of the mean. All values are pooled from three independent trials. Data collection, 
analysis, and figure preparation was performed by Marina A. Pranda, with the help of 









Cell attachment to HA is mediated by CD44, which also has been implicated in 
transducing HA stiffness cues and associated with brain tumor progression and 
invasion [266,280–282]. For breast tumor cells, CD44 increases tumor cell adhesion to 
and invasion of the endothelium, increasing the efficiency of distant metastasis [283]. 
Hence, we explored whether the morphological and migratory behavior with altered 
HA/gelatin film crosslinking were also associated with differences in CD44 binding. 
Interestingly, MDA-MB-231 cells immunostained for CD44 on HA/gelatin films with 
varying degrees of crosslinking, as well as type I collagen-coated glass, did not present 
observable differences in CD44 expression (Figure 7.2). 
 
Figure 7.2 CD44 and actin staining in MDA-MB-231 cells. Reconstructed confocal z-
stacks of MDA-MB-231 cells immunostained for CD44 (red) and stained for actin (green) 
on HA/gelatin films with 0.2, 0.8, 1.2, and 2% Extralink, as well as on glass coated with 
type I collagen. Scale bar on first image is 50 μm and applies to all images. Scale bar in the 
zoomed in inserts is 25 μm. Green: actin; red: CD44, blue: DNA. All images were 
reconstructed from a z-stack in ImageJ and intensities were adjusted equally for each 
channel and image. Data collection, analysis, and figure preparation was performed by 
Marina A. Pranda, with the help of Ariana DeCastro and Greg Dawson (Stroka Lab). 
 
 
Figure 7.2 CD44 




Meanwhile, actin arrangement was altered, with MDA-MB-231 cells on type I 
collagen and HA/gelatin films with 0.2% Extralink displaying a somewhat fibrous actin 
arrangement (Figure 7.2) which became more diffuse with increased film crosslinking, 
especially on the films with 2% Extralink (Figure 7.2). Increased cell spreading and 
mesenchymal migration are typically correlated with a more stress fiber-rich actin 
arrangement [284], which is indeed in line with our observations. A stress fiber-rich 
actin cytoskeleton is also often linked with a high degree of cellular contractility, which 
also correlates with the stiffness of the underlying cellular matrix [285]. Since increased 
crosslinking typically results in increased material stiffness, changes in film stiffness 
could drive alterations in tumor cell contractility and actin filament arrangement. 
Hence, we used atomic force microscopy to probe the effect of Extralink concentration 
on the Young’s modulus of HA/gelatin films. The average modulus of the films formed 
with 0.2, 0.8, 1.2, and 2% Extralink were measured to be 0.85, 1.1, 1.5, and 3.8 kPa, 
respectively (Figure 7.3). Interestingly, only the Young’s modulus of the film formed 
using 2% Extralink was statistically different from the Young’s modulus of the other 
film compositions. Despite this, we still found significant differences in MDA-MB-231 





7.3.2 HA/gelatin crosslinking does not affect HBMEC morphology or junction 
presentation 
Metastasis across the BBB requires that tumor cells not only overcome the 
endothelial cell barrier, but also the underlying basement membrane. Tumor cells are 
reported to actively degrade the basement membrane by secreting matrix 
metalloproteinases (MMPs) [286].  Disruption of the basement membrane could lead 
to direct endothelial cell interaction with the brain ECM, and possibly abluminal HA-
binding. Given the significant differences in MDA-MB-231 behavior on HA/gelatin 
films of varying crosslink density, we next wanted to understand how these differences 
in film composition might affect HBMEC monolayers. After two days of static culture 
on each film composition, HBMECs were fixed and immunostained for ZO-1 and VE-
cadherin (Figure 7.4.A). In general, the percent of Extralink crosslinker did not affect 
the area (Figure 7.4.B), solidity (Figure 7.4.C), circularity (Figure 7.4.C), or perimeter 
Figure 7.3: Atomic force microscopy measurements of HA/gelatin film stiffness. 
Young’s modulus measurements of HA/gelatin films as a function of film crosslinking. 
Each point represents the average Young’s modulus of a 100-curve force map covering a 
10 μm x 10 μm area. The pooled results represent five measurements taken across 4 
different samples for each film composition. The ROUT method (Q=1%) was used to 
identify and remove 1 outlier. The numbers next to each bar represent the average Young’s 
Modulus (in kPa) for that film composition.  Statistical analysis was performed using a 
one-way ANOVA with a post-hoc Tukey test for multiple comparisons, **** P ≤ 0.0001. 
 


























(Figure 7.5) of individual HBMECs within a monolayer. To assess how crosslinking 
affects cell-cell junctions, we used the JAnaP to quantify the percent of the cell 
perimeters presenting different junction types for ZO-1 and VE-cadherin (Figure 7.4.D-
E). HBMECs on HA/gelatin films with 0.8% Extralink presented the highest amounts 
of continuous, punctate, and perpendicular ZO-1 (Figure 7.4.D). For VE-cadherin, no 
difference in continuous or perpendicular junction presentation was observed across 
the different film compositions, but punctate junctions were highest on HA/gelatin 
films with 0.8% and 2.0% Extralink (Figure 7.4.E). We note that these results, and the 
results described below, were obtained for our cell culture models under static 
conditions and in the absence of other BBB cells such as astrocytes and pericytes; we 






Figure 7.4: HBMEC morphology and junction presentation on HA/gelatin films with 
varying degrees of crosslinking. A) Immunofluorescence images of HBMECs 
immunostained for ZO-1 (green) and VE-cadherin (red) on HA/gelatin films with 0.2, 0.8, 
1.2, and 2% Extralink. Scale bar on bottom right image is 20 μm and applies to all images 
in this panel. B) Area and C) solidity and circularity on HA/gelatin films with varying 
Extralink. The percent of the cell edge presenting continuous, punctate, and perpendicular 
junction for D) ZO-1 and E) VE-cadherin. The inset graphs depict the same perpendicular 
results, zoomed in to improve visibility. B-E: 182 ≤ N ≤ 223, where N is the number of 
cells. A non-parametric Kruskal-Wallis ANOVA with a Dunn’s multiple comparisons test 
was used for statistical analysis to compare results within each morphological parameter or 
junction type (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001, NS P > 0.05). All 
error bars represent standard error of the mean and dots for panels B-E represent values for 
individual cells. 
 
Figure 7.4 HBMEC morphology and junction presentation on HA/gelatin films 




7.3.3 Tumor conditioned medium alters HBMEC junction presentation 
To understand the effects of biochemical signaling between HBMECs and 
metastatic tumor cells, and how these signaling effects may be modulated by 
HA/gelatin matrix crosslinking, we treated HBMECs with TCM. TCM-treated 
HBMECs presented visually thick, continuously connected junctions with a largely 
jagged morphology (Figure 7.6.A). The cells were smallest on HA/gelatin films made 
with 2.0% Extralink (Figures 7.4.B, 7.5 and 7.6.B) and were significantly smaller than 
HBMECs not treated with TCM on 0.8% and 2.0% Extralink. However, no changes in 
circularity or solidity were observed between Extralink concentrations or due to TCM 
treatment (Figures 7.4.C and 7.6.C). While no apparent trend was observed for VE-
cadherin junctions on varying Extralink films in response to TCM, ZO-1 junctions 
generally decreased with increased Extralink, except continuous junctions on 0.2% 
(Figure 7.6.D,E).  
Figure 7.5: Effect of Extralink concentration and TCM treatment on HBMEC 
perimeter. HBMEC perimeters on HA/gelatin films with 0.2, 0.8, 1.2, and 2% 
Extralink treated with control medium or TCM. A non-parametric Kruskal-Wallis 
ANOVA with a Dunn’s multiple comparisons test was used for statistical analysis to 
compare results within each treatment group (**P ≤ 0.01, NS P > 0.05)). All error bars 
represent standard error of the mean and dots represent values for individual cells. 
 
 











Figure 7.6 (Next Page): TCM-treated HBMEC morphology and junction 
presentation on HA/gelatin films with varying degrees of crosslinking. A) 
Immunofluorescence images of HBMECs treated with TCM on HA/gelatin films with 
0.2, 0.8, 1.2, and 2% Extralink. Scale bar on bottom right image is 20 μm and applies to 
all images in this panel. B) Area and C) solidity and circularity on HA/gelatin films with 
varying Extralink. The percent of the cell edge presenting continuous, punctate, and 
perpendicular junction for D) ZO-1 and E) VE-cadherin. The inset graphs depict the 
same perpendicular junction results but zoomed in to improve visibility. B-E: 195 ≤ N 
≤ 224, where N is the number of cells. The percent difference of F) ZO-1 and G) VE-
cadherin between TCM (Fig. 7.6.D,E) and TCM-free (Fig. 7.4.D,E) for each junction 
type. F-G: N=3, where N is the number of trials. Legend in panel G applies to panels F 
and G. The colored dotted lines represent the linear regression (Lin. Reg.) of each 
respective junction type. The tip-to-tip distance (TipDist.) of H) ZO-1 and I) VE-
cadherin, where the dotted and solid lines represent the linear regression of the TCM-
free and TCM conditions, respectively. H-I: 86 ≤ N ≤ 129, where N is the number of 
cells. Legend in panel I applies to panels H and I. A non-parametric Kruskal-Wallis 
ANOVA with a Dunn’s multiple comparisons test was used for statistical analysis to 
compare results within each morphological parameter or junction type (*P ≤ 0.05, **P 
≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001, NS P > 0.05). For F-G, statistics represent the 
difference between TCM and TCM-free conditions presented in Fig 5D-E and Fig 4D-
E, respectively, calculated using a Mann-Whitney test for each condition. For H-I, 
statistics represent the difference between TCM versus TCM-free results for each 
junction type at the respective Extralink concentration within the respective graph. All 
error bars represent standard error of the mean and dots for panels B-E represent values 








To investigate the specific effects of TCM treatment on HBMEC junctional 
protein presentation, we calculated the percent difference between the TCM (Figure 
7.6.D,E) and TCM-free conditions (Figure 7.4.D,E) for each HBMEC junction type 
and film composition. For ZO-1, TCM treatment increased continuous junction 
Figure 7.6 TCM-treated HBMEC morphology and junction presentation on HA/gelatin films with 




presentation on all films except on the film with the highest Extralink concentration. A 
linear fit (slope = -33.0 %  Difference / % Extralink, R2 = 0.769) suggests a decreasing 
trend with increasing Extralink concentration, though the slope was not significantly 
non-zero (Figure 7.6.F). While perpendicular junctions responded with a similar trend 
(slope = -31.7 % Difference / % Extralink, R2 = 0.794 , non-significant non-zero slope), 
punctate ZO-1 was much less sensitive to TCM (slope = -7.2 % Difference / % 
Extralink, R2 = 0.269, non-significant non-zero slope). For VE-cadherin, both 
continuous and perpendicular junctions increased with TCM for all film compositions, 
while punctate junctions generally decreased. The response of VE-cadherin junction 
presentation to TCM was even less affected by the Extralink concentration compared 
to ZO-1, as the slope of the continuous, perpendicular, and punctate linear regressions 
were -3.1, 6.7, and -2.8  % Difference / % Extralink, respectively, and all were non-
significantly non-zero (Figure 7.6.G).  
Though quantification of junction coverage provides insight into the 
localization of each junctional protein, it does not provide an explicit measure of 
junction thickness or “protrusion”. We therefore analyzed the average tip-to-tip 
distance of each junction type to quantify the maximum distance the junction protruded 
from the cell edge for ZO-1 (Figure 7.6.H) and VE-cadherin (Figure 7.6.I). As 
expected, the punctate junctions (presented in red in Figure 7.6.H,I) had the smallest 
tip-to-tip distance compared to continuous and perpendicular junctions. For ZO-1 
(Figure 7.6.H), the perpendicular junctions had the largest tip-to-tip distance. This is in 
line with our expectations, since by definition, perpendicular junctions protrude 




observed, except for punctate junctions which increased with TCM on all films except 
the 2.0% Extralink film. On the other hand, TCM increased the protrusion thickness of 
VE-cadherin junctions in nearly every condition. Interestingly, the continuous and 
perpendicular junctions were nearly the same width, suggesting that the continuous 
junctions did not take the form of linear, mature junctions parallel to the cell border 
[15], rather protrusive perpendicular-like junctions that continuously presented 
themselves around the cell edge. Notably, the tip-to-tip distance of VE-cadherin was 
always greater than ZO-1 for each respective junction type. These results were in line 
with previous studies that reported manual width measurements of tight junctions 
(specifically, claudin-5) to be approximately 1 to 1.5 μm wide [83]  and VE-cadherin 
junctions to be approximately 1 to 3 μm wide [161]. Overall, Extralink concentration 
did not affect the tip-to-tip distance results, since all the linear regression fits returned 
non-significantly non-zero slopes, though some significant differences did emerge 
between groups (Table 7.1). 
Table 7.1: Statistical summary comparing the effect of Extralink 
concentration on junction tip-to-tip distance. A non-parametric Kruskal-Wallis 
ANOVA with a Dunn’s multiple comparisons test was used for statistical analysis 
to compare results within each treatment group (****P ≤ 0.0001, ***P ≤ 0.001, 











Metastatic breast tumor cells secrete Vascular Endothelial Growth Factor 
(VEGF) which can disrupt or rearrange cell-cell junctions [256,257], or induce elevated 
expression of Angiopoietin-2 by endothelial cells, further weakening the monolayer 
[257]. To probe whether VEGF was playing a role in the junctional changes observed 
with TCM treatment, we first checked to see if VEGF was in fact present in the TCM 
produced by MDA-MB-231 cells. Using an ELISA, we found that VEGF was present 
in TCM at approximately 9000 pg/ml, a concentration significantly greater than the 
TCM-free control medium (approximately 3 pg/ml) (Figure 7.7.A). We therefore 
investigated the effects of inhibiting VEGF in TCM on junction presentation. To do 
this, we seeded HBMECs on HA/gelatin films composed of 0.8% Extralink. As 
expected, the HBMECs treated with the TCM control presented thick, jagged junctions 
(Figure 7.7.B), similar to those observed with TCM treatment (Figure 7.7.A). When 
VEGF was blocked, however, the junctions lost this perpendicular phenotype, and 
instead presented junctions resembling the TCM-free condition. Junction 
quantification showed a significant decrease in perpendicular junction coverage and 
thickness (Tip Dist.) for both ZO-1 (Figure 7.7.C,E) and VE-cadherin (Figure 7.7.D,F) 
with VEGF inhibition, but little to no significant difference between the anti-VEGF 
and TCM-free conditions. Furthermore, VEGF inhibition not only decreased 
continuous VE-cadherin coverage, but it also decreased the thickness of both 
continuous ZO-1 (Figure 7.7.E) and continuous VE-cadherin (Figure 7.7.F), verifying 




TCM. Overall, these studies implicate tumor cell-secreted VEGF in the observed 
alterations in junctional appearance with TCM treatment. 
Figure 7.7: Role of tumor cell-secreted VEGF in HBMEC junction presentation. A) 
ELISA quantification of VEGF in TCM versus TCM-free control (N=3 biological 
replicates). B) Immunofluorescence images of HBMECs treated with TCM Control (TCM 
+ isotype antibody), anti-VEGF (TCM + VEGF antibody), and TCM-Free control on 0.8% 
Extralink film. Scale bar on bottom right image is 20 μm and applies to all images in this 
panel. The percent of the cell edge presenting continuous, punctate, and perpendicular 
junction for C) ZO-1 and D) VE-cadherin. The tip-to-tip distance (Tip Dist) of E) ZO-1 
and F) VE-cadherin. C-D: 77 ≤ N ≤ 82 and E-F: 71 ≤ N ≤ 82, where N is the number of 
cells. A t-test was used for statistical comparison for panel A, while a non-parametric 
Kruskal-Wallis ANOVA with a Dunn’s multiple comparisons test was used for panels C-
F to compare results within each junction type (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P 
≤ 0.0001, NS P > 0.05). All error bars represent standard error of the mean and dots for 
panels C-F represent values for individual cells.  
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7.3.4 MDA-MB-231 cells incorporate into HBMEC monolayers 
independently of HA/gelatin crosslinking 
Because we observed that tumor cell-derived biochemical cues from TCM can 
alter HBMEC junction morphology, we next examined the effect of HA/gelatin film 
crosslinking on breast tumor cell incorporation into HBMEC monolayers. Phase 
contrast and fluorescence microscopy were used to evaluate CellTracker-stained 
MDA-MB-231 incorporation into HBMEC monolayers (Figure 7.8.A). We found no 
statistically significant difference in the percent incorporation of MDA-MB-231 cells 
into HBMECs (Figure 7.8.B) or in the time from the start of the time-lapse to complete 
incorporation (Figure 7.8.C) as a function of Extralink concentration. This was not 
surprising, since the alterations in HBMEC cell-cell junction presentation due to TCM-
treatment were mostly not affected by the Extralink concentration of the underlying 
HA/gelatin films (Fig. 7.8.F-I). The cumulative percent of MDA-MB-231 cell 
incorporation, or percent of incorporation at each time point, was generally similar for 
all films, regardless of Extralink concentration under static conditions (Figure 7.8.D). 
Furthermore, we found that the plot of percent MDA-MB-231 cell incorporation at ~10 
hours versus the average number of MDA-MB-231 cells at the start of the time-lapse 






Figure 7.8: MDA-MB-231 cell incorporation into HBMEC monolayers on HA/gelatin 
films with varying degrees of crosslinking. A) Phase contrast images of an incorporating 
(blue arrow) and a non-incorporating (green arrow) CellTracker-stained MDA-MB-231 cell 
(red) on an HBMEC monolayer. B) Percent of MDA-MB-231 cells that incorporate (12 ≤ 
N ≤ 22, where N is the number of time-lapse sequences analyzed per condition), C) time 
from start of time-lapse to full incorporation of MDA-MB-231 cells, and D) the cumulative 
percent incorporation of MDA-MB-231 cells over time (65 ≤ N ≤ 184, where N is the 
number of incorporating cells) into HBMEC monolayers on HA/gelatin films with 0, 0.2, 
0.8, 1.2, and 2% Extralink in a total time of 9.75 hours. E) Average percent incorporation 
as a function of the number of MDA-MB-231 cells in frame at the start of the time-lapse. 
For panels B and C, P > 0.05 via a non-parametric Kruskal-Wallis ANOVA test with a 
Dunn’s multiple comparison post-hoc test between all groups. All error bars represent 
standard error of the mean. All data is pooled from three independent trials. Data collection, 
analysis, and figure preparation was performed by Marina A. Pranda, with the help of 
Ariana DeCastro and Greg Dawson (Stroka Lab). Figure 7.8 MDA-MB-231 cell incorporation 





ECM crosslinking and stiffness are known regulators of many cellular functions 
in the context of physiologic and pathologic conditions. In this work, we explored the 
effects of HA crosslinking on metastatic breast tumor cell migration and incorporation 
into the human brain endothelium. Interestingly, our results showing reduced spreading 
area and more diffuse stress fibers for cells on more crosslinked and stiffer HA/gelatin 
films is contradictory to frequent reports in literature, including our own, where cells 
spread more on stiffer ECM-coated polyacrylamide gels [287–289]. Similarly, 
previous studies have shown that when utilizing HA-methacrylate gels crosslinked with 
dithiothreitol (DTT) and functionalized with Arg-Gly-Asp (RGD) peptides for cell 
adhesion, increasing HA weight percent and crosslinking density, thus increasing 
stiffness, increased the spreading area and speed of glioblastoma cells [290]. Also in 
opposition to our studies, Narkhede et al. found that increasing the concentration of 
DTT crosslinker in a methacrylated HA system coated with integrin binding proteins 
increased the cell area and speed of MDA-MB-231-BR cells, the brain-seeking clone 
of the parental MDA-MB-231 cells [291]. Notably, the work by Narkhede et al. was 
performed on HA gels formulated with different molecular weights, using a different 
mechanism of crosslinking, and with various coatings for cell adhesion, rather than 
gelatin incorporation as was used here. On the other hand, through chemical rather than 
mechanical signaling, soft HA gels can produce identical cellular responses to those on 
stiffer substrates [292]. Hence, mechanosensitivity in this context likely involves a 




stiffness, method and degree of crosslinking, method of adhesion molecule 
incorporation, and the specific composition of the matrix. 
Our results suggest that HBMECs are less sensitive to the range of HA/gelatin 
crosslinking relative to MDA-MB-231 cells. This was not surprising, given that the 
measured Young’s modulus of the films was in the relatively small range of 0.85 to 3.8 
kPa. In Chapter 6, we showed that HBMEC morphology is sensitive to large differences 
in substrate stiffness (e.g., 194 kPa versus approximately 50 GPa) but not to smaller 
ranges of stiffness (e.g., 1-194 kPa) [215]. Thus, from a mechanobiological perspective, 
the result that HBMEC morphology was not altered as a function of the Extralink 
concentrations is consistent with our expectations. The increase in overall ZO-1 
presentation on the film made with 0.8% Extralink, including increased continuous 
junctions, suggests that the tight junctions of monolayers on this film composition may 
be more mature than those on the other films tested.  
Altogether, TCM minimally affected HBMEC size but altered ZO-1 and VE-
cadherin junctional presentation to a more continuous and perpendicular morphology 
under static conditions. Importantly, this increase in continuous junctions with TCM 
took the form of a jagged, zipper-like phenotype rather than a linear, mature continuous 
junction. This junctional data suggests that TCM treatment results in a shift of the 
monolayers to a less mature state, which appears to occur independently of matrix 
crosslinking. This shift in monolayer maturity was not surprising, since many reports 
have shown that metastatic breast tumor cell-secreted biochemical factors, such as 
VEGF, are capable of altering endothelial cells [256,257]. Our results indicate that 




the shift in junction presentation from a linear morphology to more perpendicular 
phenotype observed with TCM treatment. This is consistent with previous reports that 
VEGF induces a serrated junction presentation in HBMECs [256]. Notably, most 
reports of junctional analysis rely on qualitative observation, fluorescence intensity 
image analysis, or quantification of the protein expression levels throughout the cells. 
An added benefit of using the JAnaP is the ability to simultaneously and semi-
automatically quantify cell morphological parameters as well as the junctional proteins 
as they are presented at the cell-cell junction, providing a unique measurement 
capability to quantitatively compare between the TCM and TCM-free groups and 
assess heterogeneities in junctional morphology across the monolayer using statistical 
analysis. Together, these results suggest that the biochemical factors (e.g., VEGF) 
secreted by MDA-MB-231 cells alter HBMEC junction presentation in a manner 
unaffected by the extent of crosslinking of the underlying HA/gelatin film. It will be 
interesting to further examine this effect in the presence of physiologic flow conditions 
and in the presence of astrocytes and/or pericytes. 
Our results suggest a lack of correlation between the number of tumor cells in 
the area of observation and propensity to incorporate. We note that if a tumor cell 
interacted directly with a gap between HBMECs in the monolayer, it was not included 
in the analysis. Therefore, once a monolayer of HBMECs was present in the system, 
breast tumor cells appeared to be less sensitive to HA/gelatin matrix crosslinking than 
when they were on bare films. These results suggest that HA/gelatin crosslinking does 
not significantly affect tumor cell incorporation into HMBEC monolayers, and that 




on the bare gels without HBMECs showed such dramatic differences in morphology 
and migration. Our observations for MDA-MB-231 cells incorporating into HBMEC 
monolayers on HA/gelatin films are also consistent with our previous results, where 
percent tumor cell incorporation into HUVECs was independent of polyacrylamide gel 
stiffness [293].  
An important note to make is that HBMECs may be remodeling the underlying 
matrix and/or depositing new ECM, therefore masking the original mechanical 
properties of the HA/gelatin films to the incorporating tumor cells and altering their 
interactions with the matrix post-incorporation. Indeed, previous studies have 
demonstrated that ECs are capable of low levels of ECM deposition after just one day 
of culture in favorable conditions [294], and thus HBMEC-matrix remodeling is 
plausible during the three-day culture period. It is also possible that cell adhesion 
molecules linking tumor cells and HBMECs could physically alter the migratory 
capacity of tumor cells within an HBMEC monolayer. 
While our experiments have provided interesting insights into the biochemical 
and physical interactions between tumor cells, the HA matrix, and the brain 
endothelium, we acknowledge several important limitations of our system. First, our 
model lacks other cell types present at the in vivo BBB, including astrocytes and 
pericytes. There is a growing body of literature [295,296] to support the hypothesis that 
the presence of these cells, and/or their secreted biochemical factors, would likely 
influence tumor cell migration and incorporation into the brain endothelium, cell-cell 
junctions in the HBMECs, and possibly also the ECM. Indeed, our own previous work 




to their ECM only, can result in increased cell migration [275]. Secondly, our models 
lack physiologic flow conditions. Shear stresses in the brain capillaries of rodent 
models have been measured to be in the range of 20-40 dyne cm-2 [297], which can 
influence endothelial barrier function, cell migration, tumor cell adhesion, and tumor 
cell proliferation [298–302]. The JAnaP can already calculate cell aspect ratios, and the 
next iteration of the program should include a feature that calculates alignment of 
endothelial cells to the direction of flow. Another limitation of our model is the lack of 
cylindrical geometry, which can influence EC elongation in the presence of shear stress 
[303]. Incorporation of these additional cells and mechanical cues will continue to be 
important as the field develops benchmarks for BBB models.   
7.5 Conclusion 
We have shown that MDA-MB-231 (but not HBMEC) morphology and 
migration parameters are sensitive to the crosslinking density of HA/gelatin films, with 
a trend that is opposite of that typically observed for varying stiffness of ECM-coated 
polyacrylamide gels. Meanwhile, our novel JAnaP was used to quantify modest 
alterations in HBMEC tight and adherens junctions as a function of HA/gelatin 
crosslinking density. In addition, we found that tumor cell-secreted factors (e.g., 
VEGF) led to increased presentation of immature adherens junctions, but minimally 
affected tight junction presentation. HA/gelatin crosslinking, however, did not seem to 
affect MDA-MB-231 cell incorporation into HBMEC monolayers. Overall, our 
quantitative results suggest that a combination of biochemical and physical factors 
promote tumor cell migration through the brain endothelium and suggest that ECM 




complete. Future work will continue to build upon these results by incorporating more 




 - Summary and Conclusions  
 The cell-cell junctions of the endothelium, and especially the BBB, play a major 
role in heath and disease progression. A vast amount of work has been dedicated to 
understanding EC barrier properties and their relation to junctional protein expression. 
However, these relationships have been based primarily on qualitative and correlative 
observations, with little quantitative data regarding the localized junctional protein 
patterns. Here, we developed a program to compute junction presentations within EC 
monolayers and used it to understand the influence of junction phenotype on barrier 
permeability. Furthermore, we assessed junction presentation in brain ECs, probing the 
role of substrate stiffness and cell contractility, as well as the effects of breast cancer 
cell secreted factors, highlighting examples of physiological and pathophysiological 
applications for which this tool could be valuable.  
8.1 JAnaP Enables Junction Phenotyping  
 Here, we have established standardized junction phenotypes for continuous 
(linear and non-linear forms), perpendicular, and punctate patterns, and have developed 
and validated a user-friendly platform to semi-automate the analysis and quantification 
of these images (discussed in Chapter 4). Furthermore, the program has been made 
accessible to other researchers in the community via the Stroka Lab GitHub account 
(https://github.com/StrokaLab/JAnaP) for practitioners to download and use, 
accompanied by a thorough user guide for novice users to follow. The program is able 
to measure the percent coverage of each junction type on a full-cell and per-cell basis, 




analyzed. This occurs in a semi-automated fashion, requiring only that the user (1) 
identify a threshold value for each junction protein to be studied and (2) seed waypoints 
on each image to identify the cells of interest. Conveniently, the JAnaP has been 
developed to allow for the generated waypoints to be applied to the same image of a 
different immuno-stain, enabling the analysis of at least two proteins without the need 
for repeat waypointing. Together, this program allows for the detailed calculation of 
cell-cell junction patterns in an efficient manner, enabling the analysis of junction 
phenotypes to study mechanistic changes in conjunction with the assessment of 
endothelial cell barrier properties.  
8.2 Discontinuous Junctions Increase Barrier Permeability 
Development of the JAnaP enabled a streamlined method for junction 
phenotyping, enabling the mechanistic study of alterations in junction architecture on 
the barrier function of the endothelium. Our work in Chapter 5 highlights the 
capabilities of combining junction phenotyping with the assessment of barrier function 
for the mechanistic study of the BBB, and possibly other EC and epithelial barriers. 
The influence of cell culture parameters such as matrix protein coating, culture time, 
and cAMP treatment on cell and junction morphology was investigated, showing only 
minor differences between the protein coatings studied. cAMP treatment significantly 
increased continuous junctions and increasing cell culture time required increased 
cAMP treatment for comparable protein coverage observed in shorter experiments. A 
local permeability assay was used to account for spatial heterogeneity within the ECs 
and the monolayer, which uncovered a correlation between the area of a permeated 




coverage at the cell edge. This suggests that increased continuous junction presentation 
is associated with a less permeable barrier. These results, however, are only indicative 
of the permeability of the specific probe used, and therefore future work is needed to 
unveil the role of junction presentation, especially the differentiation between punctate 
and perpendicular junctions, on permeability of molecules of different size and charge, 
and of different cell types known to traverse the endothelium.   
8.3 Substrates of Biomimetic Stiffness Increase Continuous Junctions 
 Given the prior evidence that cell contractility influences barrier function and 
junction protein localization, and that ECs can sense and respond to the mechanics of 
their underlying substrate through a contractility-mediated mechanism, we investigated 
the role of matrix stiffness and myosin II-mediated contractility on ZO-1 junction 
presentation in HBMECs in Chapter 6. Use of the JAnaP showed the highest percentage 
of mature junctions on the 1 kPa gels, which was the most physiologically relevant to 
the brain microenvironment and within the range of reported values for subendothelial 
matrix stiffness in the vasculature. This motivates the use of mechanical cues to mimic 
the mechanical environment of the in vivo system, suggesting it may be an effective 
approach to optimizing endothelial barrier properties for in vitro study. Future studies 
of the effects of these parameters on other tight junction proteins (e.g. claudins, 
occludins), however, is needed to fully understand the effects of substrate stiffness on 
barrier phenotype. Furthermore, additional experiments are needed to better understand 
the physiological role (e.g., local permeability to molecules and cells) of each junction 
presentation in the context of the BBB. Understanding what conditions (e.g., 




properties could lead to the development of therapeutics capable of traversing the BBB 
for delivery to the brain or for diseases associated with BBB dysfunction.  
8.4 Breast Cancer Cell-Secreted VEGF Increases Non-linear Junctions 
Since breast cancer often metastasizes to the brain, and disruption of the BBB 
by cancer cells is associated with metastatic progression, the effects of breast cancer 
cell secreted factors on HBMEC junction presentation were investigated in Chapter 7. 
An HA/gelatin film of different crosslink density was used to mimic the brain 
microenvironment and probe the interplay of matrix crosslinking with tumor cell and 
HBMEC response. While tumor cells were found sensitive to the physical alterations 
of the matrix, HBMEC morphology and junction presentation remained unchanged. 
Interestingly, HA/gelatin crosslinking did not influence tumor incorporation into 
HBMEC monolayers, suggesting that matrix mechanics might become more important 
to the tumor cells post-extravasation. Analysis with the JAnaP revealed that tumor 
conditioned medium (TCM) increased presentation of immature adherens junctions, 
but minimally affected tight junction presentation, a response likely mediated through 
VEGF signaling. It will be interesting to further examine this effect in the presence of 
physiologic flow conditions and in the presence of astrocytes and/or pericytes. Overall, 
these results suggest that a combination of biochemical and physical factors promote 
tumor cell migration through the brain endothelium and highlight use of the JAnaP as 
a technique to probe junctional changes in a pathophysiological context, such as breast 




8.5 Concluding Remarks   
 Overall, this dissertation advocates for the quantification of cell-cell junction 
phenotype within the endothelium and introduces a streamlined technique enabling the 
calculation of this parameter. Development of the JAnaP provides for the detailed 
measurement of junction patterns in an efficient manner, enabling the study of 
mechanistic changes in conjunction with the assessment of endothelial cell barrier 
properties. Results from its application in this dissertation have revealed insights into 
the effect of continuous versus discontinuous junction on barrier permeability, 
mechanobiology of brain ECs, and the response of brain ECs to biochemical cues 
involved in breast cancer metastasis. Future use of this program holds significant 
potential for physiological and pathophysiological study, and drug delivery 
applications. 
8.6 Contributions to the field    
8.6.1 Scientific Contributions 
 The work in this dissertation makes the following contributions to the 
understanding of brain endothelial function and cell-cell junction phenotype:  
• Established criteria for junction categorization and developed the JAnaP 
program as a tool for junction quantification (Chapter 4); 
• Disseminated JAnaP tool through GitHub site for public access, accompanied 




• Established that HBMEC junction presentation is minimally affected by 
substrate protein coating but significantly affected by time in culture and 
treatment with cAMP supplements (Chapter 5); 
• Adapted “XPerT” assay for fibronectin-based systems (Chapter 5); 
• Established correlation between discontinuous VE-cadherin and ZO-1 
junctions and barrier permeability (Chapter 5);  
• Established quantifiable connection between HBMEC contractility and ZO-1 
junction presentation (Chapter 6); 
• Established that soft substrates of brain relevant stiffness induce the greatest 
continuous junction presentation relative to other gels of physiologically-
relevant stiffness (Chapter 6); 
• Established that while tumor cell migration is significantly affected by 
differences in the crosslinking of a brain-mimetic HA/Gtn matrix, HBMEC 
morphology and junction presentation are minimally influenced (Chapter 7); 
• Established that MDA-MB-231 cells secrete biochemical factors that increase 
immature adherens junction presentation in HBMECs, likely mediated, at least 
in part, by VEGF-signaling pathways (Chapter 7);  
• Established that the crosslinking of an HA/Gtn matrix underlying an HBMEC 
monolayer plays little role in the ability of tumor cells to incorporate into the 
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 - Future Work and Outlook  
The work in this dissertation has motivated several additional projects, many of 
which will contribute to a more comprehensive understanding of the functional role of 
junctional protein phenotypes in physiological and pathophysiological states of the 
endothelium. For example, this dissertation has only focused in the “snap shot” analysis 
of ZO-1, VE-cadherin, and claudin-5 in brain ECs within a static system. Analysis of 
several other junction proteins (e.g., Occludin, PECAM-1) could be performed to study 
the functional differences in presentation of each protein. Additionally, live-cell 
imaging could be used to study the dynamic changes of junction patterns in shear stress 
or co-culture systems (e.g., with astrocytes) as additional biomimetic parameters in our 
EC model. Several future projects that are motivated by the results presented in this 
dissertation are discussed below.  
9.1 Other Endothelial or Epithelial Cells 
As described in Chapter 2, most vascular (and lymphatic) endothelial cells 
express TJs and AJs. In this dissertation, we have focused on HBMECS, which over 
express these proteins. However, significant opportunity exists to expand the 
application of the JAnaP to study the junctions of ECs from other vascular or lymphatic 
beds. Several examples in the literature, including many references in this document, 
present different EC types with different junction patterns, such as HUVECs [27] and 
human lymphatic ECs (HLECs) [68]. Theoretically, the JAnaP could be expanded to 
any EC type to quantify their edge-localized junctions to study their basal presentation 




Additionally, while epithelial cells do not express VE-cadherin or claudin-5, 
they do express many other junction proteins. Therefore, the application of the JAnaP 
to quantify epithelial junctions also hold significant promise. One example in which 
changes in junction architecture plays a significant role in epithelial cells is in the 
context of cancer [304]. Decreased expression of cell-cell adhesion molecules, and the 
switch of cadherin protein expression from epithelial cadherin (E-cadherin) to neural 
cadherin (N-cadherin), are two signs of epithelial-to-mesenchymal transition (EMT) 
[29,305]. EMT is the process by which epithelial cells gain a migratory and invasive 
phenotype and as such, is implicated in tumor progression. Therefore, understanding 
the changes in junction presentation of various proteins known to be upregulated or 
downregulated in the context of EMT could enable a more comprehensive 
understanding of the mechanisms implicated in cancer progression. Targeting the 
molecules and pathways associated with altered cell-cell junctions could provide the 
opportunity for therapeutic treatment, diagnosis and prognosis of different epithelial-
derived cancer types [305].  
9.2 Junction Dynamics  
 Cell-cell junctions are not static in nature. Instead, they are extremely dynamic 
structures that exhibit with a great level of plasticity, enabling their regulation of 
cellular response and function in various physiological and pathological processes [27]. 
Even in confluent and stable ECs, junction proteins exist in a state of dynamic 
equilibrium, consistently shutting between the plasma membrane and intracellular 
compartments [23,306]. While the JAnaP has provided key insights into the phenotypic 




when comparing various experimental groups, expansion of this program to 
quantitatively capture the dynamic changes of junction patterns holds significant 
promise.  
 Preliminary studies of HBMEC junction dynamics have been performed using 
the JAnaP. Use of a VE-cadherin-GFP adenovirus (previously described [307], and 
generously gifted from Dr. William Luscinskas (Harvard Medical School)) in 
combination with fluorescence live-cell imaging (via 60x oil objective on an Olympus 
IX83 inverted microscope) has enabled the capture of time-lapse sequences of VE-
cadherin junctions (Figure 9.1.A.top row). Analysis with the JAnaP provided the 
visualization (Figure 9.1.A.bottom row) and quantitation of the cell morphology (e.g., 
area, Figure 9.1.B) and junction coverage for each phenotype (Figure 9.1.C) per cell 
overtime. This enabled the analysis of junction dynamics such as the fluctuations in 
presentation, where coverage changes were calculated as the absolute value of the 
junction coverage at t2 minus the junction coverage at t1 (Figure 9.1.D). Preliminary 
analysis suggests that the total coverage and continuous junction coverage fluctuates 
about 4-5% every 5 minutes. Since continuous junctions covered more of the cell edge, 
we also quantified the coverage change with respect to the junction coverage for each 
category to gauge the relative changes (Figure 9.1.E). This was calculated as the 
absolute value of the junction coverage at t2 minus the junction coverage at t1, divided 
by the junction coverage at t1. This analysis indicated that while the edge coverage by 
punctate and perpendicular junctions was only changing about 2-3% every 5 minutes, 
these changes were reflecting about a 30% change in the presentation of these patterns, 




are thought to be more stable and less dynamic than discontinuous junctions [15]. This 
example highlights the capabilities of using the JAnaP to study junctional protein 
dynamics. Expansion of this approach could enable further understanding of the 
dynamics associated with junction presentation at the basal level, and after exposure to 
various treatments that we have already shown to alter junction presentation in this 
dissertation (e.g., cAMP, blebbistatin, VEGF).   
 Future updates to the JAnaP could provide the opportunity for combination with 
other programs or tools to allow real-time multi-parametric data acquisition including 
junction phenotype. One such program could be the CellBorder Tracker (described in 
section 2.2.3), which currently tracks the edges of ECs within a monolayer over time 
for dynamic analysis [69]. Combining this capability with the JAnaP capability of 
phenotypic categorization and calculation could significantly streamline data collection 
and analysis. Additionally, use of the JAnaP in parallel with on-chip models with 
integrated TEER or permeability measurement, such as the systems described by 
Maherally et al., [205] and Genes et al., [59], could further permit not only real-time 
dynamic data acquisition, but also correlative evaluation of junction presentation and 
measurements of barrier integrity. Thus, the role of each junction presentation in barrier 






Figure 9.1 Dynamic VE-cadherin Junction Analysis. (A) The top row presents a few 
images from a time-lapse sequence of HBMECs transfected with VE-cadherin-GFP 
adenovirus. The bottom row depicts the corresponding image with the continuous 
(orange), punctate (purple) and perpendicular (yellow) junctions categorized by the 
JAnaP (scale bar = 20 μm). The cell area (B) and junction coverage (C) over time for the 
cell presented in (A). Images were collected every 5 minutes. (D) presents the change in 
junction coverage, taken as an absolute value for each junction category, while (E) 
presents the absolute junction change with respect to the junction presentation of that 
category. For D and E, N=49 where N is the number of time steps traced for the same cell 










9.3 Mechanical Cues 
 As described in Chapter 3, the mechanical cues of the cellular 
microenvironment can significantly affect EC behavior and function. As exemplified 
in Chapter 4, the alteration of junction protein presentation and localization can result 
from differences in subendothelial matrix stiffness. These, and most of the other 
experiments analyzed using the JAnaP, however, have been performed in static culture 
conditions. Thus, expanding the applications of the program to measure changes in 
junction patterning in response to various mechanical cues, especially those 
representing physiological and pathophysiological conditions, could provide further 
understanding of EC mechanobiology and mechanotransduction.  
 One example application for which the JAnaP could be used is to analyze 
images of ECs exposed to physiologic or pathological flow conditions using 
microfluidic devices such as those described in [139,225,308]. While increased 
junctional localization has been extensively previously described, the quantitative 
phenotypic analysis remains unknown. We would expect increased continuous 
junctions under physiological flows but that pathological shear would induce more 
discontinuous patterns. Particularly of interest would be the interplay of shear stress 
with additional cues such as substrate stiffness, [161] or astrocyte-conditioned medium, 
[308] which have been shown to alter EC behavior.  
Another mechanical cue that would interesting to study is cellular stretching, 
which has been previously used to model traumatic brain injury [78,196] According to 
Wen et al., TBI is a major cause of mortality and disability in young people and as 




involving TBI have shown decreased in junctional protein following the injury. As 
such, using the JAnaP to understand the time-course changes in junction presentation 
post-injury and how that affects the permeability and inflammatory responses could 
prove beneficial for mechanistic study to possibly inform therapies to combat this 
serious trauma.    
 Modification of the JAnaP to enable simultaneous analysis of cell angle (or 
chirality) [82] and junction angle [87] relative to flow would be another possibility for 
the future. These parameters have been described to influence junction presentation and 
barrier properties such as permeability. As such, correlating these parameters with 
junction patterns might help provide mechanistic insights into the mechanobiology 
influencing EC behavior under shear stress.  
9.4 Force Transduction  
 Tissues in the body are continuously undergoing rearrangement, regulated by 
tightly balanced mechanical forces between cells [309]. This force transduction is 
mediated by cell-cell adhesions and plays an integral role in the development, 
maintenance, and adaptation of various tissues. ZO-1 is thought to be a central regulator 
of actomyosin organization influencing cell-cell tension, migration, angiogenesis, and 
barrier formation by regulating the tension acting on VE-cadherin [14]. Similarly, 
vinculin is thought to control force-dependent remodeling by associating with VE-
cadherin in EC to modulate the pulling forces generated on focal adherens junctions 
via actomyosin contractility [54]. Several groups have therefore worked to quantify the 




systems with the JAnaP could reveal the tension associated with each junction 
phenotype and the subsequent influence on cell behavior and function.  
 For example, Conway et al., developed tension sensors to measure the 
mechanical tension across VE-cadherin and PECAM-1 using förster resonance energy 
transfer (FRET) [310]. Use of these sensors in bovine ECs and HUVECs showed that 
junctional VE-cadherin experienced significant myosin-dependent tension in static 
conditions, but that shear stress triggered a decrease in VE-cadherin tension but an 
increase in junctional PECAM-1 tension. In other examples, groups used a combination 
of computational and experimental methods to quantify force transmission. In other 
examples using epithelial cells, cell proliferation was found to be regulated by forces 
across cell-cell junctions [309,311]. These studies used E-cadherin tension sensors in 
combination with traction force imbalance measurements (described in [312]) to show 
that at the sub-cellular level, basal force fluctuations were coupled with E-cadherin 
localization, but at the multi-cellular level, force exchange across the cell-cell junctions 
was dependent on the cell position. Furthermore, cells with lower E-cadherin force 
showed less proliferation, a phenomenon that was also found to be modulated by cell 
position (and substrate stiffness).  
 Therefore, it would be interesting to not only correlate junction presentation 
with tension measurement, but also integrate mechanical cues such as fluid shear to 
probe the interplay of these parameters. Combining these techniques with the JAnaP 
could enable sub-cellular and multi-cellular study with temporal and spatial resolution 
to systematically investigate the complex regulation of the homeostasis of mechanical 




9.5 Transmigration of Cancer and Immune Cells 
 The infiltration of distal tissues by various cell types (e.g., cancer and immune 
cells) often requires the intravasation, and subsequent extravasation, of the vasculature.  
In Chapter 7, we described the incorporation of metastatic breast cancer cells into the 
brain endothelium; and the mechanisms used by different tumor cell types to cross 
various EC has previously been explored [228,265,313–316]. Additionally, the 
mechanisms involving neutrophil and leukocyte transendothelial migration have also 
been extensively studied [84,157,241,293,316–318]. Interestingly, many of the 
mechanisms implicated in the extravasation processes of the cells involved altered 
states of cellular contractility, where ECs become more contracted, and thus more 
permeable, in response to biochemical or biophysical cues exerted by the migratory 
cell type. In Chapter 6, we demonstrated the relation between cell contractility and 
junction presentation in HBMECs, showing increased discontinuous junctions in a 
contracted state. It would be interesting to perform live-cell imaging to visualize 
transmigration of different cell types across ECs with fluorescently-tagged junctions 
(e.g., via the VE-cadherin-GFP adenovirus described in section 9.2). Analysis of the 
captured images with the JAnaP could potentially provide information regarding 
junction presentation and transmigration location. It would be expected that the cells 
would permeate at sites of discontinuous junction, though in Chapter 5 we saw that not 
every discontinuous junction piece necessarily correlated with a permeable region. 
Therefore, performing these studies in conjunction with junction protein dynamics 
(section 9.2) to compare the rate-of-change of the junction patterns with the 




junctional changes in response to cancer cell conditioned medium in Chapter 7, it 
would also be interesting to study junctions and transmigration after pre-exposure to 
biochemical cues secreted by the transmigrating cells. Combination of these 
transmigration studies with other biologically relevant biochemical cues (e.g., 
astrocytes at the BBB) and/or mechanical cues (section 9.3) could help to understand 
the mechanisms and mechanobiology involved transendothelial migration in both 
health and disease.   
9.6 Quantitative Assessment for Drug Delivery  
 As explained in Chapters 1 and 2, the uniquely tight architecture of the BBB 
provides for tightly regulated transport control of substances into and out of the central 
nervous system. While this acts as a protective mechanism for the brain, it also acts as 
a barrier to the targeted delivery of therapeutics into the brain [199]. As such, 
significant effort has focused on the development of techniques to “open” the BBB for 
therapeutic delivery, including ultrasound,[197–199] photodynamic therapy,[200] and 
photothermal therapy [201]. Many of the methods in that literature describe disruption 
of the junctional protein structures to penetrate the barrier. Therefore, application of 
the JAnaP to compute a quantitative measure of the extent of junction disruption holds 
significant promise. For example, it could enable the development of dose-curves to 
understand the result of different doses of the respective treatment or penetration-
technique on the junctional changes regulating the extent of therapeutic delivery.  
 As one example, we have worked in collaboration with Dr. Huang Chiao 
Huang’s (University of Maryland) to study the effects of photodynamic therapy (PDT) 




treatment of glioblastoma. Glioblastoma is a brain cancer that remains extremely hard 
to treat, leading to an unfortunate median patient survival rate of less than 18 months 
[319]. PDT is a method that uses light-activated photosensitizers (PS) to induce tissue 
injury or cell death. This technique has shown great promise for BBB-disruption and 
as a treatment for glioblastoma, extending the survival time up to 3-18 months longer 
in patients suffering from this disease [320]. Light activation of the PS generates 
reactive oxygen species (ROS) which can inflict damage on subcellular organelles such 
as mitochondria and the endoplasmic reticulum, motivating its use in conjunction with 
current cancer treatments such as chemotherapy, radiation, and thermal ablation [321]. 
Importantly, there is significant potential for the translation of this approach, since the 
photosensitizers, which emit a fluorescent signal, are currently used clinically as an 
imaging agent for the fluorescence-guided resection of high-grade gliomas [322].  
 Here, we investigated the effect of PDT with benzoporphyrin derivative (BPD) 
as a PS on HBMEC junctions. BPD has shown promise in pancreatic tumor mouse 
models, [323] and has been shown to decrease the expression of claudin-5 and VE-
cadherin in peripheral ECs [324]. As expected, we observed decreased continuous VE-
cadherin and ZO-1 with increased PDT treatment time, corresponding to 0, 0.006, 
0.305, 0.61, and 1.22 J/cm2, respectively (Figure 9.2). This was accompanied by an 
increase in perpendicular junctions while punctate junctions remained unaffected. 
Increased PDT treatment was also shown to  increase permeability of HBMECs to 70 
kDa dextran and liposomes (data not shown), likely due to the altered junction 
presentations observed. Future studies will focus on the ability of PDT to modulate 





Figure 9.2 Photodynamic Therapy (PDT) of HBMEC Junctions. (A) Immuno-
fluorescence images of HBMECs exposed to increasing PDT treatment (time, in seconds) 
stained for ZO-1 (green), VE-cadherin (red), and DNA (blue). Edge presentation of 
continuous, punctate, and perpendicular ZO-1 (B-D, respectively) and VE-cadherin (E-
G, respectively). 105 ≤ N ≤ 195, where N is the number of cells collected over 3 trials. 
The Kruskal-Wallis test with a Dunn’s multiple comparison test was used to calculate 
significant differences for each parameter, where * p < 0.05, ** p < 0.01, *** p < 0.001, 
and **** p < 0.0001. (scale bar = 20 μm) The PDT treatment in this experiment was 
performed by Collin Inglut (Huang Lab).   
Figure 9.2 Photodynamic 




liposomes across the HBMEC barrier for delivery to glioma cells in the bottom well of 
a Transwell setup. The JAnaP provides useful information into the junctional changes 
in response to PDT treatment and can inform the doses selected for efficient drug 
delivery. The above example illustrates just one application of the JAnaP and highlights 
the potential for evaluating numerous other drug delivery systems involving BBB- (and 
other EC-barrier) penetration by junction modulation.     
9.7 In Vivo Study 
 While the applications of the JAnaP in this dissertation provide examples of the 
significant impact this program could have on the study of vascular endothelial cell-
cell junctions, these studies have been confined to in vitro lab cultures. To confirm the 
significance of different junction protein presentations and their impact on disease 
progression, it is imperative that we also perform studies in vivo. The two most 
commonly used in vivo models to study the vascular system are rodents and zebrafish. 
While both systems provide dynamic, real-time imaging capabilities, zebrafish offer 
the added benefits of being optically transparent and available at a low cost for high-
throughput studies [325]. Although both rodent and zebrafish models present varied 
homology for human application and require expertise for the respective animal/fish 
handling and maintenance, they do provide accurate evaluation of the complexity of 
vascular networks in vivo.   
 To visualize endothelial cells and their cell-cell junctions in mice and rats, 
fluorescence images of post-mortem extracted tissue is a common approach. 
Additionally, the isolation and reperfusion of vessels is also useful to study the 




approach enables treatment of the ex vivo vessels with various substances of interest, 
then subsequent assay or imaging to quantify or visualize changes in the barrier. JAnaP 
analysis could easily be integrated into this approach. While various live-imaging 
techniques such as positron emission tomography (PET), single-photon emission 
computed tomography (SPECT), and magnetic resonance imaging (MRI) enable the 
study of barrier transport properties, [325] their resolution for junction presentation 
visualization remains limited without invasive measures such as window placements. 
Nevertheless, thin window placement in conjunction with two-photon imaging has 
enabled the study of vascular permeability and transport properties, as well as the 
interaction of vessels with surrounding cell types. This approach offers the opportunity 
to visualize structural vascular parameters such as length and turnover of capillary 
segments, vascular network branch points, etc., [325,327,328]. 
 In zebrafish, the inherent optical transparency enables easy visualization 
without the need for intrusive techniques. Additionally, these fish can be transgenically 
modified to uniformly express fluorescently-labeled vasculature [329]. Because adult 
zebrafish possess a BBB that is surprisingly similar to humans, including tight junction 
protein (e.g., ZO-1, claudin-5) expressing ECs,[330] this model has been especially 
useful for in vivo study of the BBB. Furthermore, zebrafish have been used to study the 
extravasation dynamics of metastatic tumor cells [329], and more recently, junctional 
tension across VE-cadherin junctions using tension sensors [87]. Interestingly, use of 
the tension sensors indicated decreased tension and increased junction linearity in 
maturing junctions, determined by the age of the zebrafish. This study specifically 




of junction presentation to correlate junction patterns in vivo. Together these examples 
highlight the in vivo measurement capabilities associated with vascular structure and 
motivate the future evaluation of in vivo junction patterns using the JAnaP to confirm 
conclusions drawn from in vitro study.   
9.8 Outlook  
 It is seemingly clear that the cell-cell junctions of the endothelial and epithelial 
cells lining the structures of the human body play a significant role in health and disease 
by modulating several aspects of cellular function. Combining many of the current 
quantification techniques to measure cell function and junction presentation hold 
significant promise for the study of the mechanisms underpinning these processes. 
Future understanding of the molecules and pathways involved offers important 
potential for therapeutic targets to correct the dysregulation implicated in disease 
progression. Furthermore, the expanded study of junction phenotyping could possibly 
provide predictive capabilities for disease, in cases of, for example, melanoma where 
subtypes of cancer cells are distinguished by their intercellular contacts [331]. The 
work in this dissertation has motivated the quantification of junction patterns, 
developed a tool to perform this measurement, and applied this approach to study EC 
physiology and pathophysiology. The field will benefit from future evaluation of 
junction phenotypes for different junction proteins, in other EC systems, and in various 
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Image Requirements:  
 
1) Image resolution must be 1024 x 1024 pixels or 2048 x 2048 pixels. Record the 
resolution of your images.  
 
2) Record the image scale (i.e. pixels to µm conversion). This will be required in the 
“parameter” section for correct result calculations. 
 
3) Images must be in tiff format.  
 
4) When saving your images, consider naming the files in a consistent manner that 
includes the experimental conditions, the stain or fluorescence channel, the date, 
etc. These are all helpful as unique identifiers (i.e. “variants” or “dimensions”) for 
processing and organization via the JAnaP.     
 
5) Note that this program has been used and validated on images collected using a 
60x oil objective. Ensure your images are taken with enough magnification to 
clearly see the edge-localized junctions.    
 
Computer Requirements:  
 
1) This current version of the user guide is for use on PCs.   
 
Download Instructions:  
 
1) Navigate to the JAnaP repository on GitHub at https://github.com/StrokaLab/JAnaP  
2) Click “Clone or download” and select “Download ZIP” 
3) Unzip the contents of the repository: 
• Right click on the downloaded zip file and select “Extract All.”  
• Create Documents/GitHub folder on your PC and extract files to this location. 
 
4) On Windows, run the “setup.bat” file located in the bin folder. This will install 
Python 2.7 and all of the required packages.  
• If you use virtualenv you can find the requirements.txt file in the bin folder 
5) Run web application.py as described below 
 
Program Instructions:  
 
1) Open command prompt: 




• Type “cmd” and select the “Command Prompt” 
 
2) Within command prompt, navigate to folder containing “JAnaP-master”: 
• Within the command prompt type: cd Documents\GitHub\ JAnaP-master 
• Hit “Enter” then type: python web\application.py 
• Note: To stop the program, type “Ctrl+C” in the command prompt  
 
3) Open web browser and type “127.0.0.1:5000”. The following screen should load: 
 
4) Click “Create New Project” and when the following screen appears, type in the name 










• NOTE: If you click on “JAnaP” the home page will re-appear, and your project 
will now be listed in the “Current Projects” list. Click on the link to your project 
to return to the screen above. 
 
 
6) To load images into your project: 
•  Navigate to the “projects” folder within the “JAnaP-master” folder on your 
computer 
• Documents > GitHub > JAnaP-master > data > projects 
 
 
• Select your project folder (e.g., “example_project”) and navigate to the “images” 
folder 
• example_project > input > images 
 
 
• Drag and drop the images you would like included in your analysis into this 
folder. When you refresh your browser, your project should then reflect the total 
number of images added.  
• Here, 6 images were added into the example_project>input>images folder 






7) To select the cells of interest to be “waypointed” and analyzed, click “6 open task”: 
• Note: This “6” value will change depending on the number of images in the 
“Total Images Added” section, the total number of “open” versus “done” tasks, 
and the “Variants” identified (described below). 
 
 
8) The following screen should appear, where the tab selected is “Open” tasks and the 
number of images listed should reflect the “# open tasks” listed on the previous 
screen: 
 
9) Select “View Task” next to the image you would like to view and/or waypoint cells, 






10) Under the “Waypointing” tab, you can begin waypointing each cell using the 
instructions on the page.  
• NOTE: A mouse should be used for waypointing (i.e., a laptop trackpad will 
likely not work)   
• Hold “q” and click on a spot in the perimeter of a cell.  
• Move your cursor to another spot on the perimeter while holding “q” and the 
connecting path should appear. If you agree with the connecting path, click on 
that spot to add it as a waypoint. Otherwise, move your cursor around the cell 
perimeter until you agree with the automated path.  
• Continue seeding waypoints until the entire cell perimeter is traced.  
• Number of waypoints – This depends on the cell, the amount of junction 
presentation, and the quality of staining. If a cell has mostly continuous 
junctions and/or the edge of the cell is very distinct relative the background, less 
waypoints are likely required. Try seeding a waypoint and then trace the edge 
with your mouse holding “q” for as long as the path accurately follows the cell 
edge. Once it begins to deviate, move your mouse back closer to the last 
waypoint to seed a waypoint where the path is accurate.  
• Use your best judgement when deciding the location of the cell perimeter when 
little to no stain is present around the cell edge. More waypoints will likely be 
required in this region.  
• If you misplace a waypoint, click “c” to remove the last waypoint seeded. 
 
In the following image, the circled cell has been fully waypointed. The cell path has 
been traced in white, and a zoomed-in cropped image has been added to help show 







11) Click “Save Waypoints/Start New Cell” once the cell perimeter has been fully traced. 
 
12) The image will reappear with a rough tracing (i.e. lines connecting the waypoints) of 




13) To view or remove previously waypointed cells, click the “Review Cells” tab. The 




Here, you can click “show” to visualize the traced perimeter of each cell or click 
“Delete” to remove the waypoints associated with that cell.  
 
 
14) To navigate back to the “Tasks”, click “ Go Back to Task List” in the upper left 
corner. This will bring you to following screen: 
 
 
The remainder of the open tasks will be listed when the “Open” tab is selected, and 
the total tally should be reflected across the top of the page. Here, 5 images are still 
listed as open, but the one image that we have started is now listed as “In Progress”. 
When you click on the “In Progress” tab, all images that have been started will be 






15) To continue waypointing the cells in any image in the “Open” or “In Progress” tab, 
click “View Task” and repeat steps 10-12. 
 
• As an example, 3 cells have been traced here, each indicated by the blue 








16) Once all cells of interest in the image have been traced, navigate back to the 
“Waypointing” tab and click “Mark Image Complete” in the bottom right corner. The 






• The “Re-Open Image” button can be clicked if any adjustments are needed after 
the image has been marked as “complete”. “Re-opening” the image will allow 
you to continue waypointing new cells, or review or delete previously waypointed 
cells as described in step 14. 
• Note: If you re-open the image, be sure to “Mark Image Complete” once all 
changes have been made. “Open” images will not be processed, even if cells 
have been waypointed within that image.   
 
17) Click on the “ Go Back to Task List” link in the top left of the screen to bring you 




• In this example, the one image we have marked as complete is now registered as 
“Complete” and nothing is listed as “In Progress”. Select the “Done” tab to view 




• NOTE: Clicking “View Task” next to the image in the “Done” tab will bring you 
back to the screen in step 17 and allow you to re-open the image if needed.   
 
18) To navigate back to the project overview, click the “Input” button next to “Tasks” in 
the upper right corner. The “Overview” tab will appear and provide an updated count 
of the total images added, the percentage of the images marked as “Done”, and the 







19) Click the “Config” tab to add in the user-designated and project-specific input. The 





• Variant - The first option is to designate a “Variant Name”. Typically, this is 
used if you include more than one stain/channel of the same image. This allows 
you to waypoint a cell one time but analyze the junctions immunostained for 
different proteins using different secondary fluorophores. It requires that the same 
image name is used for the different filters/channels except for the specific 
designation of the different filter/channel. Note that the variant values must be 
written out within the image name.  
• In this case, the “Variant Name” could be something like “Stain” or “Filter”.  
• Each value of the variant (e.g., type of stain or filter, like GFP or TxRed) would 
then be typed in the “Add Value” field and “Add” would be clicked. These must 
be the specific designations that differentiate between the same images that 
otherwise have the same name. Be sure to check how it is written within the 




• The added values will appear under the “Primary Value” field and can be 




• Once you’ve added all variant values, you can then select a “Primary Value” 
which designates the channel you will perform the waypointing on. Then click 
“Save.” This will remove the other channels/stains/variant values from the 




images and will be applied to the other channels/values automatically for 
processing. 
 
I. Here, GFP has been selected as the “Primary Value”:  
 
 
• Once variants have been added, they will be included in the “Data Summary” 
tab along with the breakdown of image and cell counts within each variant 
value.  
 
In this example we have included 3 GFP images and 3 TxRed images, which is 
reflected in the “Image Count”. At this point, we have waypointed 3 cells in one 
GFP image. Those 3 cells are reflected in the “Cell Count” column. Since we 
added GFP and TxRed as variants, and selected GFP as the primary value, 
however, those 3 waypoints were also transferred to the TxRed counterparts of 
those GFP images, thus 3 cells are listed in the “Cell Count” column for that 




• Dimension - The next option is to designate “Dimensions” located in the 
“Config” tab under the “Variant” section. This allows you to designate different 
conditions, experiments, trial dates, etc. within this one project based on the 
image filenames, that will help ease data filtering/sorting for post-processing data 







• The following screen will appear and allow you to identify the name and type of 
dimension. Then click “Create”.  
I. The Dimension Name should be a descriptive title for the category you are 
sorting, for example, the name could be “Treatment Group” or “Date”, etc.  




• “Date Parse” - uses date within the filename or associated with the file to 
sort cells/files by date. If this is selected, click “create” and then select 
“Config” tab (clicking “create” auto-saves the Dimension) 
•  “String Match” - uses character strings within the filename to sort 
cells/files into the specific dimension category. If this is selected, click 
“create”, and the following screen will appear.  
• This is where the different groups within the specified category can 











• Here, a “Needle Token” is a phrase within the image title that will be 
used to sub-categorize the image and the “Map to Value” is the sub-
category to which you would like it assigned.  
• Needle Tokens: 
• Type in the phrase and then hit “Enter” or “Shift + Enter” to 
register it in the needle token field 
• Several needle tokens can be associated with one “Map to 
Value”. This is particularly helpful if there are differences in 
naming schemes between different dates or trials. 
• Note that the Needle Tokens are case and space sensitive so 
they must exactly match the phrase within the image title.   
• Importantly, the algorithm cycles through the list of needle 
tokens and assigns the filename to the “Map to Value” 
associated with the first “Needle Token” found within the 
filename. Therefore, start with the most specific “Needle 
Tokens” first on the list. 
• Map to Value: 
• This will be the sub-category listed next to the cells/images in 
the output, so use something that allows for easy “filtering” or 
“sorting” in the spreadsheet 
• This phrase must be at least 5 characters long, so if needed, 
add spaces between each letter to increase the total phrase 
character length 
• Click “Save” 
• To add more sub-categories, click “Add Row” and repeat the 
above steps to enter in each sub-category needed  
 






• We want to group this image into a sub-category called “1 kPa 
Supp” so we assign the “Needle Token” as “1 kPa + Supp” and the 




• Now, all images with “1 kPa + Supp” in the filename will be sub-
categorized to “1 kPa Supp” in the output excel spreadsheet.  
• Say, though, that for some of the images, the naming scheme was 
altered such that some of the files were instead missing a space 
between a few or all the phrases in the needle token (e.g., 160503 
1kPa+Supp 60x_Multichannel_20160503_05 – GFP Deck-
1.vsi.tif, or 160503 1kPa +Supp 60x_Multichannel_20160503_05 
– GFP Deck-1.vsi.tif). You still want them to be sub-categorized as 
“1 kPa Supp” since they are the same condition, but the needle 
tokens don’t exactly match the phrases in the filename to be 
accurately sub-categorized. Therefore, you would add each 
different naming structure in as a needle token, all to the same 




• Now, in this example, we also have a condition on 1 kPa without 








• We type in “1 kPa” as a “Needle Token” and as a “Map to Value”. 
Since perhaps the naming scheme was also an issue here, we also 




• Importantly: We added 1 kPa + Supp first before 1 kPa since the 
program cycles through the list of needle tokens in order and 
assigned the image to the first sub-category to which it fits. Since 
“1 kPa” is included in the image names containing “1 kPa + Supp”, 
all images would have been assigned to the “1 kPa” Map to Value 
if it were listed first. As written, the image name must meet the 
first criteria (e.g., include 1 kPa + Supp) otherwise it will be 
grouped a “1 kPa”. 
 
---------- End Example 
 
• Once all Dimensions have been put in and saved, you can navigate to the 




“Variants” and the “Dimensions” and the respective Image and Cell 




• Here, the counts still reflect the 3 cells in the 1 image that has been 
marked complete plus the TxRed counterpart based on the variants identified.  
 
• Parameters - The next option on the “Config” tab (below “Variant” and 








I. disk_element_size – this allows the user to define the size of the disk used 
for the tophat filter. The default is a disk size of 5 and should only be 
changed in specific circumstances.  
II. filter_intensity_cutoff – this defines the intensity threshold value used to 
differentiate between regions of junction and no junction. This value should 
be determined for each project (using the python notebook described below) 
but a good starting point is 15 for GFP images and 5 for TxRed images with 
low levels of background. See the bottom section “Jupyter Notebook” for 
how to check the appropriate threshold values for your project.  
III. image_filter_type – this defines which color channels are included in the 
analysis where the three numbers represent RGB. The default is 111 which 
keeps full RGB images in the analysis and should only be changed in 
specific circumstances.  
IV. image_scale – this defines the conversion from pixel to microns so that the 
results are reported in terms of microns. The input values are based on 
image size and put in units of micron per pixel. This value should be 
changed for each project depending on the objective and camera used for 
image collection and the resolution of the images.  
• NOTE: The default values reflect the Stroka Lab IX83 microscope using 
the 60x oil objective for 1024 x 1024 and 2048 x 2048-pixel images 
Note that a * indicates the default value applied to all images. There is a 
dropdown menu next to each variable that allows the user the designate a 
specific variable for each type/category of image. The “Delete”, “Add”, “Save” 







20) Click save in the bottom left hand corner of the Config tab to save any changes 
 
21) To check if there are any issues with the uploaded images based on the 
configurations set up in the Config tab, scroll up to the top of the “Input” screen 
and click on the “Problems Tab” indicated below 
 
 
If no problems exist, the “Problems” tab will be blank as below:   
 
 
If a problem is present, it will be listed under “Summary” with an explanation of 




• Here, two variants were added to the configuration (i.e., GFP and TxRed) 
but no images with TxRed in the filename were uploaded into the program. 
This could be because those images were accidentally skipped when 




filenames. Note: variants must be an exact match to the filename (e.g., 
Texas Red in the filename will not be included with the TxRed variant).  
 As problems are fixed, they will be removed from this list on the Problems tab.  
 
22) Click on the Tasks tab button in the top right of the project to check your 
waypointing progress on based on any changes to your configuration. Note that 
the number of images requiring waypoints will decrease depending on the number 
of variants you include (e.g., only half of the images will be listed, if two variants 




Complete the waypointing process for all images in the “Open” and “In Progress” 
tabs until the counters read “0” for each and the “Complete” count matches the 
















• The categories listed on this tab indicate each group of calculations to be 
processed by the program: 
• Image Data: processes the images as described 
• Trace: traces the outline of each cell to generate the cell path & perimeter 
• Shape Factor: uses trace data to calculate shape factors of each cell (e.g., 
area, circularity, solidity) 
o Note: a variant must be included for the shape factors to process. If 
a variant is not needed for your specific application, simply add 
something that is included in every image title as a placeholder 
variant and select it as the primary value.   
• Fast Class: categorizes junctions into continuous, punctate and 
perpendicular 
• Junction Class: generates more detailed calculations for the junctions in 
Fast Class, such as the start and end index, length, aspect ratio, tip-to-tip 





25) To process the images, navigate to the “System” page by clicking on the 
“System” tab: 
 
• Here, you will find the categories described on the “Overview” page listed to 
control which groups are being processed at any time. 
 
• Note: The denominator of the counters (e.g., 0/18) indicates the total number 
of cells to be analyzed except for “imdata” which indicates the total number of 
images to be analyzed. Here, we have 6 total images (3 GFP and 3 TxRed) 
which included 18 total cells (9 from GFP and 9 from TxRed).  
 
26) To begin processing the cells, change the “Is Active” column to “True” using the 
drop-down menu for each category you would like to process and click “Save 






• To speed up the processing time, open a new command prompt and navigate 
to the project folder (as in step 1).  
• Within the command prompt, type cd Documents\GitHub\JAnaP-master 
• Hit “Enter” then type: python web\fast-worker.py 
• Note: To stop the fast worker application, type “Ctrl+C” in the 
command prompt 
 
• Reload the window in your browser at any time to check the progress of the 
run. The counter will update to show how many images/cells have been 
processed out of the total. Below is an example where all the cells have been 







• To continue processing the other categories, change the “Is Active” status 
to “True” for the other categories. Since the run is complete for the “trace” 




• Note that you can switch all columns to “True” if you would like to leave 
the program alone to run for a long period of time (e.g., overnight). The 
first four categories are all required to generate the categorization 




The jclass takes much longer to process, so only switch this to “True” if 
you specifically need the data generated in that separate spreadsheet.  




27) Click on the “Results” button in the top right corner of the project page to 
generate the excel files for export. The following screen will load: 
 
 
28) Click on “Generate New File” for any of the files types to generate that 
spreadsheet at any point in the processing period. The details of each category are 
discussed in the next step.   
• Once the button has been pushed, the page will read “File processing is 






• After a few minutes, the file link will appear under the category header or the 
page can be re-loaded to load the file link.  
• Clicking on the link will download the file which will be opened as an 
excel spreadsheet.  
• Note that the name indicates the category of the file (e.g., 
“cell_data_v2), and the numbers indicated the date and time when the 
file was generated (e.g., 20190606071019 means the file was generated 




• A new file can be generated at any point by re-clicking on the blue “Generate 
New File” button. If so, a new file will appear with the appropriate date/time 







29) The spreadsheet categories are as follows: 
• Cell data: This provides the shape factors and junction presentation 
percentages for every cell waypointed within the project 
• File Name: The name of the image in which the specific cell is located in 
• File Root: The base name of the image (e.g., TxRed or GFP identifier 
removed) 
• Variant Columns: A column will be generated for each variant and 
dimension added in the configurations tab. Here, stain: GFP or TxRed, 
was added as the variant and date and Condition: 1 kPa + Supp, 5 kPa + 
Supp, and 280 kPa, were added as dimensions. This allows for easy 
filtering within the spreadsheet to groups results by the various sub-
dimensions.  
• Cell ID & Cell Number: This is the unique identifier assigned to each cell. 
It consists of the file/image name and the center coordinates of the 
waypoints. The center coordinates will be the same for every cell sharing 
the same waypoints (i.e., the same cell with more than one variant or stain) 
such that the difference in the Cell ID only lies in the image name 
differentiating it between variants.  
• Image Height: The height of the image in pixels calculated by the “Image 
Data”  
• Image Width : The width of the image in pixels calculated by the “Image 
Data”  
• Perimeter Count: The perimeter of the cell based on counted pixels 
• Perimeter Calc: The perimeter of the cell that accounts for pixel diagonals 
since cells are round objects not solely composed of linear edges  
• Perimeter (μm): The perimeter calc value converted to μm based on the 
conversion designated in the configuration tab for that image size 
• Area: The cell area (pixels2) calculated using the same correction for pixel 
diagonals as in perimeter calc 
• Area (μm2): The cell area converted to μm based on the conversion 




• Solidity: Calculated using the formula: (𝑐𝑐𝑎𝑎𝑐𝑐𝑐𝑐 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎) (𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑎𝑎𝑐𝑐 ℎ𝑢𝑢𝑐𝑐𝑐𝑐 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎)⁄  
as a measure of how solid the cell is. A value of 1 indicates a completely 
solid shape while a lower value indicates more protrusive features.  
• Circularity: Calculated using the formula: 4𝜋𝜋(𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎) 𝑝𝑝𝑎𝑎𝑎𝑎𝑝𝑝𝑝𝑝𝑎𝑎𝑝𝑝𝑎𝑎𝑎𝑎2⁄  as a 
measure of how close the cell is to a perfect circle. A value of 1 indicates a 
perfect circle while a lower value indicates a more oblong or protrusive 
shape.    
• Convex Area: Calculated using the Shoelace Method through the Scipy 
library and used to calculate solidity.  
• Hull Aspect Ratio: The inverse aspect ratio of the cell calculated by taking 
the minor axis of the cell divided by the major axis of the cell. The axes 
are determined based on an ellipse fit to the convex hull. 
• Coverage (%): The percent of the cell perimeter presenting junction. 
• Continuous (%): The percent of the cell perimeter presenting continuous 
junction. 
• Punct (%): The percent of the cell perimeter presenting punctate junction. 
• Perp (%): The percent of the cell perimeter presenting perpendicular 
junction. 
• Discontinuous (%): The percent of the cell perimeter presenting punctate 
and perpendicular junction. 
 
 
• Junction Data: This provides additional junction detail for that calculated in 
“Cell Data” generated in spreadsheets by variant (Here, one for GFP and one 
for TxRed). 
• Note that if you do not “run” the “jclass” job, the spreadsheets will 







• File Name, Variant Columns, Cell ID: All the same as in “Cell Data” 
spreadsheet  
• Path Start: Counter around the cell path indicating where junction piece 
begins, determined by the first waypoint seeded and continues in the 
direction of waypoint seeding around the cell 
• Path End: Counter around the cell path indicating where junction piece 
ends 
• Segment Length: Length (in pixels) that the junction piece coincides with 
the cell path 
• Path AR Length: Length of the segment taking into account square-roots 
for pixel diagonals since the segments are not solely composed of linear 
edges (similar to perimeter count versus perimeter calc as described in the 
above section).  
• Abs Tip Dist: Measure of junction thickness or maximum protrusion 
radially from cell path. 
• Relative Path AR: Calculated by dividing “Abs Tip Dist” by “Path AR 
Length”, used to determine whether a discontinuous junction is 
perpendicular or punctate 
• Classification: Category to which junction piece is designated – 
Continuous, Perpendicular or Punctate 
• Classification Simple: Simplified category to which junction piece is 






30) All the data generated using the GUI is saved in the GitHub project folder: 
• Documents > GitHub > JAnaP-master > data > projects > *your project*: 
• Artifacts – This includes all the raw files generated for each cell during the 
waypointing process and the information calculated during the run 
process.   
• Input – input images of the cells you placed here in step 6 
• Output – this is where all the excel spreadsheets that you generate in step 
28 & 29 are stored 
• System – this stores the system information and logs of any problems 
during processing 
 
31) The program can be re-run (e.g., with different parameters) at any time: 
• To do this, the artifacts need to be deleted from the individual folders within 
the artifacts folder described above. This will register in the GUI and reset the 
counters in step 26 to “0”.  
• *Important* DO NOT DELETE THE WAYPOINTS FOLDER (unless the 
waypoints specifically need to be re-done for the project). This will remove 
the saved waypoint information and require the entire waypoint process to 
be performed again. If you leave the waypoints, the cell IDs will remain, 
and the calculations will be re-calculated based on the parameters in the 
configurations tab at that time. 
• Be sure you save the original artifacts folders and/or excel spreadsheets of 
the original data in case you need to reference back, as well as the 
configuration data used to generate them (saved in the _project.config.json 
file within the project folder). The results will be saved over and the excel 







Jupyter Notebook:  
This notebook allows you to identify threshold values for use in JAnaP processing and 
generate figures based on the calculated data. The following instructions provide 
guidance on how to work through the notebook as it is currently written. Note that at any 
time, the notebook can be copied and re-saved using a different name for future reference 
or to make changes to the graphing or calculations themselves.  
A. First time use/install: 
1. Open a command prompt 
2. Right click and select “Run as Admin.” 
3. Type in “Pip install jupyter” 
 
B. Subsequent Usage: 
1. In a new command prompt, navigate to folder containing “JAnaP-master” then 
type jupyter notebook. For example: 
• cmd > cd Documents\GitHub\ JAnaP-master\ 
• cmd > jupyter notebook 
 
2. The web page will open and look like the following:  
 
 











5. Click on the first box and type in the specified parameters (e.g., project name, 




• Note: If you don’t know the cell index, you can continue through step 6 to 
view an annotated image of the waypointed cells to help identify which 
cell you would like to view moving forward. If you decide to change the 
cell index in box 1, simply rerun that box and subsequent boxes by 
selecting them and hitting Ctrl+Enter. 
• Note: If you change any parameters in any box after Ctrl+Enter has been 
hit, you must re-run box 2 prior to re-running the box of interest for the 
modified image to appear. 
• Note: What you type for “project_name” in the Thresholding notebook 
must exactly match the project name created in the JAnaP web interface. 
 
6. Click on the next two boxes and hit Ctrl+Enter to run each. After the 3rd box, your 





• Note: the following tool bar will appear below each image.  
o Selecting the square button will allow you to select an area within the 
image to zoom-in on  
 
o Click the “home” button to return to the original image at any point 
 
 




o To save the image, you must insert the following line at the bottom of 
the cell that generated the image:  
cv2.imwrite(output_prefix + ‘TitleYouWantImageSavedAs.png’, input_image) 
• input_image is the plot generated in this box. This can be 
substituted in subsequent cells for the plot generated within 
that cell (e.g., in the 6th box it would be “plotter”).  
• Adding a # symbol in front of this line will comment out the 
command if you would like to run the cell without saving the 
image but keeping the command there for future use.  
 
7. Click Ctrl+Enter in the 4th box for the center coordinates of the specified cell 










• The crop level of the image can be adjusted by changing the following 
values (decreasing the number provides a “tighter” crop). Note that this 




9. To identify the optimal threshold value, enter a value next to “Threshold” and 
click Ctrl+Enter in the 6th box. Repeat this process, adjusting the threshold as 
necessary to reflect the isolated junctions as you would expect. Note that 
increasing the threshold isolates less junction while decreasing the threshold 






• NOTE: Repeat this step for several cells to determine the optimal 
threshold value for the images within your experiment. Be sure to 
determine the optimal threshold level for each variant (e.g., GFP and 
TxRed stain). 
• The optimal threshold value(s) can now be used as parameter inputs in the 
“Config” tab of the GUI prior to processing the code in step 25.   
 









11. Clicking Ctrl+Enter in the next two boxes will generate the following images 
























• Here, the continuous junctions are colored in blue, the punctate junctions are 
colored in magenta, and the perpendicular junctions are colored in light blue. 
These colors can be changed by modifying the RBG values specified in following 










• The images will be saved in the project docs folder:  
Documents\GitHub\JAnaP-master\docs 
• Adding the # back in as shown on the left will prevent further images from 
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